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ABSTRACT 
 
 
SNAMA is the Drosophila melanogaster homologue of a group of proteins that are 
known to bind p53 and the retinoblastoma protein (Rb). This multi domain protein 
consists of a conserved N-terminal domain called Domain With No Name (DWNN), 
a zinc finger, a cysteine rich RING finger-like domain, a probable p53 binding 
region, and a glutamic acid-rich and lysine-rich region. These associated domains 
indicate that SNAMA plays an important regulatory role in the cell and may function 
in RNA processing and in apoptosis.  
 
The DWNN domain was first identified in Cytotoxic T-cell resistant Chinese hamster 
ovary (CHO) cells using promoter trap mutagenesis to screen for genes involved in 
apoptosis. Subsequently, this domain was identified in other eukaryotic organisms 
including animals and plants.  
 
The SNAMA transcriptional unit consists of  9 exons and 8 introns that code for a 
1231 amino acid protein with the 76 residue N-terminal DWNN domain. The DWNN 
domain has a 23.5% sequence identity to the ubiquitin protein and a predicted folded 
structure similar to ubiquitin. Western blots identified multiple bands indicative of 
ubiquitin tagged proteins. Taken together this suggests a role in the ubiquitin pathway 
either as an ubiquitin domain protein or the DWNN domain of SNAMA tagging other 
proteins. The cysteine rich RING finger-like domain has a histidine to serine 
substitution at the fourth position of the putative RING finger and represents a 
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distinct class of RING finger-like proteins that could have ubiquitin ligase activity. 
Northern blot analysis identified a single 4.6 kbp transcript expressed abundantly 
throughout development early in embryogenesis but reduced in older embryos and in 
adult male and females. SNAMA probably interacts with Dmp53 as a suppressor of 
apoptosis or a negative regulator of an activator of apoptosis. It is a vital gene 
required for development, as the mutant P-element insertion line in which the P-
element is inserted in the first intron of SNAMA is lethal when homozygous. 
Acridine orange staining of these mutant flies showed a direct correlation between the 
presence of SNAMA and apoptosis. An increase in the levels of apoptosis occurred in 
embryos with relatively low levels of SNAMA expression. The mode of this action is 
either direct, or via other proteins that are involved in the apoptotic pathway. 
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1. INTRODUCTION 
 
Throughout the last century, Drosophila melanogaster has been the workhorse for 
genetic studies in eukaryotes. Due to its elaborate genetics and the availability of 
many techniques that facilitate genetic manipulations, the fruit fly is one of the 
preferred models for studying developmental and molecular biology. Two processes 
that are important for the development and immune protection of organisms are 
apoptosis and the ubiquitin-proteasome pathways. These processes play major roles 
in a variety of basic pathways during cell life and death as well as in health and 
disease. Defects in these processes have been implicated in the pathogenesis of many 
diseases, cancer, allergy and autoimmunity. Characterisation of novel genes in the 
apoptosis and ubiquitin protein degradation pathways identifies potential drug targets 
to develop therapeutic agents for the treatment of diseased conditions. 
 
The focus of this thesis is to investigate the functional role of a previously 
unidentified D. melanogaster protein named SNAMA (Xhosa word meaning 
“sticky”). SNAMA is the D. melanogaster homologue of a group of proteins with a 
highly conserved N-terminal domain named DWNN (domain with no name). The 
novel DWNN domain has a three-dimensional structure similar to that of ubiquitin 
and it is likely that proteins bearing this domain play a role similar to ubiquitin.  The 
DWNN proteins were identified in a mutational study on Chinese hamster ovary cells 
(CHO). Genes were disrupted in CHO cells and screened for resistance to apoptosis 
 3 
causing agents. Based on the initial screening experiments that identified DWNN-
domain containing proteins and the ubiquitin-like fold of the DWNN domain it is 
likely that this group of proteins plays a role in apoptosis.  This thesis investigates the 
role of SNAMA in apoptosis, and whether SNAMA acts in an ubiquitin-like manner. 
This chapter presents a review of the components of the apoptotic pathway and the 
ubiquitin proteolytic protein degradation pathway. Attention will be focused on the 
apoptotic-signalling pathway involving p53 and the ubiquitin-like proteins and their 
roles.  
 
1.1 GENES INVOLVED IN PROGRAMMED CELL DEATH 
 
Programmed cell death (PCD) is a normal physiological process of cellular suicide 
essential for maintaining homeostasis. The process is essential for the removal of 
unwanted cells during tissue modelling in development and to maintain a stable 
balance between proliferation of normal cells and non-inflammatory death of 
damaged cells. Two types of programmed cell death have been reported: apoptosis 
and autophagy. The morphological features of apoptosis are cell shrinkage, 
accompanied by membrane blebbing resulting in separation of the cell into a cluster 
of membrane – bound bodies, nuclear and cytoplasmic condensation and DNA 
fragmentation. Autophagy involves the destruction of entire tissues and the presence 
of autophagic vacuoles.  
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The genes involved in apoptosis were first identified in Caenorhabditis elegans 
(Fraser, 1999). These genes were Ced-3 (a cysteine protease/caspase), Ced-4 
(involved in caspase activation), Ced-9 (an inhibitor of apoptosis) and Egl-1 (a BH3 
domain-only protein which induced apoptosis by binding Ced-9) (Meier and Evan, 
1998). Structural or functional homologues of these genes have been found in 
mammals and D. melanogaster (Bangs and White, 2000) indicating that the core 
components of PCD are highly conserved. Higher organisms show a greater degree of 
complexity in the regulatory mechanisms of programmed cell death. D. melanogaster 
provides a system of intermediate complexity between C. elegans and mammals in 
which to study PCD (Meier et al., 2000).  
 
1.2 Drosophila melanogaster CELL DEATH GENES 
 
The first PCD genes identified in D. melanogaster were the death activator genes of 
the intrinsic pathway reaper (White et al., 1994), hid (head involution 
defect/Wrinkled) (Grether et al., 1995) and grim which cooperate to mediate PCD in 
the embryo (Chen et al., 1996b). These three genes are found at position 75C on 
chromosome three (Haining et al., 1999; Igaki et al., 2000) and all share a similar 14-
amino-acid sequence at their N-terminus called the RHG motif (Wing et al., 1998). 
When the combined activity of Rpr, Hid and Grim in a cell exceeds a set threshold, 
caspases are activated and the cell undergoes apoptosis (Nordstrom and Abrams, 
2000). The human functional homologue of Rpr, Hid or Grim is the apoptosis inducer 
Smac/Diablo (DeLaurenzi and Melino, 2000; Du et al., 2000).  
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Reaper (Rpr) encodes a 65 residue cytoplasmic protein with no known homologues. 
Rpr promotes Bcl2-suppressible apoptotic activity in Xenopus egg extracts (Evans et 
al., 1997). The Rpr-induced activity is mediated by Scythe, the Xenopus protein 
containing a ubiquitin-like domain near the N-terminus (Thress et al., 1998). This 
suggests that a Scythe-like Drosophila orthologue may be an important transducer of 
the Rpr signal (Abrams, 1999). A D. melanogaster Scythe homologue has not yet 
been identified. Two pathways have been identified that activate Rpr expression; the 
steroid hormone ecdysone (Jiang et al., 2000) and the D. melanogaster homologue of 
p53, Dmp53, which acts through a p53-response element within the upstream 
regulatory region of Rpr (Brodsky et al., 2000; Ollmann et al., 2000). 
 
The predicted Hid gene product is a 410 amino acid protein rich in serine and proline. 
It is found both in cells undergoing apoptosis and in those that do not ultimately die. 
Expression of D. melanogaster Hid in mammalian cells induces apoptosis (Haining et 
al., 1999). The activity of Hid is controlled by growth factors acting via the 
Ras/Raf/MAPK pathway. Activation of these pathways promotes the down regulation 
of Hid expression resulting in suppression of Hid-induced killing (Kurada and White, 
1998; Bergmann et al., 1998).   
 
The third gene identified, Grim, maps between Rpr and Hid. The deduced open 
reading frame of Grim encodes a protein of 138 amino acids. Grim expression is 
developmentally controlled and regulated by mechanisms similar to Rpr expression 
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(Chen et al., 1996b). Grim initiates apoptosis, even when expression of Rpr is not 
able to, indicating distinct regulators and/or effectors of this gene. 
 
1.3 THE ROLE OF CASPASES IN APOPTOSIS 
 
The caspases exist as large inactive precursors (called procaspases) of between 20 to 
30 kDa that contain three domains: an NH2–terminal domain, a large subunit (~20 
kDa), and a small subunit (~10 kDa) (Thornberry and Lazebnik, 1998). Activation 
involves cleavage at aspartic acid residues by either another caspase, or by 
autocatalysis (Nicholson, 1999), followed by the association of the large and small 
subunits to form a heterodimer. The binding of cofactors or the removal of inhibitors 
from the procaspase triggers this cleavage. In apoptosis, caspases are activated in an 
amplifying proteolytic cascade, cleaving one another in sequence resulting in an 
exponential rate of activation that ensures the protease can be functional quickly 
(Raff, 1998). There are seven caspases in D. melanogaster named Dcp-1, Dredd/Dcp-
2, Drice, Dronc, Decay, Strica/Dream and Damm/Daydream. These have been 
reviewed in (Kumar and Doumanis, 2000). 
 
Caspases have been divided into two classes. The class I caspases (initiator caspases) 
contain long prodomains comprised of two subunits and the class II caspases (effector 
caspases) either lack this prodomain or have very short prodomains (Thornberry and 
Lazebnik, 1998; Nicholson, 1999; Kumar, 1999; Kumar and Colussi, 1999). The long 
prodomain of class I caspases contains two types of domains: the caspase recruitment 
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domain (CARD) or the death effector domain (DED) (Aravind et al., 1999). In 
mammals, the CARD of caspase-9 is required for the recruitment of procaspase-9 by 
Apaf-1 via a N-terminal CARD domain on Apaf-1 (Li et al., 1997; Zou et al., 1999). 
One of the two DEDs of caspase-8 interacts with the DED in the adaptor protein 
FADD (Fas-associated death domain) (Aravind et al., 1999). The recruitment of the 
procaspases with their adaptors is essential for promoting autocatalytic activation.  
 
D. melanogaster Dredd, Dronc and Strica are class I caspases with long prodomains. 
Dredd contains two DEDs in the prodomain region and Dronc has a CARD (Chen et 
al., 1998; Inohara et al., 1997; Dorstyn et al., 1999). Strica has a unique 
Serine/Threonine-rich domain at its N-terminus and lacks any DED or CARD. The 
function of the Serine/Threonine domain is not yet known (Doumanis et al., 2001). 
Dcp-1, Drice, Decay and Damm are similar to the mammalian class II effector 
caspases lacking the long prodomains (Kumar, 1999). The caspases are required for 
Rpr, Grim and Hid cell killing.  
 
1.4 REGULATORS OF PROGRAMMED CELL DEATH 
 
In mammals, apoptosis is regulated by the adaptor protein Apaf-1 which is required 
for caspase-9 activation (Zou et al., 1999). The activation of caspase-9 requires the 
release of cytochrome c from the mitochondria (Green and Reed, 1998). Cytochrome 
c binds to a specific region at the C-terminal end of Apaf-1 called the WD-40 repeats. 
The WD-40 repeats inhibit Apaf-1 function and cytochrome c binding thus initiates 
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the oligomerisation of Apaf-1 molecules (Li et al., 1997; Zou et al., 1999). Apaf-1 
then recruits procaspase-9 resulting in the proximity-induced autocatalytic activation 
of the caspase. The D. melanogaster homologue of Apaf-1 is Dark/Dapaf-1/Hac-1 
(Kanuka et al., 1999; Rodriguez et al., 1999; Zhou et al., 1999a). This protein is 
referred to as Apaf-1-related killer (Ark) in the D. melanogaster online database 
(http://flybase.bio.indiana.edu/genes/). Dark binds to the initiator caspases, Dredd and 
Dronc, through their N-terminal domains. These caspases are cleaved to the active 
form to activate apoptosis. There are conflicting reports about the binding ability of 
Dark to the executioner caspase Drice (Kanuka et al., 1999; Rodriguez et al., 1999).  
Dark has a WD-40 domain region at the C-terminal end which binds cytochrome c, 
but it is not known whether Dark requires cytochrome c for its oligomerisation. The 
specific role of Dark in Rpr, Hid and Grim mediated PCD is not clear, but there is 
evidence that Dark expression affects Rpr, Hid and Grim mediated PCD. 
 
Another class of regulators of PCD in mammals is the Bcl-2 family of proteins (Raff, 
1998). Fifteen Bcl-2 family members have been identified. Members of this family 
include Bcl-2, Bcl-xL and Bcl-w that suppress apoptosis, while Bax, Bad, Bid and 
Bok promote cell death (Adams and Cory, 1998). A BH4 domain is found 
exclusively on the anti-apoptotic Bcl-2 family members. The Bcl-2 gene product 
regulates apoptosis in several ways (Merry and Korsmeyer, 1997). They either bind 
to the Ced-4-like adaptor protein blocking their ability to activate procaspase-9, or 
they bind to the apoptosis promoters inhibiting their function. Many proteins of the 
Bcl-2 family have a hydrophobic tail that enables them to bind to the outer membrane 
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of the mitochondria, the endoplasmic reticulum and the nucleus, and are thought to 
function mainly on these organelles (Raff, 1998). Debcl/dBorg-1/dRob-1 and 
Buffy/dBorg-2 are D. melanogaster homologues of Bcl-2 (Igaki et al., 2000; Chen 
and Abrams, 2000). Both these proteins have the BH1, BH2, BH3 and C-terminal 
transmembrane domains of the Bcl-2 family of proteins, but lack the BH4 domain 
present on anti-apoptotic Bcl-2 proteins. Debcl and Buffy are related to the pro-
apoptotic Bok (Richardson and Kumar, 2002). Deblc expression promoted increased 
apoptosis indicating a pro-apoptotic function in different embryonic developmental 
stages (Colussi et al., 2000). In contrast, despite the absence of the BH4 domain, 
Buffy was found to function as an anti-apoptotic factor (Quinn et al., 2003). 
 
The inhibitors of apoptosis proteins (IAPs) regulate apoptosis by binding caspases 
thereby inhibiting their function (Goyal, 2001). All IAPs have one or more BIR 
motifs (baculovirus inhibitor of apoptosis type repeats) essential for their anti-
apoptotic activity, while other IAPs have been found to have in addition a C-terminal 
RING finger domain (Clem and Duckett, 1997). Two D. melanogaster IAP 
homologues have been reported, Diap1/thread and Diap2 (Hay, 2000). Diap1 
functions to inhibit the caspases Dcp-1, Drice and Dronc by blocking the activation of 
these proteins. Rpr, Hid and Grim promote apoptosis by disrupting the Diap1-caspase 
interaction (Goyal et al., 2000; Wang et al., 1999). Binding of Diaps to Rpr, Hid and 
Grim occurs via a homologous N-terminal region. This region of homology is found 
in mammalian Smac/Diablo which functions similar to Rpr, Hid or Grim. However, it 
has been shown that the IAP-binding domain of Smac/Diablo is not required for pro-
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apoptotic activity (Roberts et al., 2001). This data suggest that Smac/Diablo-induced 
cell death is independent of IAPs. It has also been suggested that Grim-induced cell 
death is independent of Diap and caspases (Wing et al., 2001). Functional mapping 
studies suggest that IAPs function by simultaneously preventing binding of Rpr, Hid 
and Grim to their downstream effectors while also blocking caspase function (Vucic 
et al., 1998; Vucic et al., 1997; Chen et al., 1996a). 
 
1.5 SIGNALLING PATHWAYS IN PROGRAMMED CELL DEATH       
 
One of the PCD signalling pathways in mammals involves a protein called Fadd. The 
D. melanogaster homologue of Fadd has been named Drosophila Fadd (dFadd). 
dFadd contains a death domain similar to the mammalian Fadd death domain. It also 
has the death-inducing domain found in the caspase Dredd. In vitro studies have 
indicated the binding of dFadd to Dredd through the death-inducing domain, which 
activates the death-inducing activity of Dredd by proteolytic processing of Dredd (Hu 
and Yang, 2000). The role of dFadd may be to activate Dredd (Richardson and 
Kumar, 2002), and since Dredd plays a role in the innate immune response, dFadd 
may also function in the innate immune response pathway. This assumption, 
however, needs to be confirmed experimentally. No death receptors (tumour necrosis 
factor receptor [TNFR] family) have been identified in D. melanogaster and neither 
has a genomic sequence been identified that has both a death domain and a death 
effector domain characteristic of mammalian death receptors (Vernooy et al., 2000; 
Aravind et al., 2001).  
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Grim and Rpr are expressed specifically in cells that undergo PCD while Hid has a 
general pattern of expression (White et al., 1994; Chen et al., 1996b; Grether et al., 
1995). Rpr expression is regulated by the steroid hormone ecdysone and by 
developmental signals (Jiang et al., 2000). Hid is negatively regulated by the 
epidermal growth factor receptor (EGFR)-Ras-Raf-MAPK signalling pathway 
(Kurada and White, 1998; Bergmann et al., 1998). The MAPK phosphorylation sites 
in Hid are essential for cell survival promoted by the EGFR pathway and Hid mRNA 
expression is regulated by the Pointed and Yan transcription factors which act 
downstream of the EGFR-Ras signalling pathway.     
 
1.5.1 p53 signalling and regulation by Mdm2 
 
The mammalian tumour suppressor gene, p53, encodes a 53 kDa protein that 
mediates PCD or cell cycle arrest in response to stress signals such as DNA damage 
(Levine, 1997). The p53 protein is a DNA-binding transcription factor that binds to 
enhancer/promoter elements of downstream target genes and thereby regulating 
transcription. Activation of p53 in response to cellular stress or DNA damage 
involves phosphorylation of the p53 protein. Once activated, p53 moves into the 
nucleus, and binds to specific enhancers thus regulating transcription of adjacent 
genes. Under normal cellular conditions, p53 is maintained at very low levels and 
these levels are only increased in response to stress signals. The increased levels of 
p53 either induce cell cycle arrest in the G1 phase or G2/M phase, or initiate 
apoptosis. The apoptotic pathway is initiated by activation of pro-apoptotic genes 
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Bax, Fas, and IGF-BP. Bax activates Apaf-1 and caspase 9. 
 
Dmp53 (Drosophila melanogaster p53) is the homologue of p53 (Ollmann et al., 
2000). Dmp53 induces PCD in response to DNA damage but does not play a role in 
cell cycle arrest (Lee et al., 2003; Nordstrom and Abrams, 2000).  The 42 kDa 
Dmp53 protein functions by inducing expression of Rpr through the radiation-
inducible element (p53RE) located ~5 kbp upstream of the Rpr translational start 
codon (Brodsky et al., 2000). Dmp53 also activates other pro-apoptotic genes such as 
components of the Bcl-2/Apaf-1 pathway (Steller, 2000).  
 
Mdm2, p14ARF and E2F-1 maintain the regulation of low cellular p53 levels (Jin and 
Levine, 2001; Momand et al., 2000). Mdm2 and p53 are involved in a negative 
feedback loop with each other. p53 positively regulates Mdm2 by activating its 
transcription and Mdm2 negatively regulates p53 by promoting its ubiquitination and 
degradation of (Figure 1). The N-terminal region of Mdm2 binds p53 at the N-
terminal end and acts as an ubiquitin ligase by catalyzing the transfer of ubiquitin to 
p53 via its RING finger (see Figure 2A) (Honda et al., 1997). The amino acid 
residues on p53 that make contact with Mdm2 are: Phe19, Leu22, Trp23 and Pro27 
(Figure 2B) (Chen et al., 1993).  
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Figure 1: Schematic representation of p53 regulation by Mdm2 ubiquitin 
ligase activity. p53 functions to initiate apoptosis or cell cycle arrest. 
Binding of p53 to Mdm2 inhibits p53 activity and ubiquitinates p53. The 
p53 is targeted for degradation by the 26S proteasome. Mdm2 may also 
bind p14ARF, which prevents Mdm2 binding to p53. 
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The ubiquitin tagged p53 is then degraded by the 26S proteasome. A conserved 
Cys464 on Mdm2 has been implicated in this mechanism (Honda et al., 1997).  
Mdm2 has three regions of high identity called CR1, CR2 and CR3 (Figure 2A). CR1 
(residues 42-94) binds proteins that are involved in cell growth such as p53, p73, 
E2F-1 and DP1. CR2 (residue 301-329) is a putative zinc-binding domain and 
overlaps a region required for binding the Retinoblastoma (pRB) tumour suppressor 
protein. pRB and p53 act as cell cycle checkpoint components. Unphosphorylated 
pRB suppresses cellular proliferation in G1 (Chen et al., 1989) and is found in an 
inactivated form in various types of human cancers. CR3 (residues 444-483) encodes 
the RING finger domain and binds two zinc atoms. It contains the Cys464 residue 
essential for ubiquitination of p53. Also present is a nuclear localization sequence 
(NLS) and a nuclear export sequence (NES) (Roth et al., 1998). These sequences 
allow Mdm2 to be shuttled between the nucleus and the cytoplasm and are essential 
for p53 degradation (Freedman and Levine, 1998). The regulation of p53-Mdm2 
binding is controlled by the phosphorylation of residues within or near the interaction 
domains on either p53 or Mdm2. Phosphorylation of Ser15 on p53 (Shieh et al., 
1997) or Ser20 (Unger et al., 1999) (Figure 2B), and Ser17 on Mdm2 (Mayo et al., 
1997) has been shown to prevent the binding of p53 to Mdm2 and therefore prevents 
p53 degradation which would lead to increased cellular levels of p53. An Mdm2 
homologue for D. melanogaster has not yet been identified. The regulatory 
mechanism of Dmp53 is not clearly understood although it has been suggested that a 
PEST region at the N-terminus is responsible for Dmp53 regulation (Jin et al., 2000).  
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Figure 2: (A) Schematic diagram of Mdm2 indicating domains that are 
important for the regulation of p53 function. CR1 is the p53-binding 
domain, CR2 the zinc-binding motif that binds the Retinoblastoma tumour 
suppressor protein (pRB), and CR3 the RING finger motif with ubiquitin 
ligase activity. The nuclear localization sequence (NLS) and the nuclear 
export sequence (NES) are also indicated. (B) The p53 sequence that binds 
Mdm2. Arrows indicate the residues that make contact with Mdm2 (Chen 
et al., 1993); underlined residues represent conserved residues predicted to 
be required for binding to Mdm2 and boxed residues are phosphorylated to 
inhibit p53-Mdm2 binding. 
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PEST sequences refer to proline (P), glutamic acid (E), serine (S), and threonine (T)-
rich regions in proteins. The function of PEST containing proteins is generally 
controlled by proteolysis, mostly via the ubiquitin pathway (Rechsteiner and Rogers, 
1996).  
 
The E2F-1 protein activates the ARF gene. The transcript of this gene, called p14ARF , 
is involved in the degradation of E2F-1 and it interacts with Mdm2. p14ARF binding to 
Mdm2 stabilises p53 by preventing ubiquitination and degradation of p53 by Mdm2. 
p53 also functions in suppressing transcription of the ARF gene (Stott et al., 1998).  
 
1.5.2 The domain organisation of p53 and/or pRB interacting proteins 
 
Not only does p53 interact with Mdm2, but it also forms interactions with other 
cellular proteins. I have identified a group of proteins that interact with p53 as well as 
the tumour suppressor retinoblastoma RB protein pRB. The link between the pRB 
and the p53 pathways in human cells is that p53 induces expression of the cyclin-
dependent kinase inhibitor p21WAF/CIP1 . This prevents phosphorylation of pRB at the 
G1/S transition, which inhibits E2F transcriptional activity and cell cycle progression 
(Simons et al., 1997). The proteins that interact with p53 and pRB share a similar 
domain organisation and have the ability to influence the nuclear matrix. All the 
proteins have a RING finger or RING finger-like domain (Mather et al.,2005). These 
proteins include human RBBP6 (Sakai et al., 1995), PACT (Simons et al., 1997), 
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P2P-R (Gao et al., 2002), p53BP3 (Zhou et al., 1999b) and Topors (Haluska et al., 
1999). A member of this group has also been identified in yeast. The yeast protein, 
Mpe1, forms part of the cleavage and polyadenylation factor (CPF) (Vo et al., 2001). 
RBBP6, PACT, P2P-R and Mpe1 are SNAMA orthologous proteins. All these 
proteins are characterised by a conserved cysteine-rich motif resembling a RING 
finger domain (Figure 3). Many proteins with a RING finger domain have been 
shown to have ubiquitin ligase activity (Deshaies, 1999) and this domain will be 
discussed in detail in section 1.11.  
 
 RBBP6 
The human RBBP6 protein was identified from a H69c (human small lung 
carcinoma) library by virtue of its ability to bind the tumour suppressor 
retinoblastoma RB protein (pRB) (Sakai et al., 1995). pRB suppresses cellular 
proliferation and is inactivated in various human cancers (DeCaprio et al., 1989; 
Weinberg, 1992). Underphosphorylated pRB protein is a G1 cell cycle checkpoint 
component (Weinberg, 1995).  pRB undergoes functional inactivation by being 
phosphorylated, which allows the cell cycle to proceed into late G1. RBBP6 is a 948 
amino acid polypeptide with a predicted molecular weight of 140 kDa and contains 
multiple short repeat sequences. These sequences include SRS (12 times), YRE (4 
times), VPPP (4 times), and SYSRS (3 times). The SRS sequence is found in DNA 
binding proteins. SR domain proteins are characteristic of a family of proteins 
involved in pre-mRNA splicing and are important auxiliary factors involved in 
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multiple steps of spliceosome assembly (Fu, 1995). RBBP6 binds to 
underphosphorylated pRB via a short sequence near the C-terminus of the protein.  
 
PACT 
The mouse PACT protein was identified by virtue of its ability to bind p53 (Simons 
et al., 1997). RBBP6 is the truncated human homologue of PACT and occurs as a 
result of a mutational event in the small lung carcinoma H69c cell line. PACT and 
RBBP6 share 97% homology from the N-terminus to the end of the SR region 
suggesting that these two proteins are highly conserved and that the SR region may 
be of functional significance. PACT was shown to interact with pRB at the N-
terminus and p53 at the C-terminus and is implicated in pre-mRNA splicing. PACT 
binds p53 at the p53 DNA binding region and competes for p53 specific DNA 
binding. The 250 kDa PACT protein is detected on Western blots only after 
acetylation and is localized in nuclear speckles, where splicing factors are found 
(Simons et al., 1997). PACT contains a SR rich region and a basic lysine rich region 
at the C-terminus of PACT giving this protein a positive charge. The lysine rich 
region accounts for the unusual behaviour of PACT on SDS-PAGE. 
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P2P-R 
P2P-R has been identified as being the alternately spliced product of the PACT gene 
(Scott et al., 2003). P2P-R lacks a single exon containing 102 nucleotides that 
encodes 34 amino acids. The murine protein was identified in 1997 as proliferation 
potential proteins (P2P) related (P2P-R) (Witte and Scott, 1997). The 250 kDa P2P-R 
protein is a basic protein containing multiple domains. There is a cysteine rich 
domain near the N-terminus that resembles the consensus sequence of the RING 
finger domain, a proline rich domain, an RS region, and a C-terminal lysine rich 
region. The N-terminal domain is implicated in cell growth control. The protein has 
multiple potential nuclear localization signals. The P2P-R protein binds p53 as well 
as pRB and single-stranded DNA. Amino acids 735 to 908 of P2P-R bind to the 
pocket domain of pRB, and amino acids 1204 to1314 bind to the oligomerisation and 
C-terminal regulatory domain of p53 (Witte and Scott, 1997). Expression and 
localization of P2P-R is regulated by differentiation and cell cycle events. P2P-R 
localizes to the nucleoli and nuclear speckles in interphase cells, and associates with 
the periphery of chromosomes during mitosis (Gao et al., 2002). This suggests that 
P2P-R shares characteristics with other nuclear proteins such as nucleolin and 
fibrillarin, which associates with the periphery of chromosomes during mitosis. 
Overexpression of the protein induces mitotic arrest in prometaphase and apoptosis 
(Gao and Scott, 2002). Apoptosis is induced when P2P-R binds to regions on p53 
used to transactivate expression of apoptotic genes.  The region on P2P-R responsible 
for the camptothecin-induced apoptosis is a 158 amino acid sequence at the C-
terminal end of the protein (Gao and Scott, 2003). Camptothecin is a topoisomerase I 
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inhibitor that has been shown to induce apoptosis in MCF-7 cells by increasing the 
levels of both p53 and p21 waf1/cip1 (Liu and Zhang, 1998). P2P-R has also been 
shown to interact with scaffold attachment factor B (SAF-B), a MAR (matrix 
attachment region) binding factor, and the MAR’s binding factor nucleolin (Witte and 
Scott, unpublished). 
 
 MpeI 
Mpe1 is an evolutionarily conserved S. cerevisae protein with a homologue identified 
in the human genome (Vo et al., 2001). The human homologue has been identified as 
the DWNN protein and in D. melanogaster as SNAMA. Mpe1 has a RNA-binding 
zinc finger and an uncharacterised N-terminal region. It lacks the lysine rich regions 
and the nuclear bipartite nuclear targeting region found in the other members in this 
group of proteins. It is an essential yeast gene necessary for in vitro 3 end processing 
of mRNA and is an integral subunit of the CPF complex but not directly involved in 
the stability of the complex. Mpe1 is essential for cell viability.  
  
Topors 
The yeast two-hybrid system was used to screen a HeLa cDNA library and identified 
a novel gene with p53 binding ability (p53BP3) (Zhou et al., 1999b). p53BP3 is an 
815 amino acid protein that has two bipartite nuclear localization signals and is a 
nuclear protein. The protein is rich in serine and arginine residues characteristic of the 
SR proteins involved in pre-mRNA splicing (Fu, 1995). The p53 binding region is 
located at amino acids 226 to 501. The protein is expressed ubiquitously in a wide 
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variety of tissues. The cDNA sequence of p53BP3 matched the cDNA sequence of 
Topors almost exactly (Haluska et al., 1999). Topors was identified by its ability to 
bind human topoisomerase I. The protein has a serine/arginine rich region and a 
RING finger domain. Topors localises in the nucleus of cells with a pattern similar to 
the nuclear localisation patterns of SR-rich splicing proteins and RING finger 
proteins. The RING of Topors is similar in sequence to RING finger proteins 
implicated in transcriptional control (Haluska et al., 1999).  The D. melanogaster 
homologue of Topors (dTopors) interacts with Drosophila topoisomerase I and 
Dmp53 (Secombe and Parkhurst, 2004). dTopors has similar structural motifs as 
Topors. These include the RING finger, SR repeats and bipartite nuclear localization 
sequences. The SR repeats are reduced in dTopors and lack the consensus RNA 
binding domain of SR domain splicing factors. dTopors binds specifically to the basic 
region of Hairy without affecting the ability of Hairy to bind DNA (Secombe and 
Parkhurst, 2004). Hairy is a primary pair-rule gene encoding a transcriptional 
repressor that is required for proper segmentation. The process of transcriptional 
repression plays an important role in many aspects of development. In addition, 
dTopors has E3 ubiquitin ligase activity and is able to ubiquitinate Hairy and target it 
for degradation.     
 
 
The p53 and/or Rb binding proteins have zinc binding domain and a cysteine rich 
RING finger-like region (Figure 3). In addition they may also have the 
uncharacterised N-terminal ubiquitin-like region and SR rich regions. SR domain 
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proteins are important auxiliary factors involved in multiple steps of spliceosome 
assembly and also play roles in the regulation of alternative splicing (Fu, 1995). 
Another gene that belongs to this new class of proteins is NIRF (Mori et al., 2002). 
The nuclear protein NIRF has an ubiquitin-like domain, a zinc finger, two RING 
fingers and a SR rich region. There is a potential pRb-binding region within the 
RING finger indicating possible pRB binding. The domain configuration, and its 
homology to Np95/ICBP90 suggest that NIRF is involved in functions related to cell 
proliferation. NIRF interacts with the PEST-containing nuclear protein (PCNP) (Mori 
et al., 2002).  
 
Taken together, the unique domain organisation of these proteins suggest that they are 
involved in biological processes such as transcriptional regulation, cell cycle control 
and apoptosis and links splicing to these processes. During evolution these proteins 
may have maintained both constitutive and regulated splicing functions while others 
have become transcriptional regulators involved in cell cycle control. In higher 
organism these proteins appears to function in the ubiquitin pathway as well as in 
apoptosis.    
 
1.6 THE UBIQUITIN SYSTEM 
 
Intracellular protein degradation plays an important role in the control of the levels of 
specific proteins and the elimination of damaged proteins. This proteolytic process is 
a complex process involving a cascade of enzymes that are selective for protein 
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substrates to be degraded. The process is a major system for selective protein 
degradation in eukaryotic cells and maintains protein turnover. The steps involved in 
this process have been reviewed (Hershko and Ciechanover, 1998). Briefly, protein 
degradation by the ubiquitin process involves two steps: (1) proteins that are targeted 
for degradation are covalently ligated to ubiquitin molecules in an ATP dependent 
reaction; and (2) the tagged proteins are then degraded by the 26S proteasome 
complex that acts only on ubiquitinated proteins. The ubiquitination process is a 
posttranslational process that requires three enzymatic steps. Initially, free ubiquitin is 
activated in its C-terminal glycine by a ubiquitin-activating enzyme, E1, forming a 
thiolester bond to a cysteine residue on E1. Following activation a ubiquitin carrier 
protein, E2, forms another thiolester bond at the active site cysteine residue on E2 
with the activated ubiquitin. Finally the ubiquitin is transferred to the target protein 
by an E3 ubiquitin protein ligase that is specifically bound to the substrate protein. 
This results in a covalent isopeptide bond formed between a conserved glycine of the 
ubiquitin and a lysine of the target protein. In successive reactions additional 
ubiquitin moieties are linked to one another via a Gly76-Lys48 isopeptide bond to 
synthesize the polyubiquitin chain. This chain then serves as a recognition signal for 
the 26S proteasome complex. Polyubiquitin chains are also assembled through 
conjugation to lysine residues of ubiquitin other than Lys48, and the resulting chains 
appear to function in other biological processes such as a signal for recruitment of the 
chain-elongation factor E4, DNA repair, cellular response to stress, inheritance of 
mitochondrial DNA, endocytosis of specific plasma membrane proteins and 
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ribosomal function (Spence et al., 1995; Arnason and Ellison, 1994; Fisk and Yaffe, 
1999; Soetens et al., 2001; Spence et al., 2000). 
 
Ubiquitin is a highly conserved 76 amino acid protein (Ciechanover et al., 1978) 
found in eukaryotic organisms (Figure 4). The protein folds into 2 -helices and 5 -
strands (Cornilescu et al., 1998). It is a thermostable protein found throughout the cell 
that can either exist as monomers, or conjugated to other proteins. Ubiquitin is 
conjugated with other proteins through a covalent bond between the conserved 
glycine at the C-terminal end of ubiquitin and a lysine residue on a target protein. 
Single molecules of ubiquitin may be attached to the lysine of targeted proteins, but 
more commonly, ubiquitin chains are added. Ubiquitin is involved in many cellular 
processes such as cell cycle regulation, innate immunity, signal transduction, 
development, and apoptosis. The ubiquitin protein is not expressed as a monomer, but 
instead encoded by a family of genes whose translational products are fusion proteins 
(Ozkaynak et al., 1984). The ubiquitin gene can be fused to a ribosomal protein gene 
resulting in a translational product that is a ubiquitin-ribosomal fusion protein, or 
ubiquitin can exist as a linear repeat resulting in a polyubiquitin molecule. These 
fusion proteins are then cleaved by the deubiquitinating enzyme (DUB). DUB is a C-
terminal hydrolase responsible for the release of ubiquitin monomers.   
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Figure 4: The three-dimensional structure of ubiquitin. The 2- helices (red) 
and the 5- strands (yellow) are clearly visible. This image was generated 
using the DeepView/Swiss-PdbViewer Version 3.7 (entry #1D3Z; Cornilescu 
et al., 1998).  
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1.7 UBIQUITIN ENZYMES 
 
The first enzyme involved in the ubiquitin pathway is the ubiquitin-activating enzyme 
E1. E1 is involved in the activation of ubiquitin by forming an E1-ubiquitin thioester 
via a ubiquitin-adenylate intermediate. The activated ubiquitin is then transferred to 
E2. E1 appears to be a homodimer with an apparent molecular mass of 210 kDa that 
is composed of two identical 105 kDa subunits (Ciechanover et al., 1982). E1 is 
highly conserved in evolution and is found both in the cytosol and in the nucleus 
suggesting that the ubiquitin-ligase system exist in both these compartments. The 
roles of E1 in the nucleus are not yet known but it is suggested that E1 may be 
involved in ubiquitination of specific nuclear proteins such as histones (Finley and 
Chau, 1991) or in the degradation of other nuclear proteins.     
 
The ubiquitin-carrier proteins (E2) are a family of enzymes with distinct substrate 
specificities and function. These enzymes mediate the transfer of ubiquitin from E1 to 
the targeted protein. E2s may participate in the recognition of the protein substrate, 
either directly or in combination with an E3 enzyme (Hochstrasser, 1996; Jentsch, 
1992). There is no substantial experimental evidence supporting the idea of the direct 
binding of E2s to protein substrates but rather E2s associate with E3s that in turn bind 
specific protein substrates. All known E2s have a conserved domain of ~16 kDa that 
contains the cysteine residue required for the formation of the ubiquitin-E2 thiol ester 
intermediate. Certain E2 enzymes are involved in E3 independent mono-
ubiquitination that does not target proteins for degradation. Some E2s have 
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overlapping functions while others are very specific. In D. melanogaster the E2 
enzyme UbcD1 is involved in the detachment of telomeres in mitosis and meiosis 
(Cenci et al., 1997). Another example is the D. melanogaster bendless gene required 
for the establishment of synaptic connectivity in embryo development (Muralidhar 
and Thomas, 1993). E2s in yeast have also been identified conjugating ubiquitin-like 
proteins Smt3 and Rub1 and not ubiquitin. 
 
The E3 enzymes play an important role in the selectivity of ubiquitin-mediated 
protein degradation. E3s lack sequence homologies between each other but show 
sequence similarities between members of the same E3 family. There are a variety of 
mechanisms by which different types of E3s promote ubiquitin-protein ligation. E3 
has been defined as an enzyme that binds, directly or indirectly, specific protein 
substrates and promotes the transfer of ubiquitin, directly or indirectly, from a thiol 
ester intermediate to amide linkages with proteins or polyubiquitin chains (Hershko 
and Ciechanover, 1998). The ubiquitin protein ligases are divided into two large 
groups, the HECT (homologous to E6-APC-terminus) domain and the RING finger 
motif (Real Interesting New Gene) containing proteins. The HECT domain E3s 
function to transfer the activated ubiquitin protein from E2 to an internal cysteine 
residue on E3 followed by transfer of the ubiquitin to an NH2 group on the target 
protein. The RING finger-containing enzyme serves as a scaffold that brings the E2 
and the substrate close to each other to allow for the transfer of the ubiquitin from E2 
to the substrate.  
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The hect domain family of proteins harbour a 350 amino acid residue sequence 
homologous to the C-terminal domain of the E6-associated protein (Huibregtse et al., 
1995; Huibregtse et al., 1993). This domain contains a conserved active site cysteine 
residue near the C-terminus to which the activated ubiquitin molecule is transferred 
from E2 (Scheffner et al., 1995). The highly variable N-terminal region of different 
hect proteins is responsible for the specificity to protein substrates (Huibregtse et al., 
1995). The first member of the hect family identified was the 100 kDa E6-AP (E6-
associated protein). This protein together with human papilloma virus (HPV) 
oncoprotein E6 is required for the degradation of p53 (Scheffner et al., 1993). Some 
examples of characterised hect proteins include NEDD4 (Staub et al., 1996), which 
ubiquitinates epithelial sodium channel subunits and the S. cerevisiae homologue 
Rsp5p (Huibregtse et al., 1997).  
 
1.8 THE RING FINGER E3S 
 
The RING finger (Real Interesting New Gene) is a cysteine rich motif found in many 
proteins. The function of these proteins is to mediate cellular processes such as 
oncogenesis, apoptosis, development and viral infection (Borden, 2000). The RING 
finger motif appears to be involved in protein-protein interactions resulting in multi-
protein complexes and has potential zinc binding ability. It has been identified as a 
ubiquitin ligase that facilitates the interaction between E2 proteins and their substrates 
allowing E2-dependent ubiquitination (Deshaies, 1999) by transferring ubiquitin to 
target substrates as well as to RING proteins (Tyers and Willems, 1999; Lorick et al., 
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1999; Joazeiro and Weissman, 2000; Jackson et al., 2000). A mutagenesis experiment 
has implicated Trp408 in E2 binding (Joazeiro et al., 1999). This aromatic residue is 
exposed to the outside of the domain and could directly contribute to E2-ubiquitin 
binding via hydrophobic or aromatic stacking interactions. The RING domain is 
essential for E3 activity and is defined by a pattern of cysteine and histidine residues  
arranged as Cys-x2-Cys-x(9-39)-Cys-x(1-3)-His-x(2-3)-Cys/His-x2-Cys-x(4-48)-Cys-x2-Cys, 
where x can be any amino acid (Figure 5) (Saurin et al., 1996). It binds two zinc 
atoms. The zinc atom is coordinated to four cysteines or three cysteines and a 
histidine in a tetrahedral arrangement (Borden and Freemont, 1996). This binding is 
also possible with other zinc ligands resulting in a RING finger family of proteins. 
These are structurally grouped as either the RING-H2 family that has a histidine 
residue in place of a Cys4 and the RING-HC that contains only one histidine at 
position 4. RING fingers with a histidine substitution have also been found. The 
histidine to asparagine substitution occurring at position 4 in the retinoblastoma-
binding protein RBQ-1 is one such example (Saurin et al., 1996). Other RING finger 
variants include the mouse double minute protein Mdm2 where Cys3 is replaced by 
threonine (Boddy et al., 1994) without affecting the ubiquitin ligase activity, and 
CART1 where Cys7 is substituted for an aspartate residue (Regnier et al., 1995). All 
these substitutions maintain the zinc binding ability and the overall three-dimensional 
structure of the RING domain.  
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Figure 5: Schematic representation of the ligation scheme employed by 
the RING finger showing the unique ‘cross brace’.  Red spheres represent 
cysteine residues, green spheres represent histidine residues and the blue 
spheres correspond to zinc atoms. The RING finger coordinates two zinc 
ions. A His4 to Asn4 substitution is found in the RBBP6 protein. 
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The RING finger domain-containing E3 family is composed of two distinct groups: 
single and multisubunit E3 proteins. The N-end rule E3 and the E3α are examples of 
monomers or homodimers containing both the RING finger domain as well as the 
substrate-binding/recognition domain. The N-end rule relates the in vivo half-life of a 
protein to the identity of the proteins N-terminal residues (Varshavsky, 1992). E3s are 
~200 kDa proteins that bind N-end rule protein substrates that have basic (Type I) or 
bulky-hydrophobic (Type II) N-terminal amino acid residues with specific binding 
site for these residues. N-end rule E3 also has a putative “body” site  (Type III) to 
which substrates that do not have a N-end rule terminal amino acid residue bind. E3α 
has a binding site for a specific E2 (Reiss et al., 1989). This facilitates the transfer of 
activated ubiquitin from E2 to substrate proteins.  
 
An example of the multisubunit E3 enzymes is the cyclosome (Sudakin et al., 1995) 
or the anaphase-promoting complex (APC) (King et al., 1995). These have ubiquitin 
ligase activity specific for cell-cycle regulatory proteins with a nine amino acid 
“destruction box” motif.  The anaphase-promoting complex APC contains the RING 
finger domain protein Apc11, which has been shown to bind the substrate and 
catalyse its ubiquitination (Leverson et al., 2000). Another group of multisubunit E3 
enzymes contains a RING finger domain involved in E2 recruitment and assembly of 
other components of the complex, but not in substrate recognition. These E3s are 
involved in the degradation of cell cycle regulators such as the Sic1p Cdk inhibitor or 
the G1 cyclin Cln2p. They have been designated as the phosphoprotein-ubiquitin 
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ligase complex (PULCS) (Hershko and Ciechanover, 1998), since phosphorylation of 
the substrate is required to convert it to a form susceptible to the action of the 
ubiquitin ligase complex.    
 
The ubiquitin chain elongation factor, E4, is an additional subset of the E3 group of 
enzymes. They function in the elongation of a polyubiquitin chain in a specific 
manner (Koegl et al., 1999). E4 has an essential functional domain called the U-box 
domain that acts as a scaffold for the transfer of ubiquitin from E2 to a conjugated 
ubiquitin molecule on the target protein or to elongate short polyubiquitin chains. 
This process elongates the ubiquitin chains. The U-box is a modified RING finger 
that lacks the metal chelating residues of RING finger domains (Aravind and Koonin, 
2000). Instead the U-box fold is stabilized by salt-bridges and hydrogen bonds. The 
Cys residues of the RING finger are not conserved in the U-box. The U-box proteins 
can function as a ubiquitin ligase independent of an E3 (Hatakeyama et al., 2001), or 
in some instances requiring an E3. E4 is identical to the yeast protein Ufd2 (ubiquitin 
fusion degradation). The Ufd2 protein is essential for the assembly of the 
polyubiquitin chain on artificial substrates that are targeted for degradation. 
 
1.9 THE PROCESS OF PROTEIN DEGRADATION 
 
The 26S proteasome is a large catalytic protease (~2.5 MDa) that degrades 
polyubiquitin proteins into small peptides. The protein is made up of two subunits: a 
20S core particle (CP) responsible for the catalytic activity and a regulatory 19S 
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regulatory particle (RP). The 20S CP is a barrel-shaped molecule composed of four 
stacked rings: two identical outer α-rings and two identical β-rings. The α- and β- 
rings are composed of seven subunits with a general structure of α1-7β1-7β1-7α1-7. The 
catalytic sites are found on the β-subunits (Groll et al., 1997; Lowe et al., 1995). The 
20S barrel protein can be capped at either end by the 19S RP. The 19S RP functions 
to recognise ubiquitinated proteins and substrates of the proteasome. The 19S RP also 
functions as a lid that opens the outer α-rings to allow entry of the substrate through a 
gated channel into the proteolytic centre. The 19S regulatory protein is thought to 
assist in the unfolding of substrates so that they may be inserted into the proteolytic 
core (Groll et al., 1997; Horwich et al., 1999; Kohler et al., 2001; Strickland et al., 
2000). 
 
An important function of the proteasome is the generation of antigenic peptides to be 
presented by the major histocompatibility complex (MHC) class I molecules  to 
initiate an immune response (Kloetzel, 2001; Rechsteiner et al., 2000; Yewdell and 
Bennink, 2001). The proteasome is responsible for the degradation of viral proteins 
following an invasion on the cell. The viral proteins are hydrolysed into short 
peptides to be transported to the ER and presented to the immune system by MHC 
class I.  
 
Signals for proteins to be ubiquitinated include phosphorylation of the protein at 
specific sites and/or the recruitment of ancillary substrate binding factors. One of 
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these phosphorylation sites is a region found on rapidly degraded proteins known as 
PEST elements. These regions are rich in proline, glutamic acid, serine and threonine 
amino acids (Rogers et al., 1986; Rechsteiner and Rogers, 1996). The 
phosphorylation site for Cdks and other protein kinases have PEST elements rich in 
S/TP sequences, which are the minimum consensus phosphorylation sites for these 
proteins (Yaglom et al., 1995). Another degradation signal is the recognition via the 
N-terminal residues (the N-end rule pathway). The substrates bind directly to the E3 
via their N-terminal residues. This signal is inherent in the primary structure of the 
protein (Varshavsky, 1992) and is responsible for the removal of erroneously 
transported and compartmentalised proteins in the cytosol after the destabilising N-
terminal residue is produced by cleavage with a signal peptidase. The “destruction 
box” signal is responsible for the ubiquitin-related degradation of mitotic cyclins and 
certain cell-cycle regulatory proteins. The destruction box is a 9 amino acid sequence 
motif located approximately 40 to 50 amino acid residues from the N-terminus 
(Glotzer et al., 1991). The “destruction box” is highly conserved except for the Arg1 
and Leu4 (Yamano et al., 1996). The destruction box containing cell cycle regulators 
are ligated to ubiquitin by the cyclosome/APC and are then degraded.  
 
1.10 DEUBIQUITINATING ENZYMES (DUBS) 
 
Ubiquitin molecules are synthesised as precursors either as a series of ubiquitin 
monomers or as a fusion to ribosomal proteins. Deubiquitinating enzymes (DUBs) 
function in maintaining the steady-state levels of free ubiquitin by cleaving ubiquitin 
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from ubiquitin-protein-fusions and/or isopeptide-bond-linked ubiquitin-protein 
conjugates (Chung and Baek, 1999; D'Andrea and Pellman, 1998; Wilkinson, 2000). 
DUBs are cysteine proteases that hydrolyse the amide bond immediately after the C-
terminal residue of ubiquitin. There are two groups of DUBs; ubiquitin C-terminal 
hydrolases (UCHs) and ubiquitin specific proteases (UBPs). UCHs are 20 to 30 kDa 
enzymes that remove short peptide chains from the C-terminus of ubiquitin. The 
hydrolases contain a catalytic triad in their active site comprised of cysteine, histidine 
and aspartate residues, as well as an additional conserved glutamic acid residue 
within a consensus sequence (Chung and Baek, 1999; D'Andrea and Pellman, 1998). 
UBPs are ~100 kDa enzymes that cleave the isopeptide bond linking ubiquitin-
ubiquitin or ubiquitin-protein and linear ubiquitin chains. These enzymes also contain 
conserved cysteine, histidine and aspartate residues within an active site residue, but 
differ in that the consensus sequence is divergent (D'Andrea and Pellman, 1998).     
 
Ubiquitin is a product of the proteasome activity. The ubiquitin is released from the 
proteasome and recycled back into the pathway (Hough et al., 1986; Swaminathan et 
al., 1999). The regulatory particles (RP) of the proteasome has a DUB activity 
responsible for the removal of ubiquitin from protein substrates (Eytan et al., 1993; 
Holzl et al., 2000; Lam et al., 1997b; Lam et al., 1997a). In D. melanogaster, the RP 
subunit responsible for this activity is p37a. 
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1.11 UBIQUITIN-LIKE PROTEINS  
 
Several proteins have been identified that are related to ubiquitin or function similarly 
to modify proteins by the covalent attachment of ubiquitin targeting them for 
degradation by proteasomes. Ubiquitin-like proteins are divided into two groups. 
Proteins belonging to the first group modify other proteins in a manner similar to 
ubiquitin by covalent conjugation of these small proteins to amino acid residues on 
the target proteins. The modes of conjugation and sites of attachment of these 
proteins onto target proteins resemble the ubiquitin modification process. These 
proteins have been designated ubiquitin-like proteins (UBLs). The second group of 
ubiquitin like proteins bears protein domains that are related to ubiquitin but are 
unrelated in sequence to each other. These proteins are not conjugated to other 
proteins and have been termed the ubiquitin domain proteins (UDPs).  
 
1.11.1 Ubiquitin-like proteins (UBLs) 
 
The conjugation pathways for the UBLs are very similar to that of ubiquitin. They 
form an isopeptide bond with an internal lysine of the substrate and require E1 and 
E2 enzymes. All known UBLs (except APG12 and URM1) are related by sequence 
homology to ubiquitin (Figure 6). APG12 and URM1 have been grouped with UBLs 
since they are small protein modifiers that are activated and conjugated to other 
proteins in a manner that resembles ubiquitin. Like ubiquitin, UBLs are expressed as 
inactive precursors and are activated by proteolytic cleavage of the C-terminal 
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extensions that prevents conjugation. This exposes the functional C-terminal Gly-Gly 
sequence. APG12, URM1 and FAT10 are expressed as mature proteins. An activating 
enzyme, E1, then activates the UBLs. The UBLs are then transferred to an E2 enzyme 
via a thiol-ester bond. The activation reactions of ubiquitin and UBLs are similar but 
the E1 and E2s involved in the two processes cannot replace one another. Most UBLs 
have a Gly-Gly sequence at their C-terminus as found in ubiquitin. This GG sequence 
is necessary for recognition and activation by specific activation enzymes E1s. The 
modification of cullins by the UBL protein RUB involves SCF/CBC-like E3 enzymes 
that are also involved in ubiquitination (Jentsch and Pyrowolakis, 2000). Other 
examples of UBLs include proteins such as SUMO/Smt3p/sentrin (~20% identity to 
ubiquitin), NEDD8/Rub1 (60% identity to ubiquitin), and APG12 (no sequence 
homology).  
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Figure 6: A sequence comparison of ubiquitin to ubiquitin-like proteins. The mammalian proteins UCRP and FAT10 
have two ubiquitin-related domains fused in tandem (designated I and II). APG12 and URM1 are unrelated to ubiquitin 
and are therefore not shown. The alignment was completed using DNAMAN version 4.03 (Lynnon BioSoft).  
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SUMO 
The transfer of SUMO to target proteins involves the E1 heterodimer AOS1-UBA2, a 
single E2 enzyme UBC9 (Johnson et al., 1997; Johnson and Hochstrasser, 1997) and 
in yeast a specific E3 (Johnson and Gupta, 2001). Several SUMO molecules can 
attach to the substrate at distinct sites, but unlike ubiquitin multi SUMO chains do not 
form on the substrate (Jentsch and Pyrowolakis, 2000). Attachment of SUMO 
(sumoylation) does not target proteins for degradation although there is a link 
between the ubiquitin pathway and SUMO conjugation. Sumoylated proteins are 
found in the nucleus or the nuclear envelope, which may suggest that SUMO 
attachment to substrates, targets them to the nucleus. Sumoylated PML, a putative 
RING finger-containing E3 enzyme, is found in the nucleus (Kamitani et al., 1998). 
The protein SP100 is also modified by SUMO resulting in the translocation from the 
cytoplasm or nucleus to the nuclear bodies (Muller and Dejean, 1999). Sumoylation 
of substrates RanGAP1, SP100, p53, IB also increases their levels in the nucleus as 
compared with the cytoplasm (Yeh et al., 2000). Sumo conjugation to the Ran 
GTPase-activating protein (RanGAP1) is required for the binding of RanGAP1 to 
Ran-GTP-binding protein RanBP2. This then targets the associated proteins to the 
nuclear pore complex (Mahajan et al., 1997; Melchior, 2000). SUMO modification is 
important in D. melanogaster semushi mutants for the nuclear import of Bicoid 
transcription factor (Epps and Tanda, 1998). The evidence for a link between 
sumoylation and the ubiquitin pathway is demonstrated by SUMO conjugation to the 
IB protein. IB associates with NF-B/Rel transcription factors preventing their 
movement from the cytosol to the nucleus. Signal induced phosphorylation, 
 41 
ubiquitination, and proteasomal degradation of IB enables the NF-B/Rel proteins 
to enter the nucleus. IB is also modified by SUMO conjugation to Lys21, the site 
for ubiquitin modification. Sumoylated IB is thus resistant to signal-induced 
proteasomal degradation (Desterro et al., 1998).  Mdm2, the E3 ubiquitin ligase for 
the p53 tumour suppressor protein, is conjugated to SUMO at Lys446. This reduces 
Mdm2 self-ubiquitination, which increases Mdm2 ability to ubiquitinate p53 causing 
increased p53 degradation and resulting in inhibition of p53-mediated apoptosis 
(Buschmann et al., 2000). 
 
RUB 
RUB (related to ubiquitin) is 50% identical to ubiquitin with homologues in all 
eukaryotes (Liakopoulos et al., 1998). The S. cerevisiae protein is called Rub1 and 
the human homologue NEDD8. RUB is also related to the ubiquitin pathway. RUB 
conjugation to proteins (rubylation) involves a heterodimer E1 (ULA1/UBA1) and 
the E2 UBC12 (Hori et al., 1999). The substrates are limited to a small number of 
proteins belonging to the cullin protein family. Rub1/NEDD8 conjugates to 
Cdc53/Cul-1, which are components of the SCF E3 ubiquitinating complex. This 
conjugation stabilises the interaction between Cdc53/Cul-1 with E2s such as Cdc34 
or Ubc4 and to a variety of F-box proteins (Kawakami et al., 2001; Liakopoulos et 
al., 1998) and may play a general role in down regulating SCF activity (Glickman 
and Ciechanover, 2002).  
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APG12 
This protein is unrelated in sequence to ubiquitin but functions similar to ubiquitin in 
that it forms a covalent protein complex with a lysine residue of Apg5. Conjugation 
involves the E1 enzyme Apg7, and the E2 enzyme Apg10 (Klionsky and Ohsumi, 
1999). The conjugated protein plays a role in autophagosome vesicle formation and 
delivery of cytoplasmic material to the lysosome (Furukawa et al., 2000). Both 
proteins form thioester linked complexes with Apg12. Apg7 is related in sequence to 
the E1 of ubiquitin, but Apg10 differs from the E2s. The Apg12 system is not directly 
linked to the ubiquitin system except for its similarity to the conjugation events in the 
ubiquitin system.  
 
Besides the described UBLs, there are other identified proteins that have mechanistic 
similarities to ubiquitin with respect to its conjugation to other proteins, but lack 
sequence similarities to ubiquitin. The ubiquitin related modifier (URM1) is a 99 
amino acid protein terminating with a double-glycine (Furukawa et al., 2000) that 
also conjugates to target proteins. The identification of Apg12 and URM1 indicates 
that other UBLs may exist that cannot be identified by sequence homology to 
ubiquitin but rather need to be identified by functional similarities. 
 
1.11.2 Ubiquitin domain proteins (UDPs)  
 
The ubiquitin domain proteins (UDPs) are proteins with a distinct ubiquitin-like 
domain within a large protein. The ubiquitin-like domain does not always end in a 
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Gly-Gly sequence but shows sequence homology to ubiquitin and is not processed by 
DUB-like proteases (Jentsch and Pyrowolakis, 2000) to release the domain, however, 
the UDP proteins are linked to the ubiquitin pathway. UDPs play roles in mediating 
protein folding/degradation and in the regulation of signal-transduction cascades, 
including those that regulate apoptosis. 
  
In addition to the ubiquitin-like domains, most UDPs associate with other 
characterised domains. Three of these UDPs (Rad23, Dsk2 and Bag-1) have been 
shown to bind to the 26S proteasome via the ubiquitin-like domain (Kleijnen et al., 
2000; Lambertson et al., 1999; Luders et al., 2000; Ortolan et al., 2000). The 
ubiquitin-like domain binds to the polyubiquitin-binding site in the proteasomal 
subunit S5a (Mueller and Feigon, 2003). The replacement of the ubiquitin-like 
domain in Rad23 with ubiquitin demonstrates the structural importance of this 
ubiquitin-like domain and not its sequence identity to ubiquitin in the binding to the 
proteasome (Watkins et al., 1993). In yeast the two UDPs Rad23 and Dsk2 overlap 
functionally with respect to their involvement in the spindle pole body duplication, 
and Rad23 has an additional role in DNA repair (Biggins et al., 1996). Bag-1 has 
anti-apoptotic activity. It interacting with Bcl2 and recruits the Hsp70 chaperone to 
the proteasome.  
 
The list of UDPs is growing and include proteins that play active roles in the 
ubiquitin system. Scythe, a Xenopus UDP, is involved in reaper-induced apoptosis 
pathways (Thress et al., 1998). Parkin is a UDP that is defective in patients with 
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Parkinson’s diseases. This protein has an ubiquitin-like domain with a di-glycine C-
terminal end and two RING finger domains shown to have ubiquitin ligase E2 
activity (Zhang et al., 2000). Another UDP is the UIP28 protein. UIP28 is a member 
of a group of structurally related RING finger proteins that interact with the ubiquitin-
conjugating enzyme UbcM4 (Martinez-Noel et al., 1999). The ubiquitin-like domain 
of UIP28 does not have the di-glycine residues. Most UDPs play a role as adaptors 
linking the ubiquitin pathway to functions of the proteasome. There is also an 
indication that chaperones are required in this role.  
 
One example of a UDP that functions similar to ubiquitin by attaching to target 
proteins is HUB (homologous to ubiquitin). HUB has a 22% sequence identity to 
ubiquitin but lacks the double-glycine amino acids at the C-terminal end (Luders et 
al., 2003). Instead, the highly conserved HUB proteins have an invariant C-terminal 
double-tyrosine followed by a nonconserved single amino acid. The human 
homologue of HUB is UBL5 (McNally et al., 2003) and the protein in yeast is HUB1. 
The solution structure of HUB1 indicated a folded molecule similar to that of 
ubiquitin (Ramelot et al., 2003). HUB exhibits sequence similarity to ubiquitin but its 
mechanism of attachment does not involve covalent attachment to target proteins. 
HUB1 has been reported to function as a UBL (Dittmar et al., 2002), but data from 
(Luders et al., 2003) indicates HUB1 to be a UDP. HUB1 forms SDS-resistant 
complexes with cellular proteins. These complexes are not formed through covalent 
C-terminal conjugation of HUB1 to the substrates (Luders et al., 2003). This result 
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argues strongly against a ubiquitin-like conjugation mechanism for HUB1, but rather 
suggest that they are formed by a different, possibly non-enzymatic mechanism.    
 
1.12 AIMS     
 
The aim of this study is to characterise the newly identified D. melanogaster 
homologue of the DWNN protein called SNAMA. The DWNN protein was first 
identified in a mutagenised Chinese hamster ovary (CHO) cell line. A CHO library 
was mutagenised with the defective retrovirus U3HygroTkNeo. The mutagenesis 
experiments trapped genes in CHO cells that were involved in the antigen processing 
and presentation pathway via MHC class I molecules to CD8+ T cells (cytotoxic T 
lymphocytes (CTL)). One of these genes identified was named DWNN (Domain with 
no name). This gene contains a highly conserved DWNN domain found in a wide 
variety of plant and animal species. Since the process of target cell killing by CTL 
occurs by mechanisms closely related to those described for apoptosis, the CTL 
resistant CHO cell lines were also screened for resistance to apoptosis inducing 
chemical agents. CHO cells lacking the DWNN protein were found to be resistant to 
the apoptotic inducing agent staurosporine. This suggested that the gene mutagenised 
was not only involved in antigen presentation, but also in the apoptosis pathway.  
 
Characterisation of this gene’s role in apoptosis is of primary importance in the 
understanding of the mechanisms regulating apoptosis. Such knowledge allows for 
the development of therapeutic agents for a wide range of conditions impacted upon 
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by the apoptotic pathway. Some of these diseased states prevalent today include 
conditions such as allergy, autoimmunity and cancer. Knowledge of the apoptotic 
pathways enables identification of potential drug targets.   
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2. MATERIALS AND METHODS 
 
2.1 MEDIA 
 
Media was prepared as listed in table 1. 
Table 1: Media used in this study. 
MEDIA COMPOSITION 
Apple juice agar 1.25% sucrose; 2% agar; 0.025% 
streptomycin; 0.15% methylparaben 
(3g dissolved in 30 ml ethanol made 
up to a litre); and 25% apple juice 
(v/v). 
Larval glucose agar  7.5% glucose; 2.5% agar; 7.5% yeast; 
0.15% methylparaben; and 0.025% 
streptomycin. 
LB medium 1% tryptone; 0.5% yeast extract; and 
1% NaCl. 
LB agar LB medium + 1.5% agar. 
SOB 2% tryptone; 0.5% yeast extract; 10 
mM NaCl; 2.5 mM KCl; 10 mM 
MgCl2; and 10 mM MgSO4. 
SOC SOB + 20 mM glucose. 
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2.2 BUFFERS AND SOLUTIONS 
 
Buffers and solutions were prepared as listed in table 2. 
Table 2: General molecular biology buffers and solutions. 
BUFFER COMPOSITION 
50X Tris Acetate EDTA   (TAE) 2 M Tris-base; 5.7% Glacial acetic acid; 
0.5 M EDTA (pH 8.0).  
6X DNA loading buffer  0.25% Bromophenol blue; 0.25% xylene 
cyanol; 30% glycerol. 
10X Tris Borate EDTA 0.45 M Tris-base; 0.45 M Boric Acid;    
0.01 M EDTA. 
Tris EDTA buffer (TE) 10 mM Tris-HCl (pH 8.0); 1 mM EDTA 
(pH 8.0). 
20X SSC 3 M NaCl; 0.3 M tri-sodium citrate. 
Transformation buffer 10 mM K-MES1 (pH 6.2); 100 mM KCl; 45 
mM MnCl2.4H2O; 10 mM CaCl2.2H2O; 3 
mM Hexamine Cobalt Chloride (Aldrich). 
10X MOPS buffer 0.25 M MOPS (Promega); 50 mM Sodium 
Acetate; 10 mM EDTA (pH 7.0) adjusted 
with NaOH. Store in dark. 
Lysis buffer 25 mM Tris-HCl pH7.5; 150 mM NaCl; 
0.2% SDS; 4 mM Pefabloc® SC (Roche). 
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5X SDS sample buffer 125 mM Tris-HCl pH6.8; 30% glycerol; 
10% 2-mercaptoethanol; 4 M urea;  
0.0024% Bromphenol blue; 4% SDS 
Grinding buffer 5% sucrose; 80 mM NaCl; 100 mM Tris-
HCl pH8.5; 0.5% SDS; 50 mM EDTA. 
0.1 M Sodium phosphate buffer 
pH7.2 
Prepared from 0.2 M NaH2PO4.H2O and 
0.2 M Na2HPO4.7H2O. 
Hoyer’s Mount 30 g of gum Arabic; 50 ml distilled water, 
stir overnight. 200 g chloral hydrate is 
added while stirring. Add 20 g glycerol. 
Centrifuge at 13 000g for 3 hours to clear. 
Add lactate in a 1:4 ratio. 
Western stripping buffer 2% w/v SDS; 62.5 mM Tris.HCl pH 6.8; 
and 100 mM -mercaptoethanol. 
 
1
 1 M MES was prepared, and adjusted to pH 6.3 using KOH, sterile-filtered and 
stored at -20°C. 
 
2.3 CHEMICALS AND KITS  
 
All chemicals were of AnalaR grade, either from Sigma-Aldrich (South Africa) or 
BDH Ltd (Poole, Dorset) unless otherwise indicated. Agarose D1 LE (Low 
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electroendosmosis) was obtained from Techcomp Ltd (Hong Kong). Agar, tryptone 
and yeast extracts were from Difco laboratories (Detroit, Michigan, U.S.A.). 
Ampicillin was from Sigma-Aldrich (South Africa). Restriction endonucleases were 
from Promega. Deoxynucleotide triphosphates (dNTP) and Proteinase K were from 
Roche Applied Science (South Africa). Unsweetened apple juice (Woodland) and 
commercial bleach (containing 3.5% sodium hypochlorite) (Jik, Reckitt Benckiser) 
was obtained from a local department store.  
 
2.4 BACTERIAL STRAINS 
 
The genotype of the bacterial strains used for cloning are listed in table 3. 
Table 3: Bacterial strains used in this study 
STRAIN  GENOTYPE 
Epicurian coli 
XL1 - Blue 
recA1, endA1, gyrA96, thi-1, hsdR17, supE44, relA1, 
lac [F' proAB, laclqZM15, Tn10 (Tetr)]  
JM109 recA1, endA1, gyrA96, thi, hsdR17 (rK-,mK+), relA1, 
supE44,  (lac-proAB), [F', traD36, proAB, 
laclqZM15] 
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2.5 OLIGONUCLEOTIDES  
 
Oligonucleotides were purchased from Integrated DNA Technologies. The L18F and 
L18R oligonucleotides were made at the Protein and Nucleic Acid Facility 
(Cambridge University). Table 4 lists the sequence of the oligonucleutides used in 
this study. 
 
Table 4: Oligonucleotides used for PCR and RT-PCR 
OLIGONUCLEOTIDE SEQUENCE 
DWNN1 5' GCATGCATGTCGGTACACTAT 3' 
DWNN2 5' AAGCTTGGCGATGGGGATGCG 3' 
DWNN4 5' CGTCGGCTCGAGTATGTGCTTGCAGA 3' 
L18F 5' CAAAAATGTCTCGCAGTGCTAG 3' 
L18R 5' CGTTTCGTTTAGAATAAACGTTGAT3' 
M13 Forward 5' GTAAAACGACGGCCAGTG 3' 
Pry4 5' CAATCATATCGCTGTCTCACTCA 3' 
Plac4 5' ACTGTGCGTTAGGTCCTGTTCATTGTT 3' 
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2.6 GENETIC TECHNIQUES 
 
2.6.1 Fly stocks and genetic manipulation 
All flies were reared at 25°C on standard cornmeal agar food plus yeast. Canton-S 
was used as the wild-type strain. For SNAMA gene knockout mutants the D. 
melanogaster EP0503 P-element insertion line P{PZ}l (2)rQ313rQ313 , abbreviated as 
l(2)rQ313 was used. l(2)rQ313 has a P{PZ} insertion at position 60B8-60B11. This 
insertion disrupts the expression of the SNAMA gene. It was obtained from the EP 
flystation by Exelixis Inc. PCR was used to identify the site of integration of the P-
element (see section 2.8.3). The CyO balancer chromosome on this line has an 
effective lethal phase late embryo-early larva (Kidwell, 1972). To select for 
homozygous SNAMA mutations, l(2)rQ313 was crossed with Cyo pact GFP (w; 
Sco/ln(2LR)O,Cy dp[lvl] pr cn[1] y[+] P[w+mC] from the Cambridge Drosophila  
melanogaster stock 12-135 resulting in w;l(2)rQ313/GFP;Cyo. The homozygous 
SNAMA knockout mutants did not express the GFP tag and could then be selected. 
To establish that l(2)rQ313 (loss of function mutant) is due to the P-element 
insertion, the P-element was mobilised by crossing with flies containing 2-3 
transposase. These excision lines were scored by loss of eye colour and the 
mobilisation of the P-element was confirmed by PCR using primers flanking the P-
element on the SNAMA gene.  
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2.6.2 Generation of the P-element excision line 
Females from w;Cyo/GFP;Sco were crossed with  Sb [ry+ 2-3]/ TM6b to mobilize 
the P-element. Males from this cross which are w;Cyo/+;Sb [ry+ 2-3]/+  have 
phenotype Curly (Cy) and Stubble (Sb) were crossed with females from 
w;l(2)rQ313/GFP;Cyo. The males which are w;Cyo/l(2)rQ313; Sb [ry+ 2-3]/+ have 
phenotype Cy, w+ and Sb were then crossed with females from w;Cyo/GFP;Sco. 
This will result in transposition where males are w;excision/Cyo with phenotype w  
(white eyes) and Cy. The excision was confirmed by PCR of genomic DNA to 
indicate the removal of the P-element (see section 2.8.3). The primer pair used in the 
PCR flanked the P-element and is complimentary to the genomic DNA. A PCR 
product would only be possible if the P-element was removed since the large P-
element would disrupt amplification. Males w;excision/Cyo were crossed with wild 
type females to set up a stock. 
       
 
                                             
2.7 GENERAL MOLECULAR BIOLOGY METHODS 
 
2.7.1 Small scale preparation of plasmid DNA 
Plasmid DNA was purified from E. coli cultures by means of two methods: 
(i) Qiagen mini plasmid purification kit  
(ii) Method described in (Ausubel et al., 1995). 
(i) Qiagen mini plasmid DNA purification kit 
E. coli cells were grown in 3 ml cultures overnight and plasmid DNA was purified 
following the manufacturers instructions. The purification protocol of the kit is based 
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on a modified alkaline lysis procedure, followed by binding of the plasmid DNA to 
Qiagen anion-exchange resin under appropriate salt and pH conditions. RNA, protein 
dyes, and low molecular weight impurities are removed by a medium salt wash. 
Plasmid DNA is eluted in a high salt buffer, and concentrated and desalted by 
isopropanol precipitation. 
 
(ii) Plasmid DNA preparation by alkaline lysis method  
Plasmid DNA was prepared from small (1 ml) overnight cultures of E. coli as 
described in (Ausubel et al., 1995). Briefly, cells were lysed by the alkali method 
(Birnboim and Doly, 1979; Ish-Horowicz and Burke, 1981). The plasmid DNA was 
resuspended in TE buffer (pH 8.0). 
 
2.7.2 Large scale preparation of plasmid DNA 
Large amounts of DNA were prepared using the Qiagen plasmid Maxi purification kit 
following the manufacturers instructions. Typically 100 ml cultures were grown in 
LB medium with appropriate antibiotic selection and the Qiagen-tip 500 was used to 
purify DNA from RNA, proteins and other cellular contaminants in the bacterial 
lysate. The purification protocol of the kit is based on a modified alkaline lysis 
procedure, followed by binding of the plasmid DNA to Qiagen anion-exchange resin 
under appropriate salt and pH conditions. RNA, protein dyes, and low molecular 
weight impurities are removed by a medium salt wash. Plasmid DNA is eluted in a 
high salt buffer, and concentrated and desalted by isopropanol precipitation. 
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 2.7.3 Digestion of DNA fragments with restriction enzymes 
Digestion with restriction enzymes was carried out as described (Ausubel et al., 
1995). Reaction conditions were those recommended by the manufacturer of the 
enzymes. All reactions were incubated at 37°C overnight. Adding 1X DNA loading 
buffer to the digestion after the overnight incubation stopped the reactions.    
 
2.7.4  Purification of restriction enzyme-digested DNA fragments 
The fragments of interest were carefully removed from the agarose gel after 
electrophoresis and purified using the Concert™ Matrix Gel Extraction System (Life 
Technologies Gibco-BRL) following the manufacturers instructions provided with 
the kit. This method employs a silica resin to which single and double-stranded DNA 
bind without binding any DNA contaminants. The agarose gel is dissolved by sodium 
perchlorate and the DNA is adsorbed onto the silica support (Vogelstein and 
Gillespie, 1979). Adsorption to the silica is influenced by the buffer composition and 
temperature. Agarose and electrophoresis buffers are removed with alcohol-
containing wash buffers. The DNA of interest is then eluted with TE buffer (pH 8.0). 
 
2.7.5 Preparation of competent E. coli cells 
E. coli XL1- Blue cells were made competent to take up foreign supercoiled DNA by 
modification of the method of Hanahan (Maniatis et al., 1989). Exponentially 
growing cells (OD550 =0.4) were pelleted and resuspended in two changes of TFB 
(Table 2). To make the cells competent, DMF (7 µl/200 µl cells) was added. After 5 
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minutes 0.21 M DTT  (7 µl/200 µl cells) was added. After 10 minutes 7 µl DMF/200 
µl cells was added. All steps were carried out at 4°C. Efficiency of transformation 
was typically 5x106 cfu/µg.   
 
2.7.6 Transformation of E.coli cells with plasmid DNA 
Competent E. coli XL1-Blue cells were transformed (Maniatis et al., 1989) with 30-
50 ng DNA per 200 µl aliquots and allowed to stand on ice for 30 minutes, heat 
shocked for 90 seconds at 42°C and returned to ice for 2 minutes. 800 µl cold SOC 
was added and the cells were incubated at 37°C for 45 minutes to 1 hour. Cells were 
then plated onto LB agar selection plates with appropriate antibiotics, or pelleted and 
resuspended in 1 ml SOB + 20% glycerol in eppendorf tubes, snap-frozen in liquid 
nitrogen and stored at –70°C.    
 
2.7.7 Isolation of total RNA from D. melanogaster embryos 
Total RNA was isolated from D. melanogaster embryos by either of two methods:  
(i) High Pure RNA isolation Kit – Roche Molecular Biochemicals. 
(ii) Method using TRIzol® LS reagent – Life Technologies Gibco-BRL. 
 
(i) Isolation of RNA by the High Pure RNA isolation Kit  
Embryos were collected, dechorionated in commercial bleach, and transferred to a 
homogeniser. Embryos were homogenised in 400 µl lysis/binding buffer provided in 
the kit. The homogenate was then loaded onto columns (kit) packed with glass fibre 
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fleece. The RNA binds specifically to the surface of the glass fibres since the binding 
conditions have been optimized for RNA binding. DNase I is then applied directly 
onto the glass fibre fleece and digests the contaminating DNA. The bound RNA was 
then washed and eluted in water. The RNA was heated at 65°C for 10 minutes. 
Concentration was determined by spectrophotometry. The RNA was stored at  –20°C 
until the various developmental stages were collected. RNA prepared by this method 
was used in the RT-PCR reactions. 
 
(ii) Total RNA isolation with TRIzol® LS reagent  
TRIzol® LS reagent is based on the guanidinium method of (Chomczynski, 1993). 
Embryos or adult flies were collected and transferred to a homogeniser. Embryos 
were homogenised in 1.5 ml tubes with 0.75 ml TRIzol/100 mg embryos. For 
isolation of RNA from adult flies, 50 flies were homogenised in 500 µl TRIzol 
reagent. 150 µl chloroform was then added. Samples were spun at 13 000 x g for 10 
minutes at 4°C. The RNA was then precipitated from the supernatant (aqueous layer) 
after the addition of 350 µl isopropanol and incubation at room temperature for 2 
minutes. The RNA was recovered by spinning samples at 13 000 x g for 15 minutes 
at room temperature. The pellet was washed with 70% cold ethanol and dissolved in 
50 µl RNase free water. Samples were heated at 65°C for 10 minutes, and then put on 
ice immediately. Concentrations were determined by spectrophotometry. 50 µg 
aliquots per tube were prepared by precipitating the RNA from the relevant volume 
with 2,5 volumes of 100% cold ethanol. The RNA was stored in ethanol at –20°C. 
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2.7.8 Preparation of whole embryo extracts 
To make small (~ 1 ml) preparations of total proteins, the embryos were collected and 
homogenised in 5X SDS sample buffer using a glass homogeniser. The homogenate 
was then transferred to microfuge tubes and large particulate matter was removed by 
spinning at 10 000 x g for 3 minutes. The supernatant was then retained for protein 
estimation and SDS-PAGE. Protein estimation was done using the Bio-Rad protein 
Assay (Bio-Rad Laboratories, U.S.A.). The assay is a dye-binding assay based on the 
differential colour change of a dye in response to various concentrations of proteins 
(Bradford, 1976). After protein estimation, SDS sample buffer was added and 
samples were loaded onto the polyacrylamide gel.   
 
2.7.9 Preparation of genomic DNA 
Genomic DNA was prepared using a protocol based on the method described by 
(Bender et al., 1983). 20 flies were collected and homogenised in 100 µl grinding 
buffer. After 30 minutes incubation at 70°C, 35 µl of 8 M KOAc was added and 
incubated on ice for 30 minutes to pellet the DNA (Hamilton and Zinn, 1994).  
 
2.8 BIOCHEMICAL METHODS 
 
2.8.1 In situ hybridisation to D. melanogaster embryos 
In situ hybridisation was done to detect the localisation of SNAMA RNA transcripts in 
whole mount D. melanogaster embryos using the method described by (Tautz and 
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Pfeifle, 1989) with modifications to the protocol as followed in Dr Alfonso Martinez-
Arias laboratory (Cambridge) modified by Charlie Oh and Bruce Edgar. Solutions 
were prepared as described in table 5.  
 
Table 5: Solutions used for in situ hybridisation study.  
SOLUTION COMPOSITION 
Phosphate buffered saline (PBS) 7 mM Na2HPO4; 3 mM NaH2PO4; 150 
mM NaCl. 
Phosphate buffered saline with Tween 
20 (PBT) 
PBS; 0.1% Tween 20. 
Embryo wash (10x) 0.4% Triton X-100; 7% NaCl. 
Fixative A PBS; 4% formaldehyde. 
Fixative B PBS; 10% formaldehyde. 
Hybridisation solution (HS) 50% deionised formamide; 5X SSC; 
100 µg/ml sonicated and boiled salmon 
sperm DNA; 100 µg/ml calf liver 
tRNA; 50 µg/ml heparin; 0.1% Tween 
20. 
Staining solution 100 mM Tris (pH 9.5); 50 mM MgCl2; 
100 mM NaCl; 1 mM Levamisole; 
0.1% Tween 20. 
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Collection and preparation of embryos 
Embryos were collected from apple juice agar plates by washing them with water into 
a small basket. The embryos were then dechorionated in commercial bleach for 2-3 
minutes and washed thoroughly with alternate changes of water and 1X embryo wash 
to remove the bleach. After the last wash with water the basket was dabbed briefly on 
a paper towel to remove excess water. The embryos were then collected into a 2 ml 
tube containing a 1:3 mixture of Fixative A: Heptane.  
 
Fixation and devitellinisation 
The embryos were fixed by shaking vigorously for 20 minutes. After removing the 
aqueous phase and the heptane, the embryos were devitellinized by shaking 
vigorously in methanol at room temperature. The methanol was then removed, and 
new methanol was added to wash the embryos. The methanol wash step was repeated 
3 times. The embryos were then stored in methanol at –20oC.  
 
Preparation of probes 
The probe was prepared from the POT2 vector (Figure 18) containing the cDNA for 
SNAMA. The vector was obtained from the BDGP EST sequencing project. This 
vector was digested with EcoRI and XhoI (see section 2.7.3) releasing a 914 bp 
SNAMA fragment. For a positive control, the dpp gene was used. The vector 
containing the dpp gene was digested with EcoR1 and Hind III releasing the 3200 bp 
fragment. These digests were run on a 1.5% TBE agarose gel. The bands at 914 bp 
for SNAMA and 3200 bp for dpp were excised. These DNA fragments were purified 
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out of the gel fragments using the Concert™ Matrix Gel Extraction System (Life 
Technologies) (see section 2.7.4).       
 
Labeling of probe with digoxigenin-11-dUTP 
DNA fragments to be used as probes were labelled with digoxigenin-11-dUTP by the 
random primed technique using the Dig-High Prime enzyme mix (Roche Molecular 
Biochemicals) as per the manufacturer’s protocol. 1 µg of DNA was made up to 16 µl 
with deionised water, boiled for 10 minutes and chilled immediately for 5 minutes in 
an ethanol bath at –20oC. The tubes were then placed on ice and 4 µl Dig High Prime 
enzyme mix was added. The reaction was then incubated at 37°C overnight. The 
labelling reaction was stopped by heating at 65°C for 10 minutes.  
 
Removal of unincorporated free DIG-dUTP 
The unincorporated free DIG-11-dUTP nucleotides were removed using the High 
Pure PCR Product Purification Kit (Roche) as per the manufacturers protocol. The kit 
contains High Pure filter tubes pre-packed with special glass fibres. In the presence of 
the chaotropic salt, guanidine thiocyanate, the labelled DNA binds selectively to the 
surface of the glass fibres in the column. The wash steps remove the unincorporated 
free nucleotides. The bound DIG-labelled DNA is then eluted using a low-salt buffer.  
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Yield of the DIG-High Prime labelling reaction 
The yield of DIG-labelled DNA was then estimated using the DIG Quantification and 
DIG Control Teststrips (Roche) following the manufacturers instructions. Briefly, a 
series of dilutions of the DIG-labelled DNA is applied to the squares on the DIG 
Quantification Teststrips. DIG Control Teststrips are already loaded with 5 defined 
dilutions of a control DNA and are used as standards. The teststrips are then 
subjected to immunological detection with Anti-Digoxigenin-AP conjugate and the 
premixed colour substrates NBT/BCIP. The DIG labelling efficiency is then 
determined by visually comparing the signal intensities of the spots on the 
quantification teststrips with those on the control teststrip. Before hybridisation, 50 
ng of the labelled probe in 40 µl HS was boiled for 10 minutes and immediately 
chilled in an ethanol bath (-20°C) for 5 minutes, made up to 100 µl with HS and used 
immediately on the prehybridised embryos.  
 
Hybridisation and staining 
Before hybridisation the embryos were aliquoted into 50 µl volumes, rinsed in 1 ml 
methanol, again in PBT-methanol (1:1), in 1 ml PBT and then “postfixed” (a second 
fixation step) by shaking in Fixative B for 20 minutes at room temperature. The 
embryos were then rinsed twice, washed for 5 minutes and rinsed once again in PBT. 
They were then incubated for 3 minutes in PBS containing 50 µg/ml Proteinase K. 
The digestion was stopped by removing the Proteinase K solution and adding PBT 
containing 2 mg/ml glycine for 2 minutes. Embryos were then washed 2 x 5 minutes 
in PBT. Embryos were re-fixed in 5% formaldehyde in PBS for 20 minutes. This was 
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followed by 5 x 5 minute PBT washes. The PBT was replaced with 1:1 mixture of 
PBS: Hybridisation buffer (HS) and the tube was rotated for 20 minutes at room 
temperature followed by a further 30 minutes in HS at room temperature. To pre-
hybridise, fresh HS was added and the tubes containing embryos were immersed in a 
water bath at 48°C for an hour. To hybridise, 100 µl of probe was added after the 
removing of HS. The tubes were then immersed in a water-bath at 48°C and left 
overnight without agitation. The following day 500 µl of HS (preheated to 48 °C) was 
added and the tubes were returned to the 48 °C water-bath for a further 15 minutes. 
This was followed by several 500 µl washes in decreasing concentration of HS in 
PBT: 70% at 48 °C, 50% at 48 °C, and 30% at 48 °C, rinsed twice in PBT, then 
washed three times for 5, 10, and 15 minutes in 1 ml PBT at room temperature. At 
this stage, the embryos were transferred to a multi-well (tissue culture) dish and 
incubated at room temperature with agitation for 2 hours in pre-absorbed alkaline 
phosphatase-conjugated anti-Digoxigenin antibody (supplied in the DIG High Prime 
Labelling and Detection Kit I from Roche Applied Science) diluted 1/2000. To detect 
the alkaline phosphatase linked to the anti-DIG antibody, the embryos were rinsed 4 x 
20 minutes in PBT, followed by 2 x 5 minute washes with the staining solution. To 
the last rinse 8 µl of the colorimetric substrate premix NBT/BCIP (supplied in the kit) 
was added and the embryos were incubated without agitation in the dark at 4°C. 
Staining takes 30 minutes to several hours. Washing in PBT stopped the reaction.  
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Mounting 
The embryos were washed thoroughly in PBS and then in increasing concentration 
(30%, 50%, and 80%) of glycerol in PBS. In this form, the embryos could be placed 
on a microscope slide with a coverslip and sealed with nail varnish. 
 
2.8.2 Northern hybridisation 
Agarose gel electrophoresis and transfer of RNA to membrane 
RNA was detected as described previously (Maniatis et al., 1989). Total RNA from 
various stages of embryo development was extracted as described in section 2.7.7 (ii). 
The ethanol was removed from the RNA samples by suction followed by a 70% 
ethanol wash step. After the wash step the RNA was dried at 37°C for 2 minutes. To 
this, 20 µl RNA loading buffer was added. The samples were heated at 65°C for 10 
minutes and then placed on ice. The RNA populations were then separated according 
to size by electrophoresis through 1% agarose gels containing 6% formaldehyde cast 
in 1X MOPS buffer. The RNA was transferred onto Hybond™ Nylon hybridisation 
transfer membranes (Amersham Pharmacia biotech) by capillary transfer in 10X SSC. 
To fix the RNA, the slightly damp membrane was exposed to 120 000 µjoules/cm2 
UV light for 30 seconds using the Stratagene UV crosslinker.  
 
Labelling of DNA probe with [-32P]dCTP  
The rediprime™ II (Amersham Pharmacia biotech) random prime labelling system 
was used following the manufacturer’s instructions. Typically 25 ng linearised and 
denatured DNA was labelled with Redivue [-32P] dCTP (Amersham Pharmacia 
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biotech) using the individually dispensed Rediprime reaction mix. The reaction mix 
consists of a buffered solution of dATP, dGTP, dTTP, exonuclease free Klenow 
enzyme and random primers in a dried, stabilised form. Reactions were labelled 
overnight at room temperature. After labelling, the unincorporated free nucleotides 
were removed using the High Pure PCR Product Purification Kit (Roche Applied 
Science) as per the manufacturers protocol (see section 2.8.1). 14 µl of the labelled 
probe per 5 ml hybridisation buffer was used as recommended by the manufacturers.  
 
Hybridisation and detection 
Blots were hybridised using the Rapid-hyb buffer (Amersham Pharmacia biotech) 
following the manufacturers protocol. This rate enhanced hybridisation buffer allows 
single copy genes to be detected after only a 2 hour hybridisation with 32P labelled 
DNA probes at 65°C. The non-specifically bound radiolabels were removed by 2 
washes with 0.1X SSC buffer at 65°C. Blots were wrapped in UV-transparent wrap 
and autoradiography was performed at –70°C. 
  
Stripping of blots to be reprobed 
The probe was removed from the blot by pouring a boiling solution of 0.5% (w/v) 
SDS solution. The membrane was allowed to cool to room temperature before it was 
pre-hybridised and hybridised with a new probe. Typically membranes were probed 
twice.  
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2.8.3 The polymerase chain reaction (PCR) 
The site of the integration of the P-element in l(2)rQ313 and the mobilization of the 
P-element in the excision crosses was confirmed by PCR.  The DWNN specific 
primers DWNN2 and DWNN4, and the P-element primers Plac4 (P-element 5' flank) 
and Pry4 (P-element 3' flank) were used. DNA was amplified using the Expand High 
Fidelity PCR System (Roche Applied Science). The system is composed of a unique 
enzyme mix containing thermostable Taq DNA polymerase and a proofreading 
polymerase (Barnes, 1994). The final amounts used were: 
DNA sample  400 ng 
Primers  0.3 µM 
10X PCR buffer with 15 mM MgCl2  1X 
dNTP mix  2.5 mM 
Expand High Fidelity enzyme mix  0.1 U/µl 
     
The cycle conditions were: denaturation at 94°C for 30 seconds, annealing at 60°C 
for 30 seconds and extention at 68°C for 1 minute over 35 cycles.  
 
2.8.4 Reverse transcription PCR (RT-PCR) 
A quantitative RT-PCR was performed using the Access RT-PCR system (Promega) 
using volumes suggested by the manufacturer. The L18 gene (Ntwasa et al., 1994) 
was used as a control for equal amounts of RNA loading. The following amounts 
were used:  
RNA sample 2 µg 
Primer 1 (DWNN1/L18F) 1 µM 
Primer 2 (DWNN2/L18R) 1 µM 
AMV/Tfl 5X reaction buffer 1X 
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dNTP mix 0.2 mM 
MgSO4 1 mM 
AMV reverse transcriptase 0.1 U/µl 
Tfl DNA polymerase 0.1 U/µl 
Nuclease-free water Final volume of 50 µl 
  
The cycle conditions were as follows: 48°C for 45 minutes; 94°C for 2 minutes; 
followed by 40 cycles of:  94°C for 30 seconds, 55°C for 1 minute, 68°C for 1 
minute; and a final extension at 68°C for 7 minutes. 
 
2.8.5 Western blotting 
Whole embryo extracts (section 2.7.8) were electrophoresed on a 6% polyacrylamide 
gel and transferred with Towbin buffer to a Hybond–P: PVDF membrane (Amersham 
Bioscience) (Towbin et al., 1979). Non-specific binding to the membrane was 
prevented by blocking with the SuperBlock™ Dry Blend Blocking buffer (Pierce). 
The blot was incubated with either anti-SNAMA or anti-Dmp53 antibody. The anti-
SNAMA antibody used was prepared by immunising rabbits against the DWNN 
domain of the SNAMA protein and the anti-Dmp53 antibody was obtained from 
Santa Cruz Biotechnology (p53 (dD-21), 200 µg/ml). The p53 (dD-21) antibody is an 
affinity purified goat antibody raised against a peptide mapping within an internal 
region of p53 of D. melanogaster origin.  
 
The primary anti-SNAMA antibody used was a 1:10 000 dilution for 1 hour, and a 
1:10 000 dilution of peroxidase conjugated goat anti-rabbit immunoglobulin 
secondary antibody (Sigma-Aldrich) for 1 hour. A 1:3000 dilution of anti-Dmp53 and 
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a 1:10 000 dilution of peroxidase conjugated rabbit anti-goat immunoglobulin 
secondary antibody (Santa Cruz Biotechnology) was used. To block the Dmp53 
antibody binding site, Dmp53 blocking peptide (Santa Cruz Biotechnology) was used 
at a concentration of 20 ng/ml. Between steps, the membrane was washed in PBS + 
0.1% Tween 20 twice for 10 minutes each time except after the secondary antibody 
when it was washed three times for 5 minutes in PBS + 1% Tween 20. Bound 
primary antibody was detected using the SuperSignal® West Pico chemiluminescent 
substrate (Pierce) after a 30 second exposure to X-ray film. Blots were stripped of 
blocking reagent, antibody and SuperSignal® substrate by incubation for 30 minutes 
at 70°C in Western stripping buffer. Membranes were then washed twice for 10 
minutes per wash before they could be reprobed as indicated before. 
 
To activate the Dmp53 pathway larvae were allowed to develop on media 
supplemented with the topoisomerase inhibitor Camptothecin. Camptothecin has 
been shown to activate the p53 pathway (Takada et al., 2003). Larvae media was 
prepared as before and supplemented with either 1mM Camptothecin, or DMSO. The 
DMSO control was set up since Camptothecin was dissolved in DMSO. Larvae were 
allowed to develop overnight on this media and proteins were collected as before. A 
Western blot was performed and probed with the anti-SNAMA and anti-Dmp53 
antibody. 
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2.8.6 Acridine orange staining 
To detect cells undergoing apoptosis embryos were stained with acridine orange 
(Abrams et al., 1993). They were dechorionated in bleach, washed with embryo 
wash, and then rinsed with water. The embryos were then placed in equal volumes of 
heptane and 5 µg/ml acridine orange (Sigma-Aldrich) in a 0.1 M sodium phosphate 
buffer, pH 7.2. After shaking for 5 minutes, embryos at the interphase were removed 
and placed on a cavity slide with Series 700 halocarbon oil (Sigma-Aldrich). The 
samples were viewed using a confocal microscope. 
 
2.8.7 Cuticle preparation 
Wild type embryos were collected on apple juice agar plates. They were allowed to 
age for 24-36 hours at 25°C. Unhatched embryos were rinsed into a nytex screen and 
dechorionated in commercial bleach until the embryos float to the surface. Embryos 
were rinsed and transferred to a vial with a 5 ml PBS/5 ml Heptane mixture. Embryos 
in upper heptane solution were then transferred to another tube, the volume was 
adjusted to 0.5 ml and an equal volume of 4% paraformaldehyde in PBT was added. 
Tubes were shaken for 20 minutes after which the lower aqueous layer was removed. 
An equal volume of methanol was added and tubes shaken for 15 seconds to 
devitellenize embryos. At this step most of the embryos settled to the bottom of the 
tube. Liquid was removed and embryos were washed 3X with methanol. They were 
then incubated in 1:4 glycerol: acetic acid for 1 hour at 65°C. Embryos were mounted 
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on glass slides in a drop of Hoyer’s Mount and dried overnight at 60°C. Cuticles were 
examined using dark field microscopy. 
 
For the P-element mutant P{PZ}l (2)rQ313rQ313 unhatched embryos were picked from 
apple juice agar plates into water in a small dish. The embryos were dechorionated 
with undiluted bleach added to the dish and washed with embryo wash and water. 
The embryos were incubated in 1:4 glycerol: acetic acid for 1 hour at 60°C. Embryos 
were cooled to room temperature, mounted on glass slides in a drop of Hoyer’s 
mount and viewed using dark field microscopy.      
 
2.9 BIOINFORMATICS 
 
Sequence alignments and phylogenetic trees were completed using the DNAMAN 
programme version 4.03 (Lynnon BioSoft). This programme was used for the 
generation of the phylogenetic tree. This tree is setup with the distance matrix using 
the Neighbor-Joining method (Saitou and Nei, 1987). Protein domains of SNAMA 
were identified by the SMART (Simple Modular Architecture Research Tool) 
program (Schultz et al., 1998), Pfam protein family database (Bateman et al., 2004) 
and ScanProsite (Hulo et al., 2004). For promoter prediction, the BDGP 1999 Neural 
Network Promoter Prediction (NNPP) version 2.2 programme was used (Reese, 
2001). Pair sequence alignments of the DWNN domain from various organisms was 
done using the ALIGN Query on the Genestream server at Genestream Resource 
Centre in France (Pearson et al., 1997). The ubiquitin-like domain and the secondary 
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structure of DWNN was analysed using FUGUE v2.s.07 (Shi et al., 2001) and 
PSIPRED (Jones, 1999). A comparison of the secondary structure of ubiquitin to the 
DWNN domain of SNAMA was made using the Network Protein Sequence Analysis 
tool (NPSA) (Combet et al., 2000). The web addresses of the bioinformatics tools 
used are listed in table 6. 
 
Table 6: Web addresses for the various bioinformatics tools used. 
TOOL WEB ADDRESS 
ALIGN Query www2.igh.cnrs.fr/bin/align-guess.cgi 
BLAST http://www.ncbi.nlm.nih.gov/BLAST 
FlyBase http://flybase.bio.indiana.edu 
FUGUE http://www-cryst.bioc.cam.ac.uk/fugue 
GeneBank http://www.ncbi.nlm.nih.gov 
NNPP http://www.fruitfly.org/seq_tools/promoter.html 
NPSA http://www.cmpharm.ucsf.edu/~nomi/nnpredict.html 
Pfam http://pfam.wustl.edu/hmmsearch.shtml 
PSIPRED http://bioinf.cs.ucl.ac.uk/psipred 
ScanProsite http://ca.expasy.org/tools/scanprosite 
SMART http://smart.embl-heidelberg.de 
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CHAPTER 3 
 
 
IDENTIFICATION AND SEQUENCE ANALYSIS OF SNAMA, 
THE DWNN-CONTAINING HOMOLOGUE, IN  
Drosophila melanogaster 
 
 
3.1  Introduction 
3.2 Sequence analysis of the SNAMA gene 
3.3 The domain organisation of SNAMA 
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3.1 INTRODUCTION 
 
This research describes the Drosophila melanogaster homologue of a gene product 
identified by Dr Allison George. She used a system of promoter trap retrovirus to 
induce mutations in Chinese hamster ovary (CHO) cells (Chang et al., 1993; Hubbard 
et al., 1994; George, 1995), to create cell lines that are defective in the processing or 
presentation of antigen by the major histocompatibility complex (MHC) class I 
molecules. She was interested in identifying novel components of the cellular 
pathways involved in the recognition and killing of target cells by cytotoxic T 
lymphocytes (CTL). Dr George created CHO cell lines that were susceptible to lysis 
with specific CTL and were susceptible to infection with the defective murine 
retrovirus (the insertional mutagen). These cells were then infected with the 
promoter-less retrovirus to create loss of function mutants in the immunity pathways. 
Clones resistant to CTL killing were then selected and their DNA analysed to identify 
which genes have been disrupted. These mutational experiments generated 
approximately 40 mutant clones that are defective in the antigen processing or 
presentation pathway (George, 1995), three of which showed 100% resistance to CTL 
killing compared to the parental cell line, whilst the rest of the clones tested showed 
reduced levels of resistance. The process of target cell killing by CTL occurs by 
mechanisms closely related to those described for apoptosis.  
 
Foreign viral proteins within the cell cytoplasm of antigen presenting cells are 
processed and presented to the cell surface by MHC class I molecules. Upon 
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presentation of these epitopes to the cell surface the specific CTL engages with the 
antigen presenting cell. The antigen presenting cell is then lysed by one of two 
mechanisms: either the secretion of soluble cytolytic proteins of lymphocytic origin, 
or the engagement of the Fas molecule with its ligand FasL to induce apoptosis. 
Although the induction of apoptosis by the FasL/fas interaction and by apoptosis 
inducing chemical agents follows different pathways, the activation of caspase is a 
central event in both pathways. Thus the CTL resistant cell lines were further 
screened for resistance to apoptosis induction by various apoptosis inducing agents. 
Three CTL resistant cell lines were found to show resistance to apoptosis induction 
by staurosporine (the chemical inducer of apoptosis) (Pretorius, 1999).  
 
One of these cell lines labelled Mut 7(3xHA8)3.5hrs was analysed by inverse PCR to 
obtain the 5 sequence adjacent to the site of retroviral integration (Pretorius, 1999). 
This sequence matched 21C4 in the human EST (expressed sequence tag) database 
without any entries in the DNA or protein databases. The full-length 21C4 sequence 
of 929 bases was compared with the protein database using BLASTX 2.0 (basic local 
alignment search tool) to identify open reading frames from homologies. The 
matching related protein sequences were aligned using CLUSTAL X multiple 
sequence alignment software. The sequence alignment showed a significant match to 
a highly conserved N-terminal domain called Domain With No Name (DWNN), 
found in a wide variety of eukaryotic organisms but is absent in prokaryotes (Figure 
7).  
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Figure 7:  Amino acid sequence and alignment of the conserved DWNN domains with homologous DWNN domains from a 
variety of eukaryotic organisms. In H.sapiens two transcripts have been identified and have been labelled 1 and 2. The high level 
of conservation indicates that this gene codes for an important and well-adapted protein. The alignment was completed using 
DNAMAN version 4.03 (Lynnon BioSoft). Identical residues are shaded in black, residues with greater/equal to 75% homology 
level to the consensus are shaded in pink and residues with a homology level greater/equal to 50% are shaded in blue.  
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MSSTIFYRFKSQRNTSRILFDGTGLT.VFDLKREIIQENKLGDGTDFQLKIYNPDTEEE.YDDDAFVIPRSTSVIVKRSPAIKSF
MSGVIYYKFKSQKDPSRITFDGTIGMSVFDVKREIIMQKKLGNGLDFDLLLYNANSNEE.YDDDTFIIPRSTSVIVRRVPAQKSG
..MAIYYKFKSARDYDTIAMDGPFISVGILKDK..IFETKHLGTGKDLDIVVSNAQTNEEYLDEAMLIPKNTSVLIRRVPGRPRI
MESSVFFKFKSNKEPTRVEFDGTGI.SVFELKREIILKSALGDGTDFDLIIAADEGMKEVYDDDTTIIPRSTTVIARRMPAKVQGRG
MTSVINYRFRSNKNFSRISFQGTGLPLWELKYEIINQRKMVSK..DFDLLFFDGETNEEINDEYQVVSMNSHVIVSRIPLWMSKGG
MSSTIFYRFRSQKDPSRILFDGTGIT.VFDLKRDIIQENKLGDGTGFQLRLYNPDTGEE.YDDDGTVVARSSMVIVRRAPAEHGVAG
LDKVKASKFKSARDYDSIPIEGQFISVANLKER..IFESKHLGRGTDFDLMISNAQTDEEYADEATMIPKNTSVLIRRIPGRPRKP
s ykfks dti fdg is lkk i k l d dl naq keey dd ip n svivrr p  
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The gene is also found in organisms with primitive genomes. The DWNN gene is 
found in protozoa species that have a minimum complement of genes essential for 
viability. This level of conservation between such diverse groups of organisms is rare 
and indicates that the function and structure of the gene product is both important to 
the organism and is a well-adapted protein.  
 
The DWNN homologues have been isolated in human (RBBP6) (Sakai et al., 1995), 
mouse (PACT) (Simons et al., 1997) and in yeast (Mpe1) (Vo et al., 2001) (see 
section 1.5.2). This chapter describes the identification of the DWNN protein in 
Drosophila melanogaster. This multicellular organism provides an environment that 
is easy to manipulate in which to investigate the biological function of DWNN. The 
D. melanogaster DWNN protein has been named SNAMA. The word SNAMA is 
from the Xhosa language meaning “something that sticks like glue”. A pair sequence 
alignment (Pearson et al., 1997) of proteins containing the DWNN domain was 
completed (Table 7). This supported the alignments that show that the DWNN 
proteins are highly conserved through diverse species. These proteins are 
homologous to SNAMA. The yeast homologue Mpe1 is involved in 3 end mRNA 
processing while the mammalian forms have been shown to interact with p53 and Rb. 
None of the identified homologues of SNAMA have as yet been fully characterised 
and thus this study will characterise the D. melanogaster homologue. The highest 
level of conservation between the proteins is within the first 76 amino acids, the 
DWNN domain region. The homologues lack some of the domains associated with 
SNAMA.    
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Table 7: A species comparison of the DWNN sequences. DWNN sequences from the indicated species were compared in pairs 
using the Align query at the Genestream Resource Centre and the percentage identities between them were recorded.      
 
 
D.melanogaster A.thaliana H.sapien M.musculus S.pombe O.sativa S.cerevisiae C.elegens A.gambiae 
D.melanogaster 
--- 51.3 64.9 64.9 53.2 48.7 48.7 46.8 63.6 
A.thaliana 51.3 --- 46.8 46.8 48.1 64.1 41.0 33.8 42.1 
H.sapien 64.9 46.8 --- 98.7 44.3 44.9 42.3 51.3 51.9 
M.musculus 64.9 46.8 98.7 --- 44.3 44.9 42.3 51.3 51.9 
S.pombe 53.2 48.1 44.3 44.3 --- 43.0 64.6 39.2 41.5 
O.sativa 48.7 64.1 44.9 44.9 43.0 --- 41.0 28.2 41.0 
S.cerevisiae 48.7 41.0 42.3 42.3 64.6 41.0 --- 37.2 35.9 
C.elegens 46.8 33.8 51.3 51.3 39.2 28.2 37.2 --- 37.2 
A.gambiae 63.6 42.1 51.9 51.9 41.5 41.0 35.9 37.2 --- 
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Both the human and the D. melanogaster proteins have a high percentage identity 
(64.9%). High levels of protein sequence similarity between different organisms 
suggest a common structure. Structural information about homologous domains will 
be used in molecular modelling techniques, which may give insight into the function 
of these proteins. This together with experimental data will elucidate the function of 
this recently identified protein.   
 
3.2 SEQUENCE ANALYSIS OF THE SNAMA GENE 
 
A search of FlyBase using the mammalian short DWNN gene revealed a perfectly 
matched gene CG3231 (FlyBase ID FBgn0027522) and a genomic scaffold 
(GenBank accession number AE003463.2) in Drosophila melanogaster. The gene is 
localised at 60B9 on chromosome 2R (Stapleton et al., 2002a). The protein and DNA 
sequence for SNAMA corresponds to a gene with GenBank accession number 
AF132177. The SNAMA sequence was obtained from the 1999 EST (Expressed 
Sequence Tag) project of BDGP (Rubin et al., 2000; Stapleton et al., 2002a; 
Stapleton et al., 2002b) EST clone BcDNA: LD21643.  
 
The sequence was examined visually and aligned onto the genomic scaffold (Figure 
8). The transcriptional unit of SNAMA consists of an open reading frame of 1231 
amino acids with a predicted molecular mass of 139 kDa. Although the predicted 
translational start at position 1702 bp of the genomic sequence is not in the best 
context of D. melanogaster consensus sequence C/AAA/CATG (Cavener, 1987), 
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there is no other upstream methionine codon and there is an upstream in frame stop 
codon (Mather et al., 2005). The translational initiation site identified for SNAMA is 
CAACTATG. This highly basic protein (pI 10.16) contains the 76 amino acids 
conserved DWNN domain. The overall putative protein is highly charged with 27.4% 
basic residues and 15% acidic residues. The C-terminal lysine rich region by itself 
has more than 59% basic residues making it unusually charged. 
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     1    gcgcgaggaccgcctacaccaccatcttctcaacctctgtcgttcccacagctgtcacta 
     61   gattaataaccgccaccattcccggccagccaGGCCAATCCTTCCCCAACTACTTTCCGC 
     121  CTCCTTACAATCCATTCGCCTATGTTGGCTAGTTTTTAGGAGCATCTACGCAAGCGAGAG 
     181  TGTCTAACCCCATTACTTCTTTGTAATTAGGAATCCTGTATTATATTTAAGAACACGTGC 
     241  AAATATCGAAAAGGCGGTGATACAAAAAGCAGTAGATTTTATTATATTGTATGTGCACTT 
     301  TGTCGCAAAAGTTGTTAATGTAAATACTCGAGTTAAGACTAAATTAGGATTGCATCGAAT 
     361  TTTTTGGATCTAAGATAAGCAAAATATGGTTGTAGTTCGGTTTAACTGATGTTAATAAAT 
     421  TTTTGAACCCTTTTATTCCCTAAATTAGTTTTTCATTCCGTATTTACTGCAGCTTAAGAG 
     481  TTATTTGATTCTTCAAATGATCGATACTAATAGTTATACACTGTGTTCCATTCCACCGTT 
     541  TCACGCGGAAGAGAACCGACAGAAATGCAGAATTGCTGCCTTTGCAAACAATATATAGAA 
     601  ATCGATTCCCAGCTATGCACATTTACCAAATGCTTTCCGTTACAACACTTATCAACATTA 
     661  TCTAATAAAGTTCAATACTTTCACTTTGTAATATAAATTACACTCCAACATCGATATCGA 
     721  TATCTGTGTCTCTATCGATACCCGCGTGTGCGTTCGCATTTCACATCTCTGGGGCTTTGG 
     781  CGTCACGTTCGCATCTCTAGTAAATTGGAAAAAAATAAAATCGTCGGAGTTTTTATGTGC 
 
     841  TTGCAGAGTAGTgtaagtaattgctatttttgtgccagctgcttgccggtagtaaacaac 
 
     901  gcgcgtgaactgtgatgccttgcaatcctcagcgcaattcaagtgcggtttaagtccgaa 
     961  cgacccaagaaacccgaagtgtacgtacatatgtatgttttcgcgtgtgtatttttatgc 
     1021 acatgcaattctatgctgctgccatgcaaaggtgcaaaaaatgcgaaatgcaaatatcgt 
     1081 tcacagaatgcccattgatctgaccggattttaggtggcacatacgcatatgcatatagc 
     1141 atgttcccggaattgtgcaacttcgcatacatacatatgtaatgtcttatgttggcataa 
     1201 ttatccgctgttcaagggaagtgcatggtgcaaatcgggaatctatattcggcatacttt 
     1261 ggtaaagggccaatgagatcgtatttattagaaaattgcccatccgccgtaatatatagc 
     1321 acagcaccaatgattaagttcgcacttccatcttatcccgaagcaatcaagaatgatttc 
     1381 tgaacctgcatggcttgctactgcttagtagcttattttagtgatctcttaagatttgat 
 
     1441 gcaatatcatgtttcccactaatcgactatatgcatagtttcagttttagactgtccact 
     1501 taaacgtgttaatcatgtttttaggattgcagcgcattgtcacacacattatctaaacag 
     1561 ctttatctgtttgtttattaagatatttatgaagcatattatgtattccccctgctttga 
     1621 ctctgataacgcaagtgccgtggacactataagataatcgtatttaatctcttcttcgca 
     1681 gATTTCTTTCATATGCAACTATGTCGGTACACTATAAATTTAAGAGTACACTCAACTTTG 
                               M  S  V  H  Y  K  F  K  S  T  L  N  F    
  
     1741 ATACAATTACTTTTGATGGACTTCACATTTCTGTCGGGGACTTAAAAAGGGAGATTGTGC 
          D  T  I  T  F  D  G  L  H  I  S  V  G  D  L  K  R  E  I  V      
 
     1801 AGCAGAAGCGACTGGGCAAAATCATCGACTTTGATCTCCAAATAACAAATGCGCAGAGTA 
          Q  Q  K  R  L  G  K  I  I  D  F  D  L  Q  I  T  N  A  Q  S   
    
     1861 AAGAAGgtatgtccaccgcaatttagaatttttcccctgctacatggcttccttcccttt 
          K  E  
 
     1921 tccagAATACAAGGACGATGGGTTCCTTATTCCCAAAAACACAACGCTGATCATATCGCG 
               E  Y  K  D  D  G  F  L  I  P  K  N  T  T  L  I  I  S  R 
 
     1981 CATCCCCATCGCCCATCCCACAAAAAAGGGCTGGGAGCCACCAGCAGCAGAAAATGCCTT 
            I  P  I  A  H  P  T  K  K  G  W  E  P  P  A  A  E  N  A  F 
 
     2041 TTCGGCGGCGCCTGCCAAGCAGGACAACTTCAACATGGACCTGTCCAAAATGCAAGGCAC 
            S  A  A  P  A  K  Q  D  N  F  N  M  D  L  S  K  M  Q  G  T 
 
     2101 GGAGGAGGACAAAATCCAGGCCATGATGATGCAGAGCACAGTCGACTATGATCCTAAGAC 
            E  E  D  K  I  Q  A  M  M  M  Q  S  T  V  D  Y  D  P  K  T 
      
     2161 gtatgtggttttaaattgttacaaaaccacctatctaatgtattttctgtttagGTACCA 
                                                                  Y  H 
 
     2221 TCGTATTAAAGGACAATCGCAAGTGGGAGAAGTTCCCGCATCCTACCGATGCAACAAATG 
            R  I  K  G  Q  S  Q  V  G  E  V  P  A  S  Y  R  C  N  K  C   
     P-element 
 82 
  
     2281 CAAGAAAAGCGGACACTGGATCAAAAACTGTCCCTTTGTGGGGGGAAAGGACCAGCAAGA 
            K  K  S  G  H  W  I  K  N  C  P  F  V  G  G  K  D  Q  Q  E 
      
     2341 GGTCAAACGGAATACTGGTATTCCGCGGTCTTTCCGCGACAAGCCAGATGCGGCTGAGAA 
            V  K  R  N  T  G  I  P  R  S  F  R  D  K  P  D  A  A  E  N   
   
     2401 CGAATCAGCCGATTTTGTGCTGCCTGCTGTACAAAACCAAGAGATACCGGAGGATCTGAT 
            E  S  A  D  F  V  L  P  A  V  Q  N  Q  E  I  P  E  D  L  I   
  
     2461 ATGCGGCATATGCCGAGATATATTCGTCGATGCTGTCATGATACCCTGCTGCGGAAGTTC 
            C  G  I  C  R  D  I  F  V  D  A  V  M  I  P  C  C  G  S  S 
 
     2521 CTTTTGTGACGACTGTGTGCGAACCTCCTTATTGGAGTCAGAGGATAGTGAGTGCCCCGA 
            F  C  D  D  C  V  R  T  S  L  L  E  S  E  D  S  E  C  P  D 
 
     2581 TTGCAAGGAGAAGAACTGTTCGCCTGGCTCCCTGATACCTAATCGGTTCTTGAGGAATTC 
            C  K  E  K  N  C  S  P  G  S  L  I  P  N  R  F  L  R  N  S 
 
     2641 GGTGAACGCCTTTAAAAATGAGACTGGGTATAACAAAAGCGCGGCTAAGCCAGgtaagtt 
            V  N  A  F  K  N  E  T  G  Y  N  K  S  A  A  K  P   
 
     2701 cattatactcgtttgcatcgcttaatgcaaatgaatcgaatttctctttttagCTGCAGT 
                                                               A  A  V 
 
     2761 AAAAAATGAGGAAAAACCTCCTGTTGAAAAAGAAGTGGAGAAAAAGCCAGTCGCGGAGGT 
            K  N  E  E  K  P  P  V  E  K  E  V  E  K  K  P  V  A  E  V 
 
     2821 GGAACCCGAAGAGACTGAGGTGAAACCTGAAAAGCAAAAAGAATCCGAAACCAATGGCAG 
            E  P  E  E  T  E  V  K  P  E  K  Q  K  E  S  E  T  N  G  S 
 
     2881 TAATCCGCCAAAATCGGAATCTCCAGAGCCTCCCGCAACCACAGAACCATCACAGAAGGA 
            N  P  P  K  S  E  S  P  E  P  P  A  T  T  E  P  S  Q  K  E 
 
     2941 GAAAGATAAATATGATTCAGACTACGAGGATAACATTACCATAAAAATGCCCCAGCCTGC 
            K  D  K  Y  D  S  D  Y  E  D  N  I  T  I  K  M  P  Q  P  A   
 
     3001 AGCTGATTCTACAACAGTGCCCAGCAAAgtgagacatacatatttgacacatctgcaaca 
            A  D  S  T  T  V  P  S  K 
 
     3061 tagatacataattattgccttaatgtttcagAGATCCCCCAGTTATTCCCACAGAAGTGA 
                                          R  S  P  S  Y  S  H  R  S  E 
  
     3121 ATCCTCTCATCGACGGGACAGGTCGGATTATGTTTCCGATCACGATCACAAGCACCAACG 
            S  S  H  R  R  D  R  S  D  Y  V  S  D  H  D  H  K  H  Q  R   
 
     3181 TCCATCAAAATCGGAGTCTGTTAACAAGGATCGCAGTCTCCTGCCCTTGCCCATTGGCAC 
            P  S  K  S  E  S  V  N  K  D  R  S  L  L  P  L  P  I  G  T 
 
     3241 CCTGCCTAGCTACCAGGGCCACATGATGGCCGAATCAGAAGAAGCTCGTCGATCGAGTGC 
            L  P  S  Y  Q  G  H  M  M  A  E  S  E  E  A  R  R  S  S  A 
 
     3301 CTATAAGCCCCCTTATATGCAAATGCAGCGGGGCCCACCTCCTATGCACATGATGAGTCA 
            Y  K  P  P  Y  M  Q  M  Q  R  G  P  P  P  M  H  M  M  S  H 
 
     3361 CCACATGCCAGCCTACAACAACGGGTTTAACAACATGGGACAGAGGCCTCCCCTCAGgta 
            H  M  P  A  Y  N  N  G  F  N  N  M  G  Q  R  P  P  L  S 
 
     3421 ggtttcttttccacccgtccggatcccgctaccatgtggatcgagtcaagtgtcgaggcc 
     3481 actggaactccgaggtgttgacgagtccatacgcagccggtcctgcctgatctcaatatt 
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     3541 tttaagttccaacagagactatacacacacactagttaagagtaatttaagctctgggct 
     3601 ctgcgcctttatgctttgttgaatattggttattcctaattaaaacagtattgcttacaa 
     3661 tcaacgttaagctttttgaattgtaattaacttctaaaatttcagCTATGTGCCGTATCA 
                                                         Y  V  P  Y  Q 
 
     3721 AAACCAATCCGTACACCCAATGCGTGCGCCGTACGGATCTGCAGGCGGAGGTATGAATAT 
            N  Q  S  V  H  P  M  R  A  P  Y  G  S  A  G  G  G  M  N  M   
      
     3781 GAATATGTCACAACCATTTCAGTCCCCAAATTTAGCCTCGATATACCAAGGGGTGGCAGC 
            N  M  S  Q  P  F  Q  S  P  N  L  A  S  I  Y  Q  G  V  A  A  
      
     3841 GAAGGTCGGTTCCGGgtgagtatctttagggcgttgtagaagcgtgggatgacaagtaat 
            K  V  G  S  G 
  
     3901 cccaatgttttgcagTCCCATTGACGATCCGTTGGAGGCCTTCAATCGCATCATGAAGGA 
                           P  I  D  D  P  L  E  A  F  N  R  I  M  K  E 
 
     3961 GAAGGAGCGGAAGAAGGTGGACCGCTTTCGAAGCTCTGACCGCCACAGGTCAAGGTCCCC 
            K  E  R  K  K  V  D  R  F  R  S  S  D  R  H  R  S  R  S  P 
  
     4021 GGATAGACAAAGGCACCGCTTTAAGTCTCCCATGTACGAAAAGGACAACTCCAGGGATAA 
            D  R  Q  R  H  R  F  K  S  P  M  Y  E  K  D  N  S  R  D  N 
  
     4081 TCTCAAGGACAAAAGACCGCGATCCCGGGAAAGGAAGCGAGAACATAGCTACGAACGGCA 
            L  K  D  K  R  P  R  S  R  E  R  K  R  E  H  S  Y  E  R  H 
             
     4141 TATACGCCACCCTCGTTCTAGTCGCCAGCCGAATGATGGCTCTAAGTCCCCAGGTGGCAG 
            I  R  H  P  R  S  S  R  Q  P  N  D  G  S  K  S  P  G  G  R 
 
     4201 AATCAAAAGgtagttttaccaccagcccttttccatgtgcttacattcatggtctactct 
            I  K  R 
 
     4261 ctgctttttagATCTGGACATCGTCGCTCTGCATCTCCAAAGCCGGGCTACAAGAGTGAT 
                       S  G  H  R  R  S  A  S  P  K  P  G  Y  K  S  D   
  
     4321 TACAGAGACAAGCCGTACAACAAGCCTAGTGCTCCCAAAACGGAGGCAGTTGAGCCTCCT 
           Y  R  D  K  P  Y  N  K  P  S  A  P  K  T  E  A  V  E  P  P   
 
     4381 CCCCCCGGATTCGAGCCGTTGCAGCTGACGGATGAAGACGGCTACAGGAACAAGCACCCG 
           P  P  G  F  E  P  L  Q  L  T  D  E  D  G  Y  R  N  K  H  P   
 
     4441 ACCAGTTCGGAAGCATCACAAAGCAGCAAGGGTGATAGCAGCAAGAAGAGAGGGGAAAAC 
           T  S  S  E  A  S  Q  S  S  K  G  D  S  S  K  K  R  G  E  N   
 
     4501 AGGCACGAAGAGGCGCCACGAAAGAGGCACAGGTCTCGCAGCATTAGCAAGGAACCGAAG 
           R  H  E  E  A  P  R  K  R  H  R  S  R  S  I  S  K  E  P  K 
 
     4561 CCGAATGACAGCAACTACAGGAGCCTGACTCCACCAGCAAAGATCACCACACCGAAAATG 
           P  N  D  S  N  Y  R  S  L  T  P  P  A  K  I  T  T  P  K  M 
 
     4621 ACTGCTGCCCAGTTGAGGCAACGCGAAAGTTCACCGAAGACGCCGGAAAAGAGTCACGAC 
           T  A  A  Q  L  R  Q  R  E  S  S  P  K  T  P  E  K  S  H  D 
 
     4681 GATTATCTGACCGCGAAGGCCAGAATTATGGCCTCCCAGCCCGTCATCAACGACACGGAA 
           D  Y  L  T  A  K  A  R  I  M  A  S  Q  P  V  I  N  D  T  E 
 
     4741 ATGGAGACCAATGTGGGCAAGGAGAACAAGGCCAAGAGTCCGTTGTCAAAAGATCGCAAG 
           M  E  T  N  V  G  K  E  N  K  A  K  S  P  L  S  K  D  R  K   
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     4801 AAGAAGAAGAAGGACAAGGACAAGGCTGAGCGCAAGAAAAACAAGAAGGACAAGCGCGCT 
           K  K  K  K  D  K  D  K  A  E  R  K  K  N  K  K  D  K  R  A 
 
     4861 AAGAAGGAGAAAGGGGATCGCCAGAAGAAGAGCTCCTCAGTTAATCGATCTGACTCGGAT 
           K  K  E  K  G  D  R  Q  K  K  S  S  S  V  N  R  S  D  S  D 
 
     4921 ATTAACAACAGCTCACTAATGAACGAGTCAAATTATAAAGTATTGTCTCCCAGGGCTCAA 
           I  N  N  S  S  L  M  N  E  S  N  Y  K  V  L  S  P  R  A  Q 
  
     4981 AGTCCCAGCATTGAGATCAATGCGGCTCAACTTTCCCCTACTCACAACGCTACTGAAAAC 
           S  P  S  I  E  I  N  A  A  Q  L  S  P  T  H  N  A  T  E  N 
 
     5041 GTTAATCCGAAGAGTCATTCCATCCTTACTGTGGGTGCTGCTAGCGACGATAATCTTGGC 
           V  N  P  K  S  H  S  I  L  T  V  G  A  A  S  D  D  N  L  G    
     
     5101 CCAAGAAGCAAACTCAGCGAGGCTAATTCTGTCAATCTATCCAAATGGGAAATCGACGAG 
           P  R  S  K  L  S  E  A  N  S  V  N  L  S  K  W  E  I  D  E 
      
     5161 AATATCTTAGGTTTGGAGGATTCCTCCAAAAAAGCTGCCGGGGCCTCCGACGATCCGTCG 
           N  I  L  G  L  E  D  S  S  K  K  A  A  G  A  S  D  D  P  S 
 
     5221 GAAATAACTTCAGACGTCCTGCGAAAGGCTGAGAACGCAATATTTGCAAAGGCTATTAAT 
           E  I  T  S  D  V  L  R  K  A  E  N  A  I  K  A  K  A  I  N 
 
     5281 GCCATCAGGCCTATGGAGTTTCAAGTTATTATCAATTCCAAGGACAACAGCAAGGACCGC 
           A  I  R  P  M  E  F  Q  V  I  I  N  S  K  D  N  S  K  D  R   
 
     5341 TCCGTAGTTCGAAGTGACAAGGATCGCTCCTCCTCACCCAGGCGTAACAACAGCAGCAGG 
           S  V  V  R  S  D  K  D  R  S  S  S  P  R  R  N  N  S  S  R 
 
     5401 TCGGTAAAGGATAGGCTGGGCACCAAGATTTCCAATGATAGAAGCCGTTCGCGAGACAAG 
           S  V  K  D  R  L  G  T  K  I  S  N  D  R  S  R  S  R  D  K 
 
     5461 TCGAAGGGCAGGCGCCGGGCCGCAAGGAGCTCCGACGACGATGCGAACCGCGGCAGGTCG 
           S  K  G  R  R  R  A  A  R  S  S  D  D  D  A  N  R  G  R  S 
 
     5521 GATCGTCATGGCAGCCGGAAGAGGGACAACAGATCCCGCGACAGGGCGGCGCCTTCAGAG 
           D  R  H  G  S  R  K  R  D  N  R  S  R  D  R  A  A  P  S  E 
 
     5581 AAGAGGCAGGAGCGTTCGTACAAGCGAAGCTCGCCGGAGGACGACAAGCTGAGGCGCCAG 
           K  R  Q  E  R  S  Y  K  R  S  S  P  E  D  D  K  L  R  R  Q 
  
     5641 AACAAGGAACAGTCCGAATCCAAGCACGGAAAGCATGATCAAAACAATAGCGACGACTCG 
           N  K  E  Q  S  E  S  K  H  G  K  H  D  Q  N  N  S  D  D  S 
 
     5701 GATCGGAGGGCGGCCAAAAACACCAAGTCCAGCGACAGCCGAGTGGTCTCCTCTGTAACA 
           D  R  R  A  A  K  N  T  K  S  S  D  S  R  V  V  S  S  V  T 
  
     5761 GCCGTGGTTGCTCCTCCCAAACCCTGTCGTCCAGACAACCCGTTCCGCAAGTTCGTCGAC 
           A  V  V  A  P  P  K  P  C  R  P  D  N  P  F  R  K  F  V  D 
 
     5821 ACCAGTTCGTCGAGCAGCTTAGTTGTAAAATATGATAACACGATACAGAAGGAGGGCGCG 
           T  S  S  S  S  S  L  V  V  K  Y  D  N  T  I  Q  K  E  G  A 
 
     5881 TCCTCGGACAACGGCATGGAGCACAGGAAGCAGAGGGATAAGAAGCTGAAGAAACATTCA 
           S  S  D  N  G  M  E  H  R  K  Q  R  D  K  K  L  K  K  H  S 
 
     5941 AAATATTCGTCAACCGATTCGTTGAAGAGCGAGAAGCGCAAGGATCCGAAGAGCAAAAAG 
           K  Y  S  S  T  D  S  L  K  S  E  K  R  K  D  P  K  S  K  K   
 
 85 
     6001 AAGAGCAAGATTTTGAAGAAGAAGAAAAAATCAAAGAAGTAGGTTACGGTAGGCTACGAG 
           K  S  K  I  L  K  K  K  K  K  S  K  K  * 
  
     6061 ATAAGAATGATATAAATATTGAAGATTAATGTGTACAAATCAAAGATTTTTAATGTATGT 
 
     6121 ATTTATCATGCAACTATAAGTATACAAATAAAACAGAACTACTCAAGGA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8: The sequence of the 4.595 kbp SNAMA gene. The amino acid 
sequence of the region that encodes SNAMA is also shown. Introns are 
indicated by lowercase letters. The potential polyadenylation sites are 
indicated by a bold typeface and uppercase letters. The predicted putative 
promoter is underlined indicating the transcriptional start site in large font. 
The position of the P-element insertion in l(2)rQ313 is also indicated. 
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3.2.1 The 5 untranslated region 
 
 The 5 untranslated region (5 UTR) has not been verified experimentally, but a 
putative promoter sequence and a transcriptional start site has been predicted with a 
score of 0.97 at position 1608 bp upstream from the translational start site using the 
BDGP Neural Network Promoter Prediction programme located on the web at  
http://www.fruitfly.org/seq_tools/promoter.html (Reese, 2001). The programme 
identifies elements such as the TATA box, GC box and CAAT box, the 
transcriptional start site and other common eukaryotic 5 elements. There are no exact 
sequence patterns to identify promoters and the criteria applied to identify these sites 
are very general and so the predicted promoter site should be verified by biochemical 
methods. A typical promoter includes an A/T rich region called the TATA box and 
one or more sequence elements of 8 to12 base pairs (Maniatis et al., 1987). These 
elements are known as the upstream promoter elements (UPEs) and include the 
CCAAT box (consensus GGC/TCAATCT). The UPEs act regardless of their 
orientation with respect to the TATA box. A UPE sequence has been identified as 
GGCCAATCCT within the predicted promoter region for SNAMA (Figure 8). This 
sequence has been predicted as the transcriptional start site positioned 1.6 kbp from 
the translational start site. The TATA box is required for the accurate transcription of 
the gene and the UPEs increase the rate of transcription. Most promoters contain the 
TATA box 25 to 30 bases from the transcriptional start site. A TAATA sequence is 
present 25 bp upstream the predicted transcriptional start site and could be the TATA 
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box. The SNAMA transcript would therefore consist of a 5 UTR of 778 nucleotides 
and an mRNA sequence of 4.595 kbp.  
 
3.2.2 The 3 untranslated region 
 
The 3-end processing involves endonucleolytic cleavage of the primary transcript 
followed by polyadenylation of the upstream RNA fragments. The cleavage process 
is determined by specific sequence elements in the RNA, one upstream and one 
downstream of the cleavage site (Proudfoot, 1989). A review of the elements and 
mechanisms involved in polyadenylation is given by (Wahle and Keller, 1992). These 
elements are the polyadenylation signal AATAAA upstream of the cleavage site, 
followed by a GT-rich and a T-rich region downstream the cleavage site. The 
polyadenylation signal is essential for the process of attaching the poly(A) tail to 
mRNA. The AATAAA sequence is found 10 to 35 nucleotides upstream of the 
poly(A) site in most eukaryotic mRNAs (Gil and Proudfoot, 1987). An unusual 
polyadenylation site (TATAAA) is found in hepatitis B viruses and it has been 
suggested that this signal is used to control the amount of mRNA produced (Russnak 
and Ganem, 1990). The consensus for the GT-rich region is YGTGTTYY (where Y 
is a pyrimidine) and the T-rich and the GT-rich regions are found adjacent or in close 
proximity to each other downstream of the poly(A) site.  
 
Two potential polyadenylation signals were identified at position 6072  (ATAAA) 
and 6147 (AATAAA) downstream of the SNAMA translation termination codon 
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(Figure 8). The first polyadenylation signal TATAAA is followed by a GT-rich 
region GTGTACA at position 6091 and a T-rich region TTTTT located at position 
6107. The GT-rich region and the T-rich region are in close proximity to each other 
(11 nucleotides apart). All the criteria for the 3 untranslated region (3 UTR) has been 
met by the first potential polyadenylation signal suggesting that this signal is the 
functional one. No GT-rich region or T-rich region is observed for the second 
potential polyadenylation site. Additional information is needed to confirm the 
functional polyadenylation site. Using the first polyadenylation site as the probable 
signal, cleavage would take place at a position between 6077-6090 resulting in a 3 
UTR of approximately 42 bp. It should however be noted that alternative 
polyadenylation signals in Drosophila melanogaster genes have been identified 
which results in different sized RNA (Bernstein et al., 1986) and it is plausible that 
both polyadenylation sites are functional in SNAMA. The second polyadenylation site 
would result in a 3 UTR 124 bp long. 
 
3.2.3 Splice junctions 
 
The consensus sequence for splicing of introns in many species is the 5 splice 
sequence MAGGTRAGT (where  indicates the splice point, M indicates A or C and 
R is a purine) and the 3 splice consensus sequence YAGG or AG where Y is a 
pyrimidine (Mount, 1982; Mount et al., 1992). In addition a conserved sequence 
upstream the 3 splice site in the intron is required.  This sequence is the branchpoint 
and is an important 3 splice signal crucial to the formation of a lariat structure (Keller 
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and Noon, 1985). The consensus sequence of the D. melanogaster branchpoint has 
been identified as YTRAY (where Y is a pyrimidine and R is a purine). This 
sequence occurs very often as CTAAT (Mount et al., 1992). The T and A at position 
2 and 4 respectively are invariant, and A represents the position of attack by the 5 
splice site guanidine. There exist a degree of variability at position 3 and 5 where any 
of the four nucleotides can occur (Keller and Noon, 1985). 
 
The SNAMA cDNA was aligned to the genomic DNA considering all of the above 
points. Using this criterion the SNAMA transcriptional unit was found to consist of 9 
exons and 8 introns. All the splice junctions are consistent with the consensus 
sequence of the presumptive splice junctions in D. melanogaster (Mount et al., 1992) 
(Table 8). All the introns are very short except for intron 1 (829 bp) and intron 6 (288 
bp). The possible branchpoint sequences have been identified and are within the 3 
splice region of the intron (Table 9).  
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Table 9: Introns from the SNAMA gene. The last 50 bp of the intron showing the 
putative branchpoint sequences (underlined). Distance is the number of base pairs 
between the end of the sequence and the 3 splice point. 
 
 
(5 splice junction) Position (3 splice junction) Position Size (bp) 
1. ATGTGC TTGCAGAGTAGTgtaa 852 1.  tttaatctcttcttcgcagATTTCT 1681 829 
2. ATGCGCAGAGTAAAGAAGgtat 1866 2. ggcttccttcccttttccagAATAC 1925 59 
3. CGACTATGATCCTAAGACgtatg 2160 3. ctaatgtattttctgtttagGTACC 2214 54 
4. AAAGCGCGGCTAAGCCAGgtaa 2693 4. aatcgaatttctctttttagCTGCA 2753 60 
5. ACAACAGTGCCCAGCAAAgtga 3028 5. attgccttaatgtttcagAGATCC 3091 63 
6. ACAGAGGCCTCCCCTCAGgtag 3417 6. attaacttctaaaatttcagCTATG 3705 288 
7. AGCGAAGGTCGGTTCCGGgtga 3855 7. taatcccaatgttttgcagTCCCA 3915 60 
8. AGGTGGCAGAATCAAAAGgtag 4209 8. gtctactctctgctttttagATCTG 4271 61 
Intron Sequence Position Distance 
1.caagtgccgtggacactataagataatcgtatttaatctcttcttcgcag 852 13 
2.ccgcaatttagaatttttcccctgctacatggcttccttcccttttccag 1866 39 
3.gtggttttaaattgttacaaaaccacctatctaatgtattttctgtttag 2160 15 
4.tatactcgtttgcatcgcttaatgcaaatgaatcgaatttctctttttag 2693 28 
5.atttgacacatctgcaacatagatacataattattgccttaatgtttcag 3028 7, 43 
6.tacaatcaacgttaagctttttgaattgtaattaacttctaaaatttcag 3417 25 
7.tttagggcgttgtagaagcgtgggatgacaagtaatcccaatgttttgcag 3855 46 
8.ccagcccttttccatgtgcttacattcatggtctactctctgctttttag 4209 21 
Table 8: SNAMA intron and exon splice junctions. Splice junctions were 
identified by comparing the genomic sequence (GenBank accession number 
AE003463.2) with the cDNA sequence (GenBank accession number AF132177). 
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3.3 THE DOMAIN ORGANISATION OF SNAMA    
  
The mammalian DWNN domain proteins exist in two forms, as a small protein 
containing the DWNN domain sequence with a short C-terminal extension and as a 
multi–domain protein. There are two human transcripts; a short one encoding a 118 
amino acid protein consisting of the 76 amino acid residue DWNN domain with a 
short C-terminal extension (approximately 13kDa) called DWNN-13 and a second 
much larger transcript of 1792 amino acids (200 kDa) referred to as DWNN-200 
(Dlamini, Z., personal communication). DWNN-13 has a glycine dipeptide and a 
small C-terminal extension following the conserved proline found in most of the 
DWNN proteins. The identification of the smaller DWNN-13 protein with the di-
glycine at the C-terminal end of the protein (positions 78 and 79) suggests that the 
DWNN domain in humans may be transferred to other proteins and act as a molecular 
tag in a manner similar to the transfer of ubiquitin to proteins. The ubiquitin protein 
contains a glycine at position 75 and position 76, which is important for ubiquitin 
conjugation to other proteins and to the process of de-ubiquitination (Pickart et al., 
1994). It is at this position that cleavage takes place.  
 
The multi-domain DWNN proteins are found associated with other characterised 
domains (Figure 9). The plant and fungal DWNN proteins contain a Zn2+ finger motif 
of the CCHC and a RING finger-like (RFL) C3HC4 type sequence. In addition, the 
D. melanogaster and C. elegans DWNN domain proteins also contain regions with 
homology to the mouse PACT protein (P53 Associated Cellular protein- Testes 
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derived) that binds to p53. The PACT protein is most closely related to the human 
RBBP6 (retinoblastoma binding protein 6) protein that binds to pRB. The mouse 
PACT was identified as a protein with the ability to bind p53 (Simons et al., 1997). 
RBBP6 is the truncated human homologue of PACT. A closer look at these two 
proteins revealed that they are in fact truncated mouse and human homologues of 
SNAMA, respectively. Adjacent to the stop codon of SNAMA is a basic lysine-rich 
region also found in PACT.  
 
SNAMA has been identified through homology searches using sequence identified 
from the promoter trap mutagenesis screen for apoptotic genes in CHO cells. 
Examination of the SNAMA sequence using the SMART (Simple Modular 
Architecture Research Tool) programme (Schultz et al., 1998), Pfam protein family 
database (Bateman et al., 2004) and ScanProsite (in the ExPASy Molecular Biology 
Server) (Hulo et al., 2004) revealed that the protein contains a zinc finger (CCHC) 
between amino acids 151 and 168 and a RFL motif between amino acids 217 and 258 
(Figure 10). This cysteine rich RING finger-like  (RFL) domain is discussed later.  
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Figure 9: The domain arrangement of SNAMA homologous proteins. DWNN proteins are found associated with other 
characterised domains including the zinc finger domain (CCHC) and the cysteine rich RING finger-like domain. The 
DWNN human homologue encodes 2 overlapping proteins of 13 kDa (DWNN-13) and 200 kDa (DWNN-200). 
DWNN-13 is the DWNN domain with a short C-terminal extension and DWNN-200 contains the associated domains. 
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1      MSVHYKFKST LNFDTITFDG LHISVGDLKR EIVQQKRLGK IIDFDLQITN AQSKEEYKDD 
61     GFLIPKNTTL IISRIPIAHP TKKGWEPPAA ENAFSAAPAK QDNFNMDLSK MQGTEEDKIQ 
121    AMMMQSTVDY DPKTYHRIKG QSQVGEVPAS YRCNKCKKSG HWIKNCPFVG GKDQQEVKRN 
181    TGIPRSFRDK PDAAENESAD FVLPAVQNQE IPEDLICGIC RDIFVDAVMI PCCGSSFCDD 
241    CVRTSLLESE DSECPDCKEK NCSPGSLIPN RFLRNSVNAF KNETGYNKSA AKPAAVKNEE 
301    KPPVEKEVEK KPVAEVEPEE TEVKPEKQKE SETNGSNPPK SESPEPPATT EPSQKEKDKY 
361    DSDYEDNITI KMPQPAADST TVPSKRSPSY SHRSESSHRR DRSDYVSDHD HKHQRPSKSE 
421    SVNKDRSLLP LPIGTLPSYQ GHMMAESEEA RRSSAYKPPY MQMQRGPPPM HMMSHHMPAY 
481    NNGFNNMGQR PPLSYVPYQN QSVHPMRAPY GSAGGGMNMN MSQPFQSPNL ASIYQGVAAK 
541    VGSGPIDDPL EAFNRIMKEK ERKKVDRFRS SDRHRSRSPD RQRHRFKSPM YEKDNSRDNL 
601    KDKRPRSRER KREHSYERHI RHPRSSRQPN DGSKSPGGRI KRSGHRRSAS PKPGYKSDYR 
661    DKPYNKPSAP KTEAVEPPPP GFEPLQLTDE DGYRNKHPTS SEASQSSKGD SSKKRGENRH 
721    EEAPRKRHRS RSISKEPKPN DSNYRSLTPP AKITTPKMTA AQLRQRESSP KTPEKSHDDY 
781    LTAKARIMAS QPVINDTEME TNVGKENKAK SPLSKDRKKK KKDKDKAERK KNKKDKRAKK 
841    EKGDRQKKSS SVNRSDSDIN NSSLMNESNY KVLSPRAQSP SIEINAAQLS PTHNATENVN 
901    PKSHSILTVG AASDDNLGPR SKLSEANSVN LSKWEIDENI LGLEDSSKKA AGASDDPSEI 
961    TSDVLRKAEN AIFAKAINAI RPMEFQVIIN SKDNSKDRSV VRSDKDRSSS PRRNNSSRSV 
1021   KDRLGTKISN DRSRSRDKSK GRRRAARSSD DDANRGRSDR HGSRKRDNRS RDRAAPSEKR 
1081   QERSYKRSSP EDDKLRRQNK EQSESKHGKH DQNNSDDSDR RAAKNTKSSD SRVVSSVTAV 
1141   VAPPKPCRPD NPFRKFVDTS SSSSLVVKYD NTIQKEGASS DNGMEHRKQR DKKLKKHSKY 
1201   SSTDSLKSEK RKDPKSKKKS KILKKKKKSK K 
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Figure 10: The amino acid sequence of Drosophila melanogaster SNAMA 
protein showing conserved domains and motifs. The DWNN domain and 
downstream sequence elements identified by the Pfam, SMART and PROSITE 
databases have been highlighted. 
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A domain near the amino terminus (amino acid 234-252) has been implicated in cell 
growth control and has been referred to as the cell division sequence motif (Figge and 
Smith, 1988). ScanProsite revealed sequences including four possible nuclear 
bipartite targeting sequences (residues 713-730; 818-834; 1195-1211 and 1211-
1227). There are also two lysine rich regions between amino acids 805 and 848 that 
encode 21 lysine residues and a 44 amino acid sequence adjacent to the stop codon 
from amino acid 1188 that has 21 lysine residues. The peptide has a region rich in 
arginine-serine/serine-arginine dipeptides that have been found in proteins that are 
involved in RNA processing. The zinc finger motif has been implicated in the 
interactions between proteins and single-stranded nucleic acids (Laity et al., 2001; 
Berg and Shi, 1996). These motifs indicate that the SNAMA protein may play key 
roles in cell cycle or transcriptional regulation events.  
 
Database searches also revealed regions with homology to the human RBQ-1 
(RBBP6) (retinoblastoma binding protein 6) proteins (Sakai et al., 1995), mouse 
PACT (P53 Associated Cellular protein-Testes derived) (Simons et al., 1997), mouse 
P2P-R (proliferation potential protein-related) (Witte and Scott, 1997) and the yeast 
Mpe1 (Vo et al., 2001). These four proteins are in fact the human, mouse, and yeast 
homologues of SNAMA, respectively and have been previously discussed in section 
1.5.2. The RBQ1, first identified in humans, was a truncated version of P2P-R. RBQ1 
was truncated as a result of a possible mutational event occurring in the cell line in 
which this protein was identified. The yeast homologue is involved in 3 end mRNA 
processing (Vo et al., 2001) while the mammalian forms interact with p53 and 
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Rb(Simons et al., 1997). The researchers that identified these genes failed to identify 
and characterise the novel DWNN domain.   
 
The aforementioned evidence indicates that SNAMAs homologues play a role in the 
ubiquitin pathway and in apoptosis. This together with the domain arrangement of 
SNAMA makes it possible to speculate that SNAMA itself may be involved in the 
ubiquitin pathway and in apoptosis. The diverse arrangements of domains may also 
suggest that this protein plays a role in transcriptional regulation or cellular 
proliferation. The zinc fingers may suggest the presence of a DNA binding domain. 
However, it is necessary to be cautious about interpreting the function of a zinc 
finger. Zinc fingers may be involved in the binding of RNA rather than DNA or may 
not have any nucleic acid binding activity. This thesis attempts to elucidate SNAMAs 
role in apoptosis and its ability to bind Dmp53. 
  
3.3.1 The DWNN domain of the SNAMA protein 
 
SNAMA contains the highly conserved N-terminal domain DWNN. This domain has 
a degree of identity to the ubiquitin protein although it lacks the conserved di-glycine 
residues at the C-terminal end that is essential for recognition by hydrolases and for 
modifying other proteins. The glycine is replaced by a conserved proline that is 
present in many members of this family of proteins (Figure 7). Proline has a major 
effect on the structure of a protein because of the special restrictions imposed by the 
ring structure of this amino acid. A pair sequence alignment between ubiquitin and 
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ubiquitin-like proteins using the ALIGN Query (Pearson et al., 1997) on the 
Genestream server at Genestream Resource Centre in France indicated a 23.5% 
identity between DWNN and ubiquitin. This level of identity is significant because 
the ubiquitin-like protein BemI has a 20.7% identity to ubiquitin (Table 10). This 
level of identity indicates that DWNN domains may function like ubiquitin to tag 
proteins for transport or degradation. This idea is supported by the fact that the 
SNAMA protein has a RING finger domain often found having E3 ubiquitin ligase 
activity. The DWNN domain of SNAMA lacks the double glycine motif required for 
ubiquitin precursor processing and for ubiquitin conjugation. This glycine is replaced 
by a conserved proline, present in virtually all members of the DWNN family. 
Interestingly, the two human forms and the mouse orthologue have a di-glycine 
peptide at position 78 and 79 causing speculation that cleavage could happen here 
(Figure 7). Alternatively the proline at position 76 in the DWNN domain of SNAMA 
could  indicate an entirely new enzymology pathway if in fact DWNN is used as a 
molecular tag for other proteins. Alternatively, SNAMA could be an ubiquitin 
domain protein (UDP). UDPs have ubiquitin-like domains within a large protein. 
This ubiquitin-like domain does not always end in a Gly-Gly sequence but shows 
sequence homology similar to ubiquitin (section 1.11.2). The list of UDPs is growing 
and includes proteins such as HUB (Luders et al., 2003), UIP28 (Martinez-Noel et 
al., 1999), Scythe (Thress et al., 1998), Parkin (Zhang et al., 2000), Rad23 (Watkins 
et al., 1993), Dsk2 (Biggins et al., 1996) and Bag-1 (Luders et al., 2000). 
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Table 10: Sequence relationships among ubiquitin-like proteins. Sequences were compared in pairs using the ALIGN Query on 
the Genestream server. The percentage amino acid sequence identity between each pair is recorded on the table. The DWNN 
domain of SNAMA has a 23.5% identity to the human ubiquitin protein. This percentage is substantial since the ubiquitin like 
protein Bem1 has a 20.7% identity to ubiquitin.     
 Ubiquitin Rub1 Nedd8 Ivcba2 DWNN Bem1 Bem1 yeast Mpe1p 
Ubiquitin --- 63.2 57.9 26.0 23.5 20.7 14.3 17.8 
Rub1 63.2 --- 85.5 28.2 19.5 16.0 13.6 16.7 
Nedd8 57.9 85.5 --- 23.4 19.5 11.1 16.5 14.4 
Ivcba2 26.0 28.2 23.4 --- 22.9 18.2 13.6 24.2 
SNAMA 23.5 19.5 19.5 22.9 --- 22.6 12.5 42.2 
Bem1 20.7 16.0 11.1 18.2 22.6 --- 11.1 21.3 
Bem1 yeast 14.3 13.6 16.5 13.6 12.5 11.1 --- 15.4 
Mpe1P 17.8 16.7 14.4 24.2 42.2 21.3 15.4 --- 
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3.3.2 The cysteine rich RING finger-like domain 
 
A cysteine rich domain follows the zinc finger motif. Although this motif has been 
identified by SMART and ScanProsite as a RING finger, a closer look reveals that 
this sequence does not have a histidine in the fourth position that is characteristic of 
RING finger motifs. This histidine has been substituted by a serine residue. RING 
finger motifs are known to have ubiquitin ligase activity. The association of this 
RING finger like domain with a ubiquitin-like domain could indicate that SNAMA 
functions in modifying other proteins or is responsible for catalysing its own auto-
ubiquitination. This is only true if we speculate that the RING finger fold of SNAMA 
will coordinate two zinc atoms per RING molecule with each atom ligated 
tetrahedrally by four cysteine residues and three cysteine molecules and a serine in 
the typical ‘cross-brace’ system (Figure 11 (A)) (Borden and Freemont, 1996). The 
alignment of orthologous RING finger-like domains shows that this position is 
occupied by various other polar amino acids such as lysine in A. thaliana and S. 
pombe, asparagine in H. sapiens, C .elegans and M. musculus, and arginine in O. 
sativa (Figure 11 (B)).  Interestingly, the histidine residue is retained in E. cuniculi. It 
has, however, not been shown what effect substitution at this position would have on 
the ability of the domain to coordinate zinc and maintain protein ligase activity. It is 
important to note, however, that the RING finger motif has been found to adopt 
subtle changes in key zinc ligands without losing the overall conformation of the 
motif. Examples include the retinoblastoma-binding protein RBQ-1 (RBBP6) (where 
His1 is replaced by Asn residue), the mouse double minute protein Mdm2 (where a 
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Thr residue replaces Cys3) (Boddy et al., 1994) and CART1 (where Cys7 is 
substituted for an Asp residue) (Regnier et al., 1995). In all these RING finger 
variants the substituted amino acids are able to participate in zinc ligation and thus 
the three dimensional structure of the domain is conserved (Saurin et al., 1996). In 
Mdm2 the substituted amino acid maintains ubiquitin ligase activity (Fang et al., 
2000). The alignment of the RING domains of proteins that interact with the 
ubiquitin-conjugating enzyme UbcM4 identified the UIP4 protein as having the His 
replaced by a Cys (Martinez-Noel et al., 1999). All the other UbcM4 interacting 
proteins maintain the typical RING consensus sequence. It is also important to note 
that the affinity for zinc by the RING domain is higher for site 1 than for site 2 
(Borden, 2000). There exists a degree of flexibility in site 2 for zinc binding. It has 
been shown that in cases of lowered zinc concentration, it is likely that only site 1 is 
folded and able to associate with its protein partners (Kentsis and Borden, 2000). The 
observed substitutions only occur in site 2 on the RING where this flexibility is 
possible. The conserved architecture of site 1 in the RING domain of SNAMA 
suggests that the domain is able to associate with its protein partners even though site 
2 has a substitution. The conservative replacement of histidine with serine in the 
RING domain of SNAMA is capable of ligating zinc due to ionisation of the 
hydroxyl group on the serine residue similar to the chemistry with threonine. 
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Figure 11: (A) Schematic representation of the “cross-brace” structure   
adopted by the unique RING finger-like domain of SNAMA (Mather et 
al., 2005). This scheme is identical to the arrangement adopted by the 
typical RING finger with histidine in the serine position for the SNAMA 
sequence. Red spheres represent cysteine residues, green spheres 
represent serine residues and the blue spheres correspond to zinc atoms. 
(B) Alignment (DNAMAN) of the cysteine rich RING finger-like  
domain conserved in SNAMA homologues. The E. cuniculi protein has a 
true RING finger domain. D. melanogas is Drosophila melanogaster. 
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Whether or not the SNAMA cysteine rich domain has ubiquitin ligase activity is 
unknown. It has, however, been shown that this domain exists and is conserved in a 
significant group of proteins and may represent a distinct class of RING finger-like 
proteins that have as yet not been characterised. 
 
3.3.3 The ubiquitin-like fold of the DWNN domain of SNAMA  
          
In order to establish the ubiquitin-like identity and secondary structure the N-terminal 
76 amino acid DWNN domain of SNAMA was analysed using FUGUE v2.s.07 (Shi 
et al., 2001) (Figure 12). FUGUE is a programme for recognizing distant homologues 
by sequence-structure comparison. The programme utilises environment-specific 
substitution tables and structure-dependent gap penalties where scores for amino acid 
matching and insertions/deletions are evaluated depending on the local environment 
of each amino acid residue in a known structure. Given a query sequence (or a 
sequence alignment), FUGUE scans a database of structural profiles, calculates the 
sequence-structure compatibility scores and produces a list of potential homologues 
and alignments. The fold library and substitution tables are based on a HOMSTRAD 
(HOMologous STRucture Alignment Database) database (Mizuguchi et al., 1998). 
This is a curated database of structure-based alignments for homologous protein 
families. All known protein structures are clustered into homologous families (i.e., 
common ancestry) and the sequences of representative members of each family are 
aligned on the basis of their 3D structures using the programmes MNYFIT, STAMP 
and COMPARER. The alignment generated by FUGUE included the PSI-BLAST 
 103 
homologues of SNAMA aligned against all the representative structures from the 
HOMSTRAD family. This search produced a number of similar proteins three of 
which had remarkable secondary structure similarities with the DWNN domain of 
SNAMA. The predicted structure has a z-score of 3.71 indicating a 90% level of 
confidence for the prediction. SNAMA was aligned with ubiquitin and ubiquitin-like 
proteins, Nedd8 and Rub1. An important observation is that all the other proteins 
scored were ubiquitin-like proteins. Homologues were identified from a range of 
organisms. These proteins included the yeast Mpe1 protein and human RBBP6. 
Another secondary structure prediction method used was PSIPRED (Jones, 1999). 
The PSIPRED server (McGuffin et al., 2000) allows submission of a protein 
sequence, performs a prediction and outputs the result has an animated figure (Figure 
13). The predicted secondary structure was the same as that predicted by FUGUE 
(see Figure 12). We also compared the secondary structure of ubiquitin to the DWNN 
domain of SNAMA using the Network Protein Sequence Analysis tool (NPSA) 
(Combet et al., 2000). NPSA uses ten different statistical prediction schemes applied 
to the sequence. All of the schemes agree on the approximate locations of the alpha 
helices (h) and beta strands (e), but they disagree considerably on the lengths and end 
positions of these segments. The probable position of loops (c) and turns (t) are 
inconsistently predicted. The sequence conservation suggests a similar arrangement 
of four strands and a helix (Figure 14). 
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                                10         20         30         40         50   
Ubiquitin              mqIfVk---tltgktItLeVepsdtIenVkakIqdkegi-ppdqQrLifa 
Nedd8                  mlIkVk---tltgkeieIdIeptdkVerIKerVeekegi-ppqqQrLiys 
Rub1                   mlIkVk---tltgkeIeIdIeptdtIdrIkerVeekegi-ppvqQrLiya 
     SNAMA             MSVHYKFKSTLNFDTITFD-GLHISVGDLKREIVQQKRLGKIIDFDLQIT 
A.thaliana             MAIYYKFKSARDYDTIAMD-GPFISVGILKDKIFETKHLGTGKDLDIVVS 
A.thaliana             MAIYYKFKSARDYDTISMD-GPFITVGLLKEKIYETKHLGSGKDLDIVIS 
S.pombe                --IYYKFKSQKDPSRITFD-GTGMSVFDVKREIIMQKKLGNGLDFDLLLY 
H.sapiens              --VHYKFSSKLNYDTVTFD-GLHISLCDLKKQIMGREKL-KAADCDLQIT 
M.musculus             --VHYKFSSKLSYNTITFD-GLHISLFYLKKQIMGREKL-KTGNSDLQII 
S.cerevisiae           -TIFYRFKSQRNTSRILFD-GTGLTVFDLKREIIQENKLGDGTDFQLKIY 
N.crassa               -SVFFKFKSNKEPTRVEFD-GTGISVFELKREIILKSALGDGTDFDLIIA 
E.cuniculi             --INYRFRSNKNFSRISFQ-GTGLPLWELKYEIINQRKMVS-KDFDLLFF 
A.gambiae              MSVHYKFKSALDFDTITFD-GLHISVADLKKGIIQQKRLGKTVDFDLQIT 
                                          333  
 
                                60         70         80   
Ubiquitin              gkqLedgrtLsdynIqkestLhLvlrlrgg 
Nedd8                  gkqMndektAadykIlggsvLhlvlalr   
Rub1                   gkqLaddktAkdynIeggsvLhLvlal    
     SNAMA             NAQSKEEYKDDGFLIPKNTTLIISRIP--- 
A.thaliana             NAQTNEEYLDEAMLIPKNTSVLIRRVP--- 
A.thaliana             NAQTNEEYLDEAMLIPKNTSVLIRRVP--- 
S.pombe                NANSNEEYDDDTFIIPRSTSVIVRRVP--- 
H.sapiens              NAQTKEEYTDDNALIPKNSSVIVRRIP--- 
M.musculus             NAETEEEYTDDNALIPKNSSVIVRRIP--- 
S.cerevisiae           NPDTEEEYDDDAFVIPRSTSVIVKRSP--- 
N.crassa               ADEGKEVYDDDTTIIPRSTTVIARRMP--- 
E.cuniculi             DGETNEEINDEYQVVSMNSHVIVSRIP--- 
A.gambiae              NAQTKEE----------------------- 
                               333            
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12: The alignment of SNAMA (Mather et al., 2005) with ubiquitin and 
ubiquitin-like sequences, Nedd8 and Rub1, generated using FUGUE (Shi et al., 
2001). This algorithm searches sequences against a fold library using 
environmental-specific substitution tables and structure-dependent gap penalties. 
The alignment also shows PSI-BLAST homologues from a range of organisms 
(shaded in colour) and secondary structure prediction ( indicates -strands,  
indicates -helices and 3 indicates 310 helix). Four -strands and a single -helix 
were predicted. This secondary structure prediction is similar to that of ubiquitin. 
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Figure 13: Secondary structure prediction of the DWNN domain of 
SNAMA using PSIPRED. The secondary structure compared well with the 
DWNN domain structure predicted by FUGUE. PSIPRED predicted four 
-strands and a single -helix similar to that of ubiquitin. 
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                     10        20        30        40        50        60          70  
                      |         |         |         |         |         |           | 
Ubiquitin    ---MQIFVKTLTGKTITLDVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG 
DPM          ---cceeeeeecceeeeeeetccccehhehhhhhtcccccccchhheehcchhhtccceccccehhhceeeeeeheccc 
DSC          ---ceeeeeccccceeeeeecccchhhhheeecccccccccchhhhhhhccccccccccceeecccccceeeeeeeccc 
GOR1         ---hheeeeeccteeeeeeeechhhhhhhhhhhheettccttheeeeehcchchhteeccteehhhhhhhheeeeettt 
GOR2         ---hhhehhhhcccceeececccchhhhhhhhhhhcccccchhhhhhhhhhhhccceehcccchhhhhhhhhheeeccc 
GOR4         ---cceeeeeeccceeeeecccccchhhhhhhhccccccccchhhhhhhhcccccccccccccccchhhhheeeeeeec 
HNNC         ---ceeeeeeeccceeeeeecccchhhhhhhhhhhccccccchhheeeecccccccccccccccchhhhhhhheehccc 
PHD          ---ceeeeeccccceeeeeccchhhhhhhhhhhhcccccccccceeeecccccccccccccccccccceeeeeeeeecc 
Predator     ---ceeeeeecccceeeeecccccchhhhhhhhhhhhcccccceeeeecccccccccccccccccccceeeeeechccc 
SIMPA96      ---ceeeeeecccceeeeecccchhhhhhhhhhhcccccccccceeeeccccccccceecccccccccceeeeeeeccc 
SOPM         ---heeeeeecttceeeeecccccchhhhhhhhctttccccccceeeeetccccttceeeeecccccccheeeehhctt 
Sec.Cons.    ---ceeeeeecccceeeee?cccchhhhhhhhhhcccccccc?h?eeehccccccccccccccccc?ch?eeeeeeccc 
 
 
SNAMA        MSVHYKFKSTLNFDTITFDGLHISVGDLKREIVQQKRLGKIIDFDLQITNAQSKEEYKDDGFLIPKNTTL-IISRIP-- 
DPM          cceeehhccchteceeeecceeeeecchhhhhehhhhhcheehhhhhecchhcchhtttcccccccccee-eeeecc-- 
DSC          ceeeeeeeccccceeeeeccceeeeecchhhheeeccccccceeeeeeeccccccccccceeeeccccee-eeeccc-- 
GOR1         hhhhhhheeeceeeeeeehceeeehhhhhhhhhhhhhteeeeeeehhhhhhhhhhhhhhhhheeetteee-eeeeee-- 
GOR2         hehhhhhceeccchheeehcheecccchhhhhhhhhhhccehhhhhhhhhhcchhhhhhhhhhcccccee-eeeecc-- 
GOR4         cccceeecccccccceeeccceecccchhhhhhhhhhccceecchhhhhhhhhhhhhcccceecccccee-eeeeec-- 
HNNC         ceeeeeeecceccceeeeccceehhhhhhhhhhhhhhhchheeeceeecccccchcccccceeeccccee-eeeecc-- 
PHD          cceeeeeecccccceeeeccceeeehhhhhhhhhhhhhccccceeeeeccccccccccccceeeecccee-eeeecc-- 
Predator     ccccccccccccccccccccceeeccchhhhhhhhhhcccccchhhhhhhchhhhhcccccccccccccc-cccccc-- 
SIMPA96      ccceeecccccccceeeecceeechhhhhhhhhhhhhcceeeccceeeccccchhhhcccceeeccccee-eeeccc-- 
SOPM         eeeeeecccccccceeeetteeeehhhhhhhhhhhtttteeeeeeeeecccccchhccttteeccttcee-eeeecc-- 
Sec.Cons.    cceeeeeccccccceeeeccceeehh?hhhhhhhhhh?ccee?e???eccccc?hhcccccee?ccccee-eeeecc-- 
Consensus       hqiFkkTLngdTITlDgehidtg#nkrai!Q#Krggkid#qrLqianaQle#erkddd%nIqK#sTL I!LRir 
Prim.cons.   MSV222F22TL222TIT2D22222222222222Q2K222222222L22222Q22222222222I2K22TLH222R22GG 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14: Secondary structure prediction of ubiquitin and SNAMA using the 
Network protein sequence analysis tool (NPSA). The alignment shows structure 
prediction of ubiquitin comparing to SNAMA. The various prediction methods are 
indicated. They all predict an ubiquitin-like fold for SNAMA. The consensus 
prediction is also indicated (Sec. Cons). Alpha helices (h), beta strands (e), loops (c) 
and turns (t) are indicated. 
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Taken together these results indicate that the DWNN domain of SNAMA adopts a 
fold similar to that of ubiquitin. The fold is characterised by two -helices and four -
strands ordered as ----- along the sequence. The structural fold of the DWNN 
domain is significantly similar to ubiquitin even though the sequence has only a 
23.5% identity with ubiquitin. The predicted SNAMA structure lacks the second and 
smaller -helix found in ubiquitin. This much smaller 310 helix is not significant and 
does appear when SNAMA is modelled against ubiquitin and only disappears upon 
minimisation (Figure 15). Preliminary NMR structural analysis of the human 
DWNN-13 protein does indicate a folded structure similar to that of ubiquitin (Pugh, 
personal communication). 
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A B 
Figure 15: (A) The three-dimensional structure of ubiquitin (Cornilescu  et 
al., 1998). The figure was generated using DeepView/Swiss-PdbViewer 
Version 3.7. (B) A structural model of the DWNN domain generated by 
aligning the sequence with the human ubiquitin sequence (1UBI). The 
predicted DWNN structure was generated after a first minimisation 
involving first 500 steps and a second minimisation involving 500 steps of 
steepest descent and 500 steps conjugated gradient method using Insight II 
(Ntwasa, unpublished). The structure generated for DWNN compares well 
to the structure of ubiquitin.    
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CHAPTER 4   
 
 
TEMPORAL AND SPATIAL DISTRIBUTION OF SNAMA  
IN Drosophila melanogaster 
 
 
4.1 Introduction 
4.2 SNAMA is a developmentally regulated gene 
4.3 SNAMA cDNA sequence 
4.4  SNAMA is expressed throughout development  
4.5 SNAMA may be localised in the nucleus of D. melanogaster embryos  
4.6 SNAMA interacts with Dmp53 
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4.1 INTRODUCTION 
 
The localisation of SNAMA transcripts together with information about protein 
distribution may shed light on the translational control of SNAMA. This information 
can be related to gene activity at the DNA, mRNA, and protein level and may shed 
light on the regulation of SNAMA during embryonic development. D. melanogaster 
provides a perfect multicellular environment in which to investigate SNAMA 
localisation. The identification of SNAMA homologues by other researchers involved 
a functional analysis of these proteins based on their binding ability to p53 and pRb 
(see section 3.3). This chapter investigates the distribution of SNAMA during D. 
melanogaster development. 
 
4.2 SNAMA IS A DEVELOPMENTALLY REGULATED GENE 
 
The coupled reverse transcription and PCR amplification (RT-PCR) technique has 
been developed to measure gene expression in tissues and cells. Of all the available 
techniques, RT-PCR is the most sensitive and versatile. The technique can be used to 
determine the presence or absence of a transcript, to estimate expression levels and to 
clone cDNA products without the necessity of constructing and screening a cDNA 
library. To determine the levels of SNAMA transcription, RT-PCR was performed on 
total embryonic RNA at various developmental stages using primers DWNN1 and 
DWNN2. These primers amplify the DWNN domain of SNAMA. RNA was 
collected from a 0-3, 3-6, 6-12, and 12-18 hour stage of development of the embryo. 
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To standardise the amount of RNA amplified for each of the developmental stages, 
the ribosomal gene L18a (Ntwasa et al., 1994) was amplified. The L18a RNA is 
expressed throughout the development of the embryo and the levels of L18a 
transcripts have been found to be the same throughout the early developmental stages 
(0-18hr). By comparing the levels of RNA expression of L18a in the various 
developmental stages we were able to establish that equal amounts of RNA were 
amplified for each developmental stage. The levels of SNAMA expression decreased 
as the embryo developed (Figure 16). Two SNAMA transcripts are clearly visible in 
stages 0-3hr, 3-6hr, and 6-12hr of embryonic development. The larger of these two 
transcripts (SNAMA-1) disappears in 12-18hr embryos. This may indicate that there 
are two transcripts of SNAMA in 0-12hr embryonic stages, or that the two bands are 
splice variants of SNAMA. Indeed, DWNN proteins do exist either as the DWNN 
domain by themselves or associated with other domains as observed in humans where 
a 13 kDa (DWNN-13) and a 200 kDa (DWNN-200) DWNN protein has been 
identified (Figure 9).  
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Figure 16: Reverse transcriptase PCR was performed on various 
developmental stages of D. melanogaster embryonic RNA and resolved on a 
1.5% agarose gel. To standardise the amount of RNA amplified per 
developmental stage, a ribosomal protein L18a was amplified. Lanes 1,3,5 and 
7: SNAMA transcripts and lanes 2,4,6 and 8: L18a transcripts. Lanes 1 and 2: 
0-3hr embryonic development, lanes 3 and 4: 3-6hr embryonic development, 
lanes 5 & 6: 6-12hr embryonic development, lanes 7 and 8: 12-18hr embryonic 
developmental stage and M: marker (HinfI digested pTZ plasmid). SNAMA 
transcripts were detected throughout embryonic development. Two transcripts 
are expressed in 0-3hr, 3-6hr, and 6-12hr embryos. The level of SNAMA-2 
(234 bp) decreases as development progresses. SNAMA-1 was not detected in 
12-18hr embryos. 
   1      2     3     4     5      6     7     8     M 
 
1200 bp 
 
 
 
 
517 bp 
396 bp 
356 bp 
 
 201 bp 
 
SNAMA-1 
SNAMA-2 
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The presence of two transcripts in early embryonic development and evidence that 
the DWNN domain of SNAMA assumes a folded structure similar to ubiquitin 
(section 3.3.3) together with the presence of the cysteine rich RING finger-like 
domain suggest that SNAMA functions in a role as an ubiquitin-like protein. 
SNAMA could function similarly to ubiquitin to modify proteins by covalent 
attachment of this ubiquitin-like domain to other proteins. But the absence of the C-
terminal di-glycine residues on SNAMA suggest that some other enzymatic 
mechanism is involved in this attachment of the ubiquitin-like domain, since the 
known ubiquitin ligase requires this di-glycine residues.  
 
To determine whether these two amplicons are splice variants of each other, the 
bands containing the cDNA were excised and purified from the agarose gel as 
indicated in section 2.7.4. The purified DNA was sequenced using the automated 
sequencer at the School of Molecular and Cell Biology, University of the 
Witwatersrand. Alignment of the sequences of these DNA fragments with SNAMA 
genomic DNA indicated that SNAMA-1 included sequence that aligned to intron 1 
(Figure 17). It is therefore clear that genomic DNA had been amplified in the RNA 
samples collected since the primer pair used flanked the region including intron 1. 
This would, however, not explain the additional nucleotide at position 193 resulting 
in a frame shift.  It is likely that an additional nucleotide was introduced during the 
RT-PCR.  
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Figure 17: Sequence alignment of the two RT-PCR products SNAMA-1 and 
SNAMA-2 with genomic DNA sequence (SNAMAgDNA). SNAMA-1 includes 
sequence that aligns to intron 1. An additional nucleotide resulting in a frame shift is 
observed at position 193 (underlined). RT-PCR amplified genomic DNA in the 
RNA samples. 
    60SNAMA-1
    60SNAMA-2
    60SNAMAgDNA
Consensus
ATGTCGGTACACTATAAATTTAAGAGTACACTCAACTTTGATACAATTACTTTTGATGGA
ATGTCGGTACACTATAAATTTAAGAGTACACTCAACTTTGATACAATTACTTTTGATGGA
ATGTCGGTACACTATAAATTTAAGAGTACACTCAACTTTGATACAATTACTTTTGATGGA
atgtcggtacactataaatttaagagtacactcaactttgatacaattacttttgatgga
   119SNAMA-1
   120SNAMA-2
   119SNAMAgDNA
Consensus
CTTCACATTTCTGTCGGGGACTTAAAAAGGGAGATTGTGCAACAG.AAGCGACTGGGCAA
CTTCACATTTCTGTCGGGGACTTAAAAAGGGAGATTGTGCAACAGNAAGCGACTGGGCAA
CTTCACATTTCTGTCGGGGACTTAAAAAGGGAGATTGTGCAGCAG.AAGCGACTGGGCAA
cttcacatttctgtcggggacttaaaaagggagattgtgca cag aagcgactgggcaa
   179SNAMA-1
   165SNAMA-2
   179SNAMAgDNA
Consensus
AATCATCGACTTTGATCTTCAAATAACAAATGCGCAGAGTAAAGAAGGTATGTTCACCGC
AATCATCGACTTTGATCTTCAAATAACAAATGCGCAGAGTAAAGA...............
AATCATCGACTTTGATCTCCAAATAACAAATGCGCAGAGTAAAGAAGGTATGTCCACCGC
aatcatcgactttgatct caaataacaaatgcgcagagtaaaga
   239SNAMA-1
   180SNAMA-2
   238SNAMAgDNA
Consensus
AATTTAGGATTTTATCCCCTGCTACATGGTTTCCTTCCCTTTTCCAGAATACAAGGACGA
.............................................AGAATACAAGGACGA
AATTTAGAATTTT.TCCCCTGCTACATGGCTTCCTTCCCTTTTCCAGAATACAAGGACGA
agaatacaaggacga
   297SNAMA-1
   238SNAMA-2
   296SNAMAgDNA
Consensus
TGGGTTCCTTATTCCCAAAAACACAACGCTGATCATATCGCGCATCCCCATCGCCAAG
TGGGTTCCTTATTCCCAAAAACACAACGCTGATCATATCGCGCATCCCCATCGCCAAG
TGGGTTCCTTATTCCCAAAAACACAACGCTGATCATATCGCGCATCCCCATCGCCCAT
tgggttccttattcccaaaaacacaacgctgatcatatcgcgcatccccatcgcc a  
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This result suggests that there exist a single SNAMA transcript in developing 
embryos. The RT-PCR results indicated SNAMA to be a developmentally controlled 
gene with levels decreasing as development progresses. Drosophila melanogaster cell 
death begins at stage 11 (~7 hr) of embryogenesis marking the beginning of the 
patterning of the embryo (Abrams et al., 1993). Based on initial screening 
experiments used to identify DWNN (Pretorius, 1999), we propose that SNAMA 
plays a key role in the apoptosis pathway. This is consistent with evidence that CHO 
cells lacking the DWNN protein are resistant to staurosporine, the apoptosis-causing 
agent. The RT-PCR result indicates that the levels of SNAMA transcripts are 
increased during early embryonic developmental stages. After sequencing SNAMA-1 
and SNAMA-2 transcripts it is clear that there is a single transcript.  Northern blot 
analysis will verify the observations above.  
 
4.3 SNAMA cDNA SEQUENCE 
 
The cDNA for SNAMA was obtained from Berkley Drosophila Genome Project 
(BDGP), University of California Berkley, Berkley, CA 94720. The BDGP is a 
consortium of the Drosophila Genome Centre. The SNAMA gene was identified 
during the 1999 EST Project of the BDGP in the LD library made by Ling Hong 
(Rubin et al., 2000). SNAMA was submitted to the EST database on 02/14/2000, as 
clone number BcDNA: LD21643. The sequence has been submitted to GenBank by 
BDGP on the 01/03/1999, accession number AF132177. The cDNA for SNAMA was 
cloned into the 5 EcoRI site and the 3 XhoI site of the pOT2 vector  
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[SP6Promoter.XhoI.SNAMA.EcoRI.BstXI.EcoRV.BglIII.T7 Promoter] (Figure 18). 
The pOT2 vector was constructed by Oroon Hubbard, and was designed to give 
optimal results for transposon mapping and sequencing. The inserts were then 
sequenced to construct the cDNA library for the BDGP EST sequencing project. We 
obtained the SNAMA cDNA from BDGP. The SNAMA insert was released after 
restriction digest with EcoRI and XhoI. This results in two fragments because of an 
internal EcoRI site within the cDNA of SNAMA downstream to the DWNN domain. 
The digest was electrophoressed and the 914 bp insert purified from the gel. The 
cDNA fragment includes the conserved DWNN domain. This DNA was used as a 
probe in the Northern blot analysis and in in situ hybridisation experiments. 
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SNAMA 
Figure 18: pOT2 vector with the SNAMA insert. SNAMA DNA probes were 
obtained after a restriction enzyme digest with EcoRI and XhoI. This insert was 
labeled either for use in the Northern blotting experiment (section 2.8.2) or for 
probes in the In situ hybridisation experiments (2.8.1). 
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4.4  SNAMA IS EXPRESSED THROUGHOUT DEVELOPMENT 
 
To establish the temporal distribution and the size of the SNAMA mRNA, 
developmental Northern blots were prepared as indicated in the materials and 
methods section 2.8.2. The blot was probed with a radioactive 32P-labeled DNA 
probe prepared using random prime labelling of a 914 bp SNAMA fragment (EcoRI 
and XhoI restricted). The 914 bp N-terminal SNAMA fragment included sequence for 
the conserved DWNN domain. A single 4.6 kbp transcript is clearly visible 
throughout embryogenesis (Figure 19(A)). The transcript is present at higher levels in 
early embryogenesis and is significantly reduced in the late stages of embryonic 
development. Few genes are transcribed in the first 3 hours after fertilisation (Edgar 
and Schubiger, 1986). Thus, the high levels of expression of SNAMA in 0-3hr 
embryos indicate its vital role in development. This is consistent with a similar 
observation in l(2)rQ313 flies. Homozygous offspring of the P-element flies 
l(2)rQ313 die during embryogenesis since  they lack SNAMA transcription. The 
SNAMA transcript is not easily detected by the Northern blot in adult flies, but was 
detected by RT-PCR (Figure 20(B)). This indicates that SNAMA expression is 
reduced in both male and female flies. RT- PCR is a sensitive technique for detection 
of very low levels of RNA. The Northern blot result is not consistent with results 
obtained from RT-PCR (section 4.2).  
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Figure 19: Developmental Northern blot of D. melanogaster RNA from 
various embryonic developmental stages and adult flies. Approximately 50 µg 
of total RNA was loaded on each lane. Lane 1: 0-3hr, lane 2: 3-6hr, lane 3: 6-
12hr, lane 4: 12-18hr, lane 5: adult males and lane 6: adult females. The 
transcripts were detected using radiolabeled DNA probes. (A) The blots were 
first probed with a 914 bp SNAMA probe, then stripped and (B) reprobed with 
L18a as a control. A single 4.6 kbp SNAMA transcript was detected in embryos 
but not in adults. The 0.6 kbp L18a was detected on the same blot after 
stripping and reprobing. L18a was detected in adult male and female flies.   
  4.6 kbp 
  0.6 kbp 
  1          2          3           4          5       6     1         2          3        4        5         6  
A B 
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It is now obvious that there was possible genomic DNA amplification in the RT-PCR 
(Figure 17) resulting in the two transcripts. After repeating the RT-PCR using the 
same RNA samples collected for the Northern blot, a single transcript was detected in 
the 0-3 hr, 6-12 hr and 12-18 hr embryos. A decreased level of SNAMA transcription 
was observed in later stages of embryogenesis (Figure 20(A)), consistent with 
Northern blot results. SNAMA is expressed at very low levels in adult male and 
female flies indicating the importance of the protein in early development. It is now 
evident that there is only a single SNAMA transcript in all stages of development.  
 
To confirm that an equal amount of RNA was loaded into each lane, the blot was 
stripped and reprobed using a probe complementary to the D. melanogaster 
ribosomal protein L18a. L18a is expressed at equal levels throughout embryonic 
development (Ntwasa et al., 1994). L18a is only weakly expressed in adult male 
embryos and also appears at lower levels in female adults. The larger band on the 
L18a blot was SNAMA transcripts that were not removed after stripping of the blot 
before reprobing.  
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Figure 20: Reverse transcriptase PCR was performed on various 
developmental stages of D. melanogaster RNA and resolved on a 2% 
agarose gel (A) or on a 1.5% gel (B). To standardize the amount of RNA 
amplified per developmental stage, a ribosomal protein L18a was amplified. 
Lanes 1,3,5,7,9,11 and 13: SNAMA transcripts, lanes 2,4,6,8,10,12 and 14: 
L18a transcripts. Lanes 1 and 2: 0-3hr embryonic development, lanes 3 and 
4: 3-6hr embryonic development, lanes 5 and 6: 6-12hr embryonic 
development, lanes 7 and 8: 12-18hr embryonic developmental stage, lanes 
9,10,11 and 12: adult males, lanes 13 and 14: adult females and M: marker 
(Roche Marker III). Single transcripts at 234 bp are noticed in 0-3hr, 6-12hr, 
12-18hr embryos and in adult males and females.  
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4.5  SNAMA MAY BE LOCALISED IN THE NUCLEUS OF D. melanogaster 
EMBRYOS 
 
The technique for the localisation of mRNA In situ was first developed in the late 
1970s. This technique reveals patterns of gene expression, both temporally and 
spatially, at a cellular resolution.  Whole mount embryo in situ hybridisation was 
used to investigate the tissue expression of SNAMA transcripts. Embryos from various 
stages of development ranging from stages 1-15 (0-12hr development) (Campos-
Ortega and Hartenstein, 1997) were collected in the same tube. DNA probes specific 
to SNAMA were prepared as indicated in the materials and methods section 2.8.1. 
SNAMA transcripts were detected throughout the precellular blastoderm distributed 
uniformly seemingly expressed throughout the embryo (Figure 21). Stronger staining 
is observed in stage 5, cellular blastoderm stage embryos as compared to stage 11 
embryos. Stage 11 embryos stain along the germ band with no staining near the head 
region. Further investigation of the staining pattern is necessary to confirm the 
authenticity of the staining reactions. 
 
 
 
 
 
 
 124 
C 
A 
B 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 125 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
E 
 
 
 
 
 
 
 
 
 
D 
 126 
Figure 21: In situ staining of developmental stages of D. melanogaster 
embryos to detect SNAMA transcription. All embryos are orientated with 
anterior to the left. (A) Expression of SNAMA transcripts at syncitial 
blastoderm stage. (B) Stage 5, cellular blastoderm stage. (C) Stage 11, lateral 
view. (D) Stage 14, lateral view. Inset is a 1000X magnification of the head 
region showing nuclear localisation of SNAMA transcripts. Transcripts are 
distributed randomly throughout the embryo in all stages of development. (F) 
and (E) Controls done in parallel with the above experiments. (E) Blastoderm 
embryos stained with evenskipped DNA probe. (F) Stage 11 embryos stained 
with Dpp DNA probe.   
F
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4.6 SNAMA INTERACTS WITH Dmp53  
 
The homologues of SNAMA, PACT and RBBP6 in humans and mouse respectively, 
have been shown to bind and inactivate p53 and Rb. This suggests that SNAMA also 
has p53 and pRB binding properties and may inactivate p53. To investigate this 
interaction, Western blots were prepared as described in section 2.8.5. Protein 
extracts were run on a 12% SDS-polyacrylamide gel. The blot was first probed with 
anti-Dmp53 (Figure 22(A)), stripped and then reprobed with anti-SNAMA antibody 
(Figure 22(B)), stripped again and then blocked with p53 blocking peptide and 
probed with anti-SNAMA (Figure 22(C)). A 42 kDa band was identified as Dmp53 
on a Western blot using cell lysates from wild-type homozygous larvae (Lee et al., 
2003). This anti-Dmp53 antibody cross-reacted with other proteins as indicated by 
multiple bands ranging from 19 kDa to about 118 kDa on the Western blot (Figure 
22(B)). This is not unusual and a Western blot using this anti-Dmp53 antibody has 
been shown to result in a banding pattern (Lee et al., 2003). It is important to note 
that a major band at 20 kDa was also observed in addition to the band at 42 kDa and 
that most of the banding is found at the larval stage. In a personal communication, the 
suppliers of the antibody agreed that multiple banding is observed with the antibody. 
Smaller bands probably represent degradation products of Dmp53. The pattern of 
multiple bands is more dramatic at larval stages when significant apoptosis takes 
place (Figure 22(D)). All the bands disappear when the blot is first blocked with 
Dmp53 blocking peptide and then probed with Dmp53. When the blot is blocked with 
Dmp53 blocking peptide and probed with anti-SNAMA some of the bands remain. In 
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this way a set of bands have been isolated that are recognised by both antibodies 
indicating a tight association between SNAMA and Dmp53. It is also possible that 
SNAMA interacts with other proteins in addition to Dmp53 because the anti-
SNAMA antibodies cross-reacts with these proteins. A possible reason for this is that 
these are degradation products of SNAMA. A similar result has been observed on 
Western blots of the human DWNN homologue (Mbita Z., personal communication). 
Western blots on the human SNAMA homologue probed with anti-DWNN human 
antibody also identified multiple bands. It is also likely that SNAMA is attached to 
other proteins in a manner similar to that of ubiquitin. This attachment may be either 
non-covalent as seen in the Hub1 protein, or a covalent attachment requiring a yet 
unidentified set of ligases. This would explain the multiple banding patterns in the 
larval developmental stage on the anti-SNAMA blot. Yet another possibility is that 
the multiple bands observed in the larval stages for SNAMA may be due to the very 
basic charge centred at the C-terminus of the protein interfering with the migration of 
SNAMA on the gel. This would result in antibodies reacting with SNAMA protein 
through charge recognition and not through conformational recognition entirely. This 
point needs to be clarified by an in vitro acetylation reaction. This chemical 
modification will neutralise the positive charge at the C-terminus, and throughout the 
protein, and ensure antibody interaction with SNAMA protein through 
conformational recognition and also ensure that the protein enters the SDS-PAGE 
gel. 
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47 kDa 
26 kDa 
19 kDa 
34 kDa 
B A C 
Anti-SNAMA             +                                     -                                       + 
Anti-Dmp53                -                                     +                                      - 
p53 blocking                -                                     -                                       +    
peptide 
 
   0-3 3-6 6-12  L    M     F   0-3  3-6 6-12  L     M    F   0-3  3-6 6-12   L    M    F 
D 
Anti-SNAMA                      +          -          + 
Anti-Dmp53                         -          +          - 
p53 blocking peptide            -           -         +    
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D. melanogaster larvae that were fed with the apoptosis-inducing agent camptothecin 
showed increased levels of SNAMA protein expression on Western blots probed with 
anti-SNAMA. Camptothecin is a topoisomerase inhibitor shown to affect the p53 
pathway (Takada et al., 2003). Protein extract from larvae fed with media 
supplemented with 1 mM camptothecin overnight indicated increased levels of 
Dmp53 expression when Western blots were probed with anti-Dmp53 (Figure 
23(A)). When the same blot is stripped and probed with anti-SNAMA we noticed 
increased levels of SNAMA expression indicated by the arrow (Figure 23(B)). The 
anti-SNAMA antibody forms immunoreactive complexes with both SNAMA and 
Dmp53. These results indicate interactions between Dmp53 and SNAMA and also 
establish SNAMA as a protein involved in apoptosis via the Dmp53 pathway.      
Figure 22: Western blot analysis of proteins from embryonic, larval and adult 
stages of wild-type D. melanogaster development. Protein extracts were 
separated on a 12% SDS PAGE gel. Lane 1: 0-3hr, lane 2: 3-6hr, lane 3: 0-12hr, 
lane 4: lavae (L), lane 5: male adults (M) and lane 6: female adults (F). Marker 
position is indicated by distance migrated on the polyacrylamide gel. The blot 
was first probed with (A) anti-SNAMA antibody, stripped and then reprobed 
with (B) anti-Dmp53 antibody and (C) with anti-SNAMA after blocking with 
Dmp53 blocking peptide. The lanes of the larval stages are aligned in (D). A 42 
kDa-Dmp53 signal was detected (arrowhead in (B)). The banding pattern is 
characteristic for this anti-Dmp53 antibody. Arrows indicate proteins that are 
recognised by both antibodies.  
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Figure 23: Western blot analyses of proteins from D. melanogaster larvae 
that have been fed with 1 mM camptothecin overnight. Marker positions are 
indicated. (A) Camptothecin activates Dmp53 protein expression. (B) The 
blot was stripped and probed with anti-SNAMA. Proteins with increased 
levels of expression are indicated by arrowheads. Again we noticed the anti-
SNAMA antibody cross-reacting with Dmp53 suggesting association of 
Dmp53 with SNAMA. Lanes 1: larvae fed with 1 mM camptothecin, Lane 2: 
larvae media supplemented with DMSO (control) and Lane 3: Wild-type 
larvae.     
B 
 1      2       3 
A 
  1      2       3 
Dmp53 
50 kDa 
37 kDa 
20 kDa 
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5.1 INTRODUCTION 
 
The functional roles of DWNN proteins have not been established. The isolation of 
SNAMA, the D. melanogaster DWNN homologous protein, offers us the opportunity 
to study its role in a complex biological system. The D. melanogaster embryo is an 
ideal tool to determine developmental roles of genes. The D. melanogaster embryo is 
easy to manipulate and goes through very distinct developmental stages. The embryo 
starts as a unicellular blastoderm that eventually develops into a multicellular 
complex organism. In addition, we have also obtained a P{PZ} insertion fly line 
l(2)rQ313rQ313  (accession number AQ026141) (Spradling et al., 1999) from the EP 
flystation by Exelixis Inc. This fly stock has a P-element single insertion at position 
60B9 and was developed as part of the BDGP gene disruption project. The P-element 
insertion results in disruption of the SNAMA gene. This fly stock was used to 
investigate the role of SNAMA in developing embryos. 
 
5.2 SNAMA IS AN ESSENTIAL GENE REQUIRED FOR DEVELOPMENT 
 
5.2.1 P-ELEMENT MUTATIONS IN Drosophila melanogaster  
         
P-elements are natural transposable elements that are active in the germline of flies. 
They encode an enzyme called transposase that enables these elements to move to 
other chromosomal locations. P-element plasmid constructs have been used as genetic 
vehicles for the introduction of cloned DNA into the germline. The introduction of 
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these elements allow for the functional analysis of any piece of DNA in the context of 
the whole organism (Tautz, 1992). This has become an important tool for the 
determination of molecular interactions and gene functions. The P-element insertion 
EP line P{PZ}l(2)rQ313rQ313  has a P{PZ} insertion at 60B9. This insertion results in 
a disruption of the SNAMA gene resulting in a lethal mutation. It is thus evident that 
SNAMA protein has a vital role during the development of D. melanogaster embryos 
since embryos from l(2)rQ313 flies do not develop to adulthood and die during late 
embryonic stages.     
 
The gene disrupted by the P-element insertion is likely to be lost from the population 
because it is an essential gene for survival. This lethal recessive gene confers a 
disadvantage on the progeny of the heterozygotes. To keep the mutant P-insertion 
lines alive, the flies are crossed with another recessive lethal gene on the same 
chromosome. This is known as the balancer chromosome. The balancer carries a 
clearly visible dominant marker that allows us to follow the fate of the balancer 
chromosome in any further crosses. The balancer chromosome in l2rQ313 flies is the 
CyO gene. 
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5.2.2 IDENTIFICATION OF THE POSITION OF THE P-ELEMENT IN   
         l(2)rQ313 FLIES 
 
The P-element insertion line P{PZ}l(2)rQ313rQ313  has a P-element inserted in the 
first intron in the 5´-untranslated region of the SNAMA gene. This fly line was 
obtained from the EP flystation by Exelixis Inc., stock EP0503. The P-element 
insertion that resulted in the disruption of the expression of the SNAMA gene is lethal 
in homozygous offspring and embryos never develop to adulthood. These flies were 
used to investigate the functional role of SNAMA in developing embryos. The 
balancer chromosome on l(2)rQ313 flies is CyO. This results in extra veinage in the 
wing cells and the vein V does not go to the margin resulting in the wing forking. The 
CyO phenotype has wings curled upwards. This curvature is caused by the unequal 
contraction of the upper and lower epithelia during the drying period following 
emergence from the pupa case. The CyO balancer chromosome is also an essential 
gene that results in death during late embryo or early lavae stages when not expressed 
(Kidwell, 1972). The sequence for the P-element insertion was recovered by inverse 
PCR (Spradling et al., 1999) and we have identified its position on the D. 
melanogaster genome (Figure 8). PCR was used to identify the P-element insertion 
site. Genomic DNA was collected from wild-type Canton-S adults, heterozygous 
l(2)rQ313 adults and homozygous l(2)rQ313 unhatched embryos. The genomic DNA 
was then amplified using 5and 3 primers designed to complement the P-element 
inverted terminal repeat sequence (Pry4 and Plac4) and the flanking region of 
SNAMA (DWNN4 and DWNN2), respectively (Figure 24).                                  
 136 
Figure 24: Schematic representation of the primer positions on the genomic 
DNA from l(2)rQ3131 flies. The table indicates the expected PCR product 
from wild-type and l(2)rQ313 flies using the chosen primer combinations. 
The PCR products expected differ because w/type flies do not contain the P-
element insert. The P-element insert prevents amplification across the length 
due to the large size of the insert in l(2)rQ313 flies. 
    P-Element (2907 bp) 
Pry4 DWNN2 
DWNN4 Plac4 
5 3 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Primer Combination 
Wild-type 
genomic DNA 
Homozygous 
l(2)rQ313 
genomic DNA 
Heterozygous 
l(2)rQ313 
genomic DNA 
Plac4/ DWNN4 --- --- --- 
Pry4/ DWNN4 --- 663bp 663bp 
DWNN2/ DWNN4 1172bp 1172bp --- 
genomic DNA 
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DNA concentrations were determined spectroscopically so that equal amounts could 
be amplified by PCR. For l(2)rQ313 mutants that had a P-element insertion at the 
expected position, PCR products would be observed at the indicated position for the 
chosen primer combinations (Figure 24). As expected, a 1172 bp product was 
detected in lane 3 and no product was amplified for the wild-type genomic DNA in 
lanes 1 and 2 (Figure 25(A)). No PCR product from the heterozygous l(2)rQ313 
genomic DNA in lane 4, a 663 bp product in lane 5 and a 1172 bp product in lane 6 
was detected. For the homozygous l(2)rQ313,  there was no PCR product in lane 7, a 
663 bp product in lane 8 and no amplification in lane 9.  
 
A primer combination of Plac4 and DWNN4 results in no amplification products for 
the wild-type, heterozygous and homozygous l(2)rQ313 since these primers are in the 
same direction. This primer combination was chosen as an internal control. Primers 
Pry4 and DWNN4 results in no amplification products in the wild-type DNA due to 
the absence of the P-element in these flies. Pry4 is complementary to sequence on the 
P-element. For this primer set, both the l(2)rQ313 extractions amplified a 663 bp 
product. There was reduced amplification in the heterozygous extraction since only a 
single copy of the insertion exists in these flies. They develop to adulthood, while the 
homozygous embryos never hatch. Primers DWNN2 and DWNN4 amplified a 1172 
bp product in wild-type flies and in heterozygous flies while no amplification 
occurred in homozygous flies. The P-element is large and amplification across the P-
element is not possible in the homozygous mutants. A decrease in amplification 
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product was observed for the heterozygous flies since they only have a single copy of 
the P-insertion.  
 
Homozygous l(2)rQ313 embryos were selected from apple juice agar plates since 
these embryos don’t hatch because of the SNAMA gene being disrupted. l(2)rQ313 
was balanced with CyO ( with an effective lethal phase late embryo, early larva) 
(Kidwell, 1972). Thus the collection of unhatched embryos not only contained 
homozygous l(2)rQ313 , but also flies that died due disruption of the balancer gene. 
To ensure that only homozygous l(2)rQ313 are collected, these flies were crossed 
with CyO pAct GFP. Cyo pAct GFP flies express GFP (green fluorescent protein) 
ubiquitously. Embryos from these flies fluoresce green when placed under white 
light. Crossing these flies with the l(2)rQ313 mutants would result in the 
homozygous SNAMA P-element flies not expressing the GFP tag and the required 
flies are then selected from GFP fluorescent embryos. To establish the presence of the 
P-element in this new cross, the l(2)rQ313/GFP DNA was amplified using primers 
specific for the P-element sequence (Figure 25(B)). Again, the same bands were 
observed as for the l(2)rQ313 mutants. These PCR results indicated that a P-element 
has been inserted into the l(2)rQ313 line at the expected position and that this P-
element was not lost in the l(2)rQ313/GFP fly line.    
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Figure 25: PCR amplification products on a 0.8% TAE agarose gel to detect 
P-element insertion in l(2)rQ313 (A) and l(2)rQ313/GFP (B). Lanes 1,2,3: 
wild-type flies (Plac4/DWNN4 primer set), lanes 4,5,6: heterozygous flies 
(Pry4/DWNN4) and lanes 7,8,9: homozygous embryos (DWNN2/DWNN4). 
M: Marker III (Roche). The bands were observed at the expected sizes 
respectively (see Figure 24). This confirmed the presence of the P-element in 
both the l(2)rQ313 and the l(2)rQ313/GFP fly lines.     
       1    2   3   4    5   6    7   8    9   M 
B 
1584 bp 
 
831 bp 
564 bp 
   1   2    3   4    5   6    7    8    9   M 
1584 bp 
 
 
831 bp 
 
564 bp 
A 
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5.2.3 MOBILISATION OF THE P-ELEMENT FROM l(2)rQ313 FLIES 
 
To establish whether the P-element insertion in l(2)rQ313/GFP contributed to the 
observed phenotype, the P-element from l(2)rQ313/GFP was mobilised by crossing 
these flies with flies containing 2-3 transposase. To mobilise the P-element 
w;Cy/GFP;Sco female flies were crossed with Sb [ry+ 2-3]/ TM6b males. The male 
offspring were crossed with l(2)rQ313 to generate the flies in which the P-element 
had been mobilised. This excision line (scored by the loss of eye colour) was 
analysed by a PCR method using the primers flanking the P-element in the SNAMA 
gene (Figure 26). A primer combination of Plac4/DWNN4 and Pry4/DWNN2 were 
used in lane 1 and 2 respectively. No PCR amplification was observed since primers 
Plac4 and Pry4 are complementary to the P-element sequence that had been excised. 
An amplification product was observed at 1172 bp in lane 3 using primers DWNN4 
and DWNN2. This PCR product could only be amplified when the large P-element 
sequence was excised. This indicated mobilisation of the P-element that disrupted the 
SNAMA gene. These flies are viable and develop to adulthood unlike the l(2)rQ313 
flies. Some offspring show only small defects as a result of imprecise excision of the 
P-element. These crosses establish that SNAMA is a vital gene necessary for D. 
melanogaster development.  
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      1           2            3          M 
1375 bp 
 
947 bp 
Figure 26: PCR of genomic DNA from excision cross flies to test for excisions 
of the P-element. Lane 1: primer combination Plac4 and DWNN4 results in no 
PCR product, lane 2: primers Pry4 and DWNN4 results in no PCR product and 
lane 3: primers DWNN2 and DWNN4 amplifies a 1172 bp product. The P-
element has been removed in the cross. 
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5.2.4 CUTICLE ANALYSIS OF l(2)rQ313 EMBRYOS 
 
Analysis of the cuticles of D. melanogaster embryos highlighted structures such as 
the denticle bands. These are hair-like projections on the ventral cuticle of a larva and 
are indicative of development of segmental structures. D. melanogaster embryos 
homozygous for l(2)rQ313 display a spectrum of developmental defects as indicated 
by the irregular and disrupted denticle bands. Figure 27(A-C) indicates missing 
denticle belts at the posterior end of the embryo. Embryos were observed that had 
bands missing at abdominal segments a5, a6, a7, and a8. Some embryos are able to 
form a normal number of segments, but the posterior segments are severely 
compressed (Figure 27(D)). This suggests a failure in posterior midgut involution. 
The l(2)rQ313 embryos show severe and variable pattern defects indicative of 
morphological defects.    
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Figure 27: Cuticle pattern of l(2)rQ313 embryos. Cuticles prepared from 
unhatched embryos laid by l(2)rQ313 flies shows severe and variable pattern 
defects. (A-C) Unhatched mutant embryos showing an unusual complement of 
denticle bands with a very disordered arrangement. (D) Mutant embryos with a 
normal complement of denticle belts, but bands at the posterior end are 
compressed. (E) Wild-type embryo has a very regular and ordered denticle 
banding pattern.   
D 
E 
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5.3 SNAMA IS CHARACTERISTIC OF GENES INVOLVED     
      IN APOPTOSIS     
 
A large number of cells die during normal embryonic development in D. 
melanogaster. Apoptosis can be visualised in living wild-type and l(2)rQ313 
embryos using the vital stain acridine orange (Abrams et al., 1993). Acridine orange 
selectively stains apoptotic cells while necrotic cells are not labelled. D. melanogaster 
cell death begins at stage 11 (~7 hours) of embryogenesis becoming widespread 
throughout the embryo. The initial screen that identified the DWNN proteins was a 
screen for the resistance of mutated cells to apoptotic inducing agents. This indicated 
a possible role of the DWNN proteins and the SNAMA protein in apoptosis. To test 
whether SNAMA plays a role in apoptosis the P-element flies in which the SNAMA 
gene was disrupted were examined. This would indicate the levels of apoptosis in 
l(2)rQ313 flies where levels of SNAMA have been decreased.    
 
The insertion of a P-element into the first intron of SNAMA disrupts the SNAMA 
gene creating recessive lethal mutants with abnormal patterns of apoptosis (Figure 
28). Embryos were stained with the vital stain, acridine orange, which is specific for 
cells undergoing apoptotic cell death (Abrams et al., 1993). These P-element mutants 
show abnormal levels of apoptosis as compared to levels in wild-type flies. This is 
observed as increased levels of staining in these embryos. The acridine orange stained 
embryos show ectopic apoptosis in late stage embryos (Figure 28(B)) and early 
occurrence of apoptosis in the blastoderm (Figure 28(A)). The blastoderm is a 
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developmental stage characterised by rapid nuclear divisions with only low levels of 
apoptosis. This pattern of acridine orange staining was not present in wild-type 
embryos or after the P-element was completely removed from the l(2)rQ313 flies. 
This showed a direct correlation between the presence of SNAMA and apoptosis. An 
increase in the levels of apoptosis occurred in embryos with relatively low levels of 
SNAMA expression. SNAMA thus acts as an apoptosis suppressor. The mode of this 
action is either direct, or via other proteins that are involved in the apoptotic pathway.    
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A B 
C D 
Figure 28: Acridine orange staining of embryos viewed using confocal 
microscopy. (A) l(2)rQ313 cellular blastoderm. (B) Stage 10 l(2)rQ313 
embryos and (C and D) Wild-type embryos. The embryos were stained as 
described in section 2.8.6. Increased levels of apoptosis are observed in 
embryos lacking SNAMA. This is observed as increased levels of acridine 
orange staining. 
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6.1 THE DOMAIN ORGANISATION OF SNAMA PROTEIN AND ITS       
      FUNCTIONAL IMPLICATIONS 
 
The DWNN proteins have been identified in a large number of organisms, but their 
exact function remains unknown. This study characterised the Drosophila 
melanogaster DWNN homologue, SNAMA, and attempted to identify its possible 
role. These proteins have been identified by virtue of their ability to prevent apoptosis 
in mammalian cells lacking expression of the gene. They are a novel family of 
proteins characterised by a highly conserved amino terminal DWNN domain which is 
found in many eukaryotic species but absent in prokaryotes. The domain was 
identified through mutagenesis experiments in Chinese hamster ovary (CHO) cell 
lines screening for genes involved in the antigen presentation pathway and in 
apoptosis (George, 1995). SNAMA was identified through homology searches using 
the DWNN domain sequence. Its DWNN domain is found associated with a zinc 
finger, a cysteine rich modified RING finger domain and a C-terminal region that 
aligns to the PACT protein. All these domains are well characterised except for the 
N-terminal DWNN domain.  
 
Homologues of the SNAMA protein have been identified and characterised in a few 
organisms. These are the human RBBP6 protein, mouse PACT protein, mouse P2P-R 
protein, and the yeast Mpe1 protein. These proteins were identified based on their 
functional roles in these organisms rather than identified as DWNN-domain proteins. 
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The researchers that identified these proteins failed to identify the unique DWNN 
domain and overlooked its role in these proteins.  
 
The SNAMA protein consists of the 76 residue DWNN domain (amino acid 1-76), a 
zinc binding domain (CCHC) (amino acids 151-168), a unique cysteine rich RING 
finger-like domain (amino acids 217-258) (Mather et al., 2005), two basic lysine rich 
regions (amino acids 805-848 and 1188), and a p53-associated region (Figure 29). 
 
Although very little is known about the function of the DWNN proteins, the high 
level of evolutionary conservation in eukaryotes suggests that they play an important 
functional role. There are two human DWNN proteins (Dlamini, unpublished). 
DWNN-13 is a very short 13 kDa protein of 118 amino acids and DWNN-200 is a 
200 kDa protein associated with several characterised domains such a the zinc finger 
and cysteine rich RING finger-like domains (Mbita, 2004). DWNN-13 is the DWNN 
domain with a glycine dipeptide together with a C-terminal extension of 39 amino 
acids. The DWNN domain of SNAMA lacks this glycine dipeptide but retains a 
conserved proline. Because of the presence of DWNN-13 with a glycine dipeptide it 
is speculated that the DWNN domain may function similar to ubiquitin by attachment 
to other target proteins. This possible role of the human DWNN-13 protein suggests 
that SNAMA may also play a role in the ubiquitin pathway with a folded DWNN 
domain structure similar to ubiquitin. This thesis investigated the ability of SNAMA 
to target proteins.  
 
 151 
Figure 29: Schematic representation of the domain arrangement of 
SNAMA protein identified using the SMART programme. The protein has 
the N-terminal DWNN domain, a zinc finger domain (CCHC) and a 
cysteine rich RING finger-like domain. It also has a region with high 
homology to the mouse PACT protein (p53 associated protein) and a 
lysine-rich C-terminal region.  
DWNN domain 
p53 association 
region 
Cysteine rich RING finger-like domain  
Lysine rich region 
CCHC zinc finger 
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A closer look at the function of the mammalian SNAMA homologous proteins 
indicates that SNAMA plays a role in the apoptotic pathway with possible p53 and or 
pRb binding properties. The SNAMA homologues are the RBBP6, PACT, P2P-R and 
Mpe1 proteins. RBBP6 is the truncated human homologue of PACT and was 
identified by virtue of its binding to Rb proteins. PACT binds to wild type p53 and 
effects p53 specific DNA binding. PACT also interacts with Rb. P2P-R, the 
alternatively spliced product of the PACT gene (Gao and Scott, 2003), induces 
mitotic arrest and mitotic apoptosis, indicating that P2P-R has the potential to serve 
an important role in apoptosis. The mammalian SNAMA homologues have been 
shown to have p53 and Rb binding ability and are nuclear proteins. The Rb protein is 
involved in cell differentiation and is localized to centres of mRNA processing in the 
nucleus. Mpe1, the yeast homologue of SNAMA is involved in 3 end processing of 
pre-mRNA forming part of the endonucleolytic complex at the cleavage and 
polyadenylation site. It is a putative RNA-binding protein because of the zinc finger 
between amino acids 181 and 192 (Vo et al., 2001). This is supported by evidence 
that the zinc finger domain present in the CPSF 30K subunit of the mammalian 
cleavage and polyadenylation specific factor is involved in the interactions of this 
protein with the pre-mRNA (Barabino et al., 1997). SNAMA shares the RNA binding 
zinc finger with Mpe1 protein suggesting that SNAMA may have a role in 3 end 
processing as well. Taken together these homologues function in transcriptional 
regulation and the apoptotic pathways by binding p53 and Rb. Sequence homology 
suggests that SNAMA may have similar functions to its homologues. It is also 
important to note that p53 and Rb binding proteins are few and that Mdm2 also has 
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p53 and Rb binding ability (Lohrum et al., 2000). Since Drosophila melanogaster 
lacks an Mdm2 homologue, it is plausible that SNAMA is the functional homologue. 
The role of SNAMA in the apoptosis pathway was investigated by looking at the 
interaction of SNAMA with the apoptosis suppressor Dmp53. 
 
The CCHC type zinc finger domain of SNAMA suggests possible nucleic acid 
binding properties or a role in protein-protein interactions. Zinc finger proteins have 
been implicated in DNA or RNA binding, protein-protein interactions and membrane 
association. The C2H2 zinc finger is the first member of the zinc binding family of 
proteins. The structure of the CCHC finger of the D. melanogaster U-shaped protein 
has been reported as being similar to that of the classical C2H2 motif (Laity et al., 
2001). The CCHC zinc finger of D. melanogaster U-shaped protein mediates the 
functional interaction between the GATA-1 transcriptional activator and the Friend 
Of GATA (FOG) protein (Fox et al., 1999). They have subsequently also been found 
in proteins involved in DNA binding.  
 
SMART and ScanProsite identified the cysteine rich RING finger-like domain of 
SNAMA as a RING finger. A closer look at this domain indicates that the RING 
finger does not have a histidine in the fourth position that is typical of RING finger 
domains, but has a serine residue substitution at this position (amino acid 235) 
(Mather et al., 2005). The SNAMA RING finger-like domain is unique and may form 
a new group of the variant RING fingers. These types of RING fingers have a 
histidine substituted with a functionally conserved amino acid. In the case of 
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SNAMA this is a histidine to serine substitution. This histidine substitution is 
observed in all of the SNAMA homologues with the exception of E. cuniculi. Here 
the histidine has been conserved. The RING finger-like domain of SNAMA extends 
from amino acids 214 to 272. It is likely that this domain functions as a RING finger 
with ubiquitin ligase ability and would enable SNAMA to modify other proteins or to 
catalyse auto attachment of the SNAMA domain to itself. However, it has not been 
experimentally determined what effect the histidine to serine substitution at position 
four of the RING finger (amino acid position 235) will have on its ability to 
coordinate zinc and maintain ubiquitin ligase activity. It is not uncommon to find the 
appropriation of a new set of residues to stabilise this domain in proteins, along with 
the loss of the original metal chelating residues. The U-box is one such example of a 
modified version of the RING finger domain. The U-box lacks the hallmark metal 
chelating cysteine and histidine residues of RING fingers. They are structurally 
similar to RING domains and are likely to function similar to the RING fingers 
(Aravind and Koonin, 2000). The U-box scaffold is stabilised by salt-bridges and 
hydrogen bonding rather than by zinc ion coordination, and it is possible that these 
interactions stabilise the RING of SNAMA.  The metal chelating residues are 
replaced by other amino acids in U-box proteins. In the case of the U-box of the 
human UIP5 protein, a serine residue replaces the cysteine of the RING finger 
domain (Pringa et al., 2001). The U-box of UIP5 is able to form physical interactions 
with E2 enzymes in the same way that RING fingers function. This indicates that a 
serine substitution is capable of maintaining the three-dimensional structure of the U-
box domain and would be able to maintain the three-dimensional structure of the 
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RING finger domain when the histidine is replaced by serine in the RING of 
SNAMA.  Alignment of the SNAMA homologues shows that this position is 
occupied by various other polar amino acids such as lysine, asparagine and arginine. 
The suggestion that the cysteine rich region of SNAMA functions as a RING finger is 
supported by the fact that that substitution in the RING domain has been observed in 
proteins such as Mdm2, RBQ-1 and CART1. These substitutions do not affect the 
three dimensional structure of the RING finger and in the case of Mdm2 the protein 
maintains ubiquitin ligase activity. The serine substitution is in the second zinc 
coordination site. This site shows a degree of flexibility for zinc binding, and since 
site one in SNAMA remains intact it is possible that only site one binds zinc to 
maintain the integrity of the RING domain. The serine substitution is also a 
conservative replacement of histidine and could also possibly ligate zinc due to 
ionisation of the hydroxyl group on the serine residue similar to the chemistry with 
threonine in Mdm2. Other examples of substitutions in the RING domain include the 
RBR family of proteins. A phylogenetic analysis of these proteins identified a 
substitution of the characteristic histidine in the C-terminal RING finger domain by a 
range of amino acids in 28 proteins (Marin and Ferrus, 2002). The RBR proteins play 
a role in ubiquitination. The protein dTopors is an E3 ligase with a RING finger 
(Secombe and Parkhurst, 2004). The first cysteine of the RING finger in dTopors is 
essential for E3 activity. RING fingers activate E2-dependent ubiquitination, which 
suggest a general role of these proteins in the ubiquitin pathway (Lorick et al., 1999). 
The E3 proteins containing RING finger domains do not form thiol conjugates with 
ubiquitin but rather allosterically activate E2 to transfer ubiquitin to the substrate 
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lysine (Seol et al., 1999). Several nuclear RING finger proteins are involved in the 
regulation of chromatin structure and RNA polymerase II-mediated transcription. The 
presence of a modified RING finger on SNAMA and evidence that this cysteine rich 
region could fold as a RING finger suggests that SNAMA has E3 ubiquitin ligase 
activity or may be an E4 type ubiquitin ligase. SNAMA may also be involved in 
transcription. 
 
6.2 THE SEQUENCE ANALYSIS OF SNAMA  
 
The cDNA for SNAMA was received from the Berkley Drosophila Genome Project. 
The cDNA is 3937 bp long with an open reading frame of 3783 bp coding for 1231 
amino acids. The cDNA of SNAMA was compared to the Drosophila genomic 
sequence to identify the exon-intron organisation. SNAMA consists of nine exons and 
eight introns (Figure 30). The Northern blot detected a single transcript at 
approximately 4.6 kbp in all the developmental stages. The difference of almost 0.8 
kbp between the mRNA and the observed ORF can be accounted for by the 5 and 3 
untranslated regions. The high levels of expression during early developmental stages 
of the embryo indicates the vital role this gene plays in development since very few 
genes are expressed in the first three hours after fertilisation. Transcripts are also 
markedly reduced in the adult flies when the organism’s body pattern is established. 
Again we notice a requirement for the SNAMA gene during stages of development 
when apoptosis is widely spread to mould the organism into its final form.  
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Figure 30: A schematic representation of the genomic organisation of the 
SNAMA gene (Mather et al., 2005). The exons are indicated by filled 
boxes interrupted by the introns. Introns 1 and 6 are much larger than the 
other introns. The first intron is in the 5 UTR. The position of the P-
element insertion in l(2)rQ313 is also indicated. The P-element was 
inserted into the first intron.     
Predicted promoter sequence 
                         
             tgtcactagattaataaccgccaccattcccggccagccaggccaatcct 
Transcription start 
                P-element exons
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These transcripts were also observed after amplification with primers complementary 
to the DWNN domain. The RT-PCR reaction is a more sensitive technique than 
Northern blot analysis and was able to detect the low levels of expression of SNAMA 
in adult flies. In addition, initial screening experiments detected two transcripts after 
PCR. This evidence seemed convincing since two transcripts exist for the SNAMA 
mammalian homologues. Sequence alignments of these two transcripts with SNAMA 
genomic DNA identified the larger transcript as having sequence that aligns to intron 
one. The sequence of the 234 bp fragment aligned perfectly with the cDNA. The 
larger amplicon included intron sequence with an in frame internal stop codon that 
could not code for a protein of the larger size. Repeating the RT-PCR then identified 
only a single transcript in embryos consistent with what was observed on Northern 
blots. The larger amplicon was amplification of genomic DNA that was present in the 
RNA samples.      
 
The predicted molecular weight of SNAMA is 139 kDa. This size was never 
observed on Western blots. Typically Western blot analysis indicated a banding 
pattern with proteins ranging from 19 kDa to 118 kDa. The SNAMA mammalian 
homologues have two transcripts, DWNN-13 and DWNN-200. The Western blot was 
unable to identify bands at these positions. It is possible that the banding pattern 
observed is a result of SNAMA degradation or DWNN of SNAMA being attached by 
some yet unidentified mechanism to other proteins. This attachment would require 
the ubiquitin ligase activity of the RING finger-like domain together with the 
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ubiquitin-like fold of the DWNN domain. The banding pattern on the Western blot is 
typical for ubiquitinated proteins suggesting that SNAMA attaches the N-terminal 
DWNN domain to a range of target proteins.  
 
A putative promoter sequence and a transcriptional start site was predicted at 2.2 kbp 
from the translational start site (Mather et al., 2005). This could not be verified 
experimentally, though its likelihood was examined using information of known 
Drosophila melanogaster promoters and their regulatory regions. More evidence 
about the nature of the 5 region of SNAMA mRNA is required before the regulatory 
regions can be delineated conclusively. This research is continuing and involves 
ligating the putative promoter into a promoter-less reporter vector and observing if 
the promoter is capable of driving expression of the reporter gene (Hull, personal 
communication).   
 
SNAMA also contains a region rich in arginine-serine/serine-arginine dipeptides. 
There are 33 RS or SR dipeptides with most of these repeats clustered towards a 
specific region of the protein (Figure 10). RS-rich proteins are involved in mRNA 
splicing and include proteins such as SRP75 (Zahler et al., 1993) and CARS-Cyp 
(Mattioni et al., 1992; Khan et al., 1994). However, SNAMA lacks the consensus 
RNA-binding domain (CS-RBDs) found in the RS proteins (Fu, 1995). Other RS 
proteins have been found lacking the CS-RBDs. These proteins are either kinases 
(e.g. Clk-1) or helicases (e.g. HRH-1) and also function in the regulation of mRNA 
splicing (Colwill et al., 1996; Ohno and Shimura, 1996). Of particular interest is the 
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human topoisomerase I binding protein named Topors. This protein has an 
arrangement of domains similar to that of SNAMA. Topors has a RING domain, RS 
domains and bipartite nuclear targeting domains. This suggests that Topors is 
involved in transcription, possibly recruiting topoisomerase I to RNA polymerase II 
transcriptional complexes (Haluska et al., 1999). We have already established that the 
SNAMA yeast homologue Mpe1 is involved in transcriptional processing. The PACT 
protein has also been shown to include an RS region. This suggests that SNAMA 
could belong to a large group of RS related proteins (described by Fu, 1995) and may 
play a role in mRNA processing. The RS domain has been found to cause 
aggregation of the RS containing proteins in 20 mM MgCl2  (Zahler et al., 1992) and 
this may account for the difficulty experienced in SNAMA protein expression 
(Zungu, 2003). The SR domains are positively charged and may undergo functionally 
significant chemical modifications in vivo. The RS domain is known to be a site in 
which serine residues are phosphorylated by a kinase specific for this region (Gui et 
al., 1994a; Gui et al., 1994b). Phosphorylation of the RS region of RS family splicing 
factors regulates splice site recognition. The Drosophila Topors homologue has been 
named dTopors (Secombe and Parkhurst, 2004). It does not align with SNAMA 
although they share a RS region and a RING finger domain. dTopors is similar to 
human Topors, the p53 binding protein p53BP3 (Zhou et al., 1999) and to LUN (Chu 
et al., 2001). This protein binds specifically to the basic region of Hairy; a pair rule 
gene involved in transcriptional repression and also has ubiquitin-protein isopeptide 
ligase activity in vitro. There is a reduced density of RS repeats in dTopors and it 
lacks the consensus RNA-binding domain suggesting that although the RS region of 
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dTopors may be involved in protein-protein interactions or phosphorylation, it is 
unlikely to be a direct regulator of mRNA splicing. The RS region of dTopors has 
been suggested to act as a regulatory phosphor domain to affect the E3 activity of 
dTopor. It is likely that SNAMA, too, is not directly involved in mRNA splicing but 
does play a role in splicing and that these RS regions act as regulatory phosphor 
domains that regulates the possible E3 activity of the protein. There exist two 
reported connections between the tumor suppressor proteins and the pre-mRNA 
splicing machinery. This connection would then be possible in SNAMA, which has 
been shown to play a role in apoptosis by interacting with Dmp53. In addition the 
presence of the RS region and related evidence establishes a possible function in 
mRNA processing.   
 
The lysine rich regions of SNAMA are also found in PACT. These regions may 
undergo chemical modification in vivo. We have no data to support this, however, 
this domain is reminiscent of the basic N-termini of several histones. Core histones 
are known to undergo cell cycle dependent acetylation and deacetylation. These 
modifications may cause a differential affinity of the nucleosomes to DNA, allowing 
differential chromatin packaging throughout the cell cycle. The positively charged 
lysine rich region in SNAMA is adjacent to the C-terminal and has relatively low 
secondary structure (DNAMAN programme). Upon acetylation of this area in PACT 
the protein develops a neutral charge overall and may alter the functional capabilities 
of the protein (Simons et al., 1997). Acetylation of the SNAMA protein needs to be 
investigated.   
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 The presence of a potential nuclear localisation signal suggests that SNAMA may be 
a nuclear protein. To investigate this we looked at In situ staining of embryos.  The 
SNAMA protein localises non-homogeneously in the nucleus and is marked by an 
area of staining. This nuclear staining is similar to the nuclear localisation patterns 
exhibited by RS-splicing proteins (Misteli et al., 1997) and RING finger proteins 
such as the viral protein family ICP0 (Everett and Maul, 1994) that are implicated in 
transcriptional control.  
 
6.3 THE CYTOLOGICAL POSITION OF SNAMA 
 
Polytene chromosomes are found in the salivary glands of Drosophila. They consist 
of a hundred or more copies of DNA arranged side by side. The high local DNA 
concentration of aligned DNA sequences in polytene chromosomes makes them ideal 
targets for in situ hybridisation with specific sequence probes. The banding pattern 
that is observed is an indicator of genomic organisation and reflects the position of 
specific DNA sequences. The bands also provide a tool to assess major chromosomal 
rearrangements that accompany species divergence (Pardue, 1986). The SNAMA 
gene has been localised by in situ hybridisation to the polytene chromosomes and 
correspond to position 60B9 on the right arm of chromosome 2 (Rubin et al., 2000).  
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6.3.1 GENES OCCUPYING POSITION 60B 
 
The SNAMA homologous proteins have DNA and RNA binding ability and are 
involved in protein-protein interactions with transcription factor p53 and with the Rb 
protein. Transcriptional factors and chromosomal proteins are found localised to 
various bands on the chromosome. Localisation of these proteins to specific regions 
is thought to have a functional significance and to reflect the activity of these proteins 
in gene regulation. It is for that reason that it was necessary to identify genes in the 
region of SNAMA. Several genes occupy position 60B8 to 60B12; the region flanking 
SNAMA on the chromosome. These genes include Mlp60A, gek, enok, tamo, and 
Zfrp8. We will discuss and assess the relationship of these genes to SNAMA. 
 
6.3.1.1 Muscle LIM protein at 60A (Mlp60A) 
 
Muscle LIM proteins (Mlp) is a conserved LIM finger protein found in striated 
muscle. They are essential promoters of myogenesis and play a role in cell 
differentiation (Arber et al., 1994). They control muscle differentiation by binding to 
the myogenic regulatory factors myocyte enhancer-binding 2 (MEF2) protein 
(Stronach et al., 1999). The muscle LIM protein at 60A(Mlp60A) protein is involved 
in the regulation of myogenesis in Drosophila.  Mlp60A contains the LIM domain, 
which is a zinc-binding domain, found in a number of eukaryotic proteins that 
regulate cell growth and differentiation during development. Mlp60A encodes a 96 
amino acid protein with a single LIM domain linked to a glycine-rich region. 
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Expression is spatially restricted to larval somatic muscle, larval visceral muscle, 
pharyngeal muscle, somatic mesoderm and visceral mesoderm. Mlp60A transcripts 
are found throughout the muscle fibres. Gene expression is developmentally regulated 
with a biphasic pattern over the course of the Drosophila life cycle (Stronach et al., 
1996). It has been mapped cytologically to position 60B8.   
 
6.3.1.2 Genghis Khan (Gek) 
 
The Rho family of small GTPases consists of the Rho, Rac and Cdc42 subfamilies. 
This family of proteins controls morphogenetic processes that involve the remodeling 
of the actin cytoskeleton by acting as molecular switches (Mizuno et al., 1999). 
Cdc42 regulates a variety of biological processes including actin polymerisation, cell 
proliferation, and JNK/mitogen-activated protein kinase activation via specific 
effectors. Genghis Khan (Gek), a multidomain protein kinase, is a downstream 
effector of D. melanogaster Cdc42 and a regulator of actin polymerisation (Luo et al., 
1997). Gek binds to Dcdc42 in a GTP-dependent and effector domain-dependent 
manner. Gek is a protein of 1613 amino acids which contains a serine/threonine 
kinase catalytic domain, a coiled-coil domain, a cysteine-rich domain similar to the 
phorbol ester binding domain, a pleckstrin homology domain which is found in 
signalling molecules, and the Cdc42 binding consensus sequence. Gek has been 
mapped cytologically to position 60B9-60B10.   
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6.3.1.3 Enoki mushroom (Enok) 
 
Enok encodes a product with histone acetyltransferase (HAT) activity of the MYST 
family of proteins involved in neuroblast proliferation. This family of proteins is 
responsible for the acetylation of histones. The significance of this modification is to 
regulate processes such as gene repression, gene activation and replication. Lysines at 
the N-terminal ends of the histones are the sites of acetylation (Pandey et al., 2002). 
Enok is 2291 amino acids long containing a zinc finger C2H2 type, a histone H1 and 
H5 family and a PHD finger. It has been mapped cytologically to position 60B10-
60B11. Enok is required for mushroom body neuroblast proliferation. 
 
6.3.1.4 Tamo 
 
Tamo is a cytoplasmic protein that binds to Drosophila Rel protein Dorsal. Tamo 
functions during oogenesis and controls the levels of the nuclear protein Dorsal in 
early embryos. It also regulates the accumulation of Dorsal in the nucleus after 
immune challenge. Tamo negatively regulates Dorsal nuclear targeting. Tamo 
interacts with Dorsal via the nuclear localisation signal (NLS). The NLSs are 6 amino 
acids that bind adapter proteins such as importins (Nakielny and Dreyfuss, 1999). 
Tamo encodes three different transcripts; a 4.1 kbp transcript expressed throughout 
development, a 3.6 kbp transcript present mainly in ovaries and early embryos and a 
1.2 kbp transcript which is highly expressed in third instar larvae and weakly in 
adults. The 3.6 kbp and 4.1 kbp mRNAs encode the same polypeptide of 797 amino 
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acids with a predicted molecular weight of   89 kDa (Minakhina et al., 2003). The 
protein has been mapped cytological to 60B11. Tamo has a zinc finger domain at the 
C-terminus of the protein. This domain interacts with Ran on Ran GDP and is thus 
likely to function in nuclear import, and may be regulated by the Ran-GDP-GTP 
gradient.  
 
6.3.1.5 Zinc finger RP-8 (Zfrp8) 
 
Zfrp8 encodes a product that has DNA binding ability and is a component of the 
nucleus. Zfrp8 encodes a 347 amino acid protein that is an apoptotic gene. The gene 
has been mapped cytologically to position 60B12 (Owens et al., 1991). 
 
None of these genes and their translational products matched the nucleotide and 
protein sequence, respectively, of SNAMA during searches of the databases. The only 
significant similarity to SNAMA is the presence of the zinc finger in Mlp60A, Enok, 
Tamo and Zfrp-8. Zinc finger domains occur in a variety of eukaryotic transcription 
factors, in Drosophila developmental regulators, and certain proto-oncogene proteins. 
It is evident that the genes occupy position 60B8 - 60B12, the region flanking 
SNAMA on the chromosome codes for proteins that are all regulatory proteins 
involved in the development of the organisms. This suggests that SNAMA plays a 
role in embryo development acting as a regulatory protein in an unknown pathway.       
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6.4 THE BIOLOGICAL FUNCTION OF SNAMA 
 
6.4.1 THE DWNN DOMAIN OF SNAMA HAS A UBIQUITIN-LIKE FOLD  
 
It has been predicted that the N-terminal 76 amino acid residue of the DWNN domain 
of SNAMA has a ubiquitin-like fold (chapter 3.3.3). Preliminary NMR structural 
analysis of the human DWNN domain also indicates a folded structure similar to that 
of ubiquitin (Pugh, personal communication). This identifies SNAMA has a protein 
possibly functioning in the ubiquitin pathway. It should however be noted that the 
DWNN domain lacks the double glycine motif that is required both for ubiquitin 
precursor processing and for ubiquitin conjugation. The ubiquitin molecule consists 
of a five-stranded -sheet and a -helix and a flexible tail formed by four protruding 
residues. The predicted fold of the N-terminal region of SNAMA has this typical 
fold, but lacks some important surface residues essential for ubiquitin conjugation 
and deubiquitination (Figure 31(A)). The ubiquitin tail consists of the essential 
residues Leu73, Arg74, Gly75, and Gly76 (Sloper-Mould et al., 2001). Gly75 and 
Gly76 are essential for ubiquitin conjugation and Arg74 is essential but not important 
for E1 interaction or ubiquitin conjugation. Arg74 and Leu73 play minor roles in 
endocytosis. Isoleucine and proline residues replace the Gly75 and Gly76, 
respectively, in the DWNN domain of SNAMA. The proline imparts restrictions on 
the three-dimensional structure of the protein. Pro76 of SNAMA is observed in most 
of the homologues and is observed in a yeast ubiquitin-like protein DSK2 where it 
prevents cleavage of the ubiquitin-like domain by specific hydrolases (Vucic et al.,  
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Figure 31: (A) Ubiquitin amino acid sequence and a comparison with the 
DWNN domain of SNAMA. Conserved residues are indicated in black. SNAMA 
lacks the di-glycine residues at the C-terminal end, which has been replaced by 
an isoleucine and a proline. (B) Neighbour-joining (NJ) phylogenetic tree of the 
ubiquitin-like domain of the DWNN family of proteins. Proteins with the C-
terminal di-glycine residues are indicated by GG.  
B 
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1998). The Arg74 of ubiquitin is conserved in SNAMA. Although many of the 
SNAMA homologues have a proline, there are some homologues that have a di-
glycine near the proline and this appears to be an evolutionary event (Figure 31(B)). 
The DWNN proteins from animals, plants and fungi form groups. None of the plant 
proteins have a di-glycine. The fungi diversified independently with two examples 
that have a di-glycine (the microsporidea and a ascomycota pezizomycotina). In 
animals, metazoa chordata have the di-glycine while the arthropoda do not. It appears 
that the more complex metazoan have diverged to maintain the di-glycine essential 
for conjugation (Table 11). The presence of the Pro76 of SNAMA suggests that the 
ubiquitin-like domain does not modify other proteins, at least not in a manner that 
requires cleavage by the known hydrolases. Alternatively, it could mean that it is 
cleaved by a different and as yet uncharacterised set of enzymes.      
 
Lysine residues at positions 29, 48 and 63 of ubiquitin have been implicated in the 
formation of polyubiquitin chains in S. cerevisiae. The DWNN domain of SNAMA 
has eight lysine residues at positions 6, 8, 29, 36, 40, 54, 58 and 66 capable of 
forming polyubiquitin chains. Lys48 and Lys63 are also important for targeting 
proteins for 26S proteasome degradation and for mediating cellular functions such as 
DNA repair and intracellular cell sorting. The E3 enzymes conjugate the C-terminal 
glycine of one ubiquitin molecule to the internal Lys48 of the adjacent ubiquitin 
molecule. A Lys48Arg mutation is unable to mediate ubiquitination by E3 
enzymes (Hatakeyama et al., 2001) but dependence on this lysine residue appears to 
differ amongst U-box proteins.  
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ORGANISM PHYLA PRESENCE OF DI-
GLYCINE 
Saccharomyces 
cerevisiae 
Fungi; Ascomycota; 
Saccharomycotina 
NO 
Eremothecium gossypii 
 
Fungi; Ascomycota; 
Saccharomycotina 
NO 
Schizosaccharomyces 
pombe 
Fungi; Ascomycota; 
Schizosaccharomycetes 
NO 
Neurospora crassa Fungi; Ascomycota; 
Pezizomycotina 
YES 
Encephalitozoon 
cuniculi 
Fungi; Microsporidia YES 
Arabidopsis thaliana 
 
Viridiplantae NO 
Oryza sativa   
 
Viridiplantae NO 
Caenorhabditis elegans 
 
Metazoa; Nematoda NO 
Drosophila 
melanogaster 
 
Metazoa; Arthropoda NO 
Anopheles gambiae  
 
Metazoa; Arthropoda NO 
Mus musculus 
 
Metazoa; Chordata YES 
Homo sapiens 
 
Metazoa; Chordata YES 
Table 11: Presence of the di-glycine residues at the C-terminal end of the DWNN 
domain in SNAMA homologous proteins. Organisms have been arranged in order 
of complexity to see if any evolutionary pattern exists.   
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Polyubiquitin chains that are assembled through lysine residues of ubiquitin other 
than Lys48 may function in distinct biological processes and not only in proteolysis 
(Hatakeyama and Nakayama, 2003). SNAMA lacks the conserved Lys48 but retains 
the Lys63 required for poly-ubiquitin chain formation and targeting modified proteins 
for 26S proteasome degradation. The Leu8, Ile44 and Val70 amino acids in ubiquitin 
are collectively known as the hydrophobic patch and are critical for proteasomal 
degradation. Leu8 and Ile44 in SNAMA are conserved. Val70 has been substituted by 
a hydrophobic isoleucine conserving the overall hydrophobic patch of the ubiquitin-
like DWNN domain essential for proteasomal binding and degradation. The amino 
acids essential for endocytosis Phe4 and Thr12 are conserved in SNAMA. Taken 
together, this comparison supports our hypothesis that the DWNN domain of 
SNAMA could be involved in poly chain formation, being transferred to proteins in a 
manner similar to ubiquitin either targeting them for proteasomal degradation or some 
other biological process. The mode of transfer is not yet understood.  
 
The ubiquitin domain proteins (UDP) have a ubiquitin-like domain within a large 
protein. The ubiquitin-like domains of these proteins do not always end in a di-
glycine and this domain is not processed by proteases. The domain is not released as 
in ubiquitin but these proteins are linked to the ubiquitin pathway. An interesting 
example of a UDP is UIP28. UIP28 does not have a di-glycine at the C-terminal end 
of the ubiquitin-like domain. The domain organisation is similar to that of SNAMA 
with a ubiquitin-like domain, a zinc finger domain and a RING finger domain. UIP 
28 interacts with the ubiquitin-conjugating enzyme UbcM4. The domain arrangement 
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of SNAMA, as in UIP28, may indicate a role for SNAMA as a UDP interacting with 
a ubiquitin-conjugating enzyme.   
 
6.4.2 SNAMA IS INVOLVED IN APOPTOSIS 
 
Initial experiments that led to the identification of the DWNN proteins were based on 
the screening of a mutated CHO cell line for resistance to apoptosis inducing agents. 
The resistance developed because of disruption of DWNN expression. Subsequently 
the mammalian SNAMA homologues have been shown to bind Rb and p53. A C-
terminal region of SNAMA aligns with the mammalian PACT protein suggesting that 
SNAMA could interact with proapoptotic molecules such as Dmp53 and RBF. These 
are the D. melanogaster homologues of p53 and Rb, respectively. The RBF protein 
acts downstream of dE2F; a transcription factor that regulates Dmp53 (Du and 
Dyson, 1999). To establish whether SNAMA plays a role in apoptosis, I took 
advantage of a P-element insertion fly line l(2)rQ313. Homozygous offspring 
develop to late embryonic stages and then die because of the P-element insertion in 
the first intron of the SNAMA gene. This gene codes for protein that is vital for 
embryonic development. l(2)rQ313 embryos were stained with the vital dye acridine 
orange. The staining pattern indicated abnormal ectopic apoptosis in late 
developmental stage embryos and early occurrence of apoptosis in the blastoderm as 
compared to wild-type flies. The blastoderm is characterised by rapid nuclear division 
with very limited apoptosis. When the P-element was excised, the staining pattern 
resembles that of wild-type embryos. Further evidence of a link between apoptosis 
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and development is observed in Northern blots where there are reduced levels of 
SNAMA mRNA expression in late stages of development (12-18hrs) when normal 
apoptosis in the embryo is taking place.  
 
Western analysis of embryonic, larval and adult protein extracts identified bands 
recognised by both anti-Dmp53 and anti-SNAMA. This banding pattern is more 
dramatic at larval stages when significant apoptosis takes place. This indicated a 
possible association between Dmp53 and SNAMA. The Western blots also identified 
bands not recognised by the anti-Dmp53 antibody, which suggest that SNAMA 
interacts with other proteins in addition to Dmp53 because of the immunoreactive 
complexes formed with the anti-SNAMA antibody. This is consistent with the 
suggested ubiquitin-like function of SNAMAs DWNN domain. These bands could 
also possibly be degradation products of SNAMA given the presence of proteasomal 
recognition patches on the DWNN domain. But  there is no C-terminal di-glycine in 
the DWNN domain necessary for conjugation. It is however possible that there exists 
some other, yet unidentified, alternative mechanism that allows cleavage of the 
DWNN domain at the conserved Pro76 freeing the domain to associate with Dmp53. 
An alternative to this mechanism would be that SNAMA associates with Dmp53 
forming a bond that is resistant to boiling in SDS. Such associations have been 
observed in the UBL (ubiquitin-like protein) Hub1 (Luders et al., 2003). Although 
Hub1 lacks a C-terminal tail bearing the glycine residue it associates tightly with 
other proteins.  
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Given that no Mdm2 homologue has been identified in D. melanogaster, SNAMA is 
a good candidate regulator of Dmp53 though the mechanism of this regulation has 
not been established. Mdm2 in mammals represses p53 or promotes p53 degradation 
via the proteasomal pathway. The importance of negative regulation of p53 by Mdm2 
was demonstrated in two similar but independent experiments using homozygotes for 
Mdm2 and p53 null alleles (Jones et al., 1995; Montes et al., 1995). Mice deficient 
for both p53 and Mdm2 develop normally and resemble wild-type mice while those 
deficient in Mdm2 only die during embryogenesis. In l(2)rQ313 embryos apoptosis is 
detected very soon after egg laying and homozygous embryos die. SNAMA may be 
the negative regulator of Dmp53 similar to the function of Mdm2 in mammals. 
Dmp53 null homozygotes have normal phenotypes similar to that seen in mammals. 
It should be noted that Dmp53 controls only apoptosis and not cell cycle arrest like 
the p53 protein (Sogame et al., 2003). Interaction of SNAMA with Dmp53 is also 
observed in Western blots on protein extracts from lavae that were fed with 
Camptothecin, an activator of the Dmp53 protein. When the Dmp53 pathway is 
activated by the topoisomerase inhibitor, Camptothecin, the levels of SNAMA 
expression increase and the anti-SNAMA antibody forms immunoreactive complexes 
with both the Dmp53 and SNAMA indicating possible interactions between these 
proteins. Immunoprecipitation experiments using anti-Dmp53 and anti-SNAMA 
antibody also strongly suggest that SNAMA interacts with Dmp53 (Rakgotho, 
personal communication).          
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6.5 CONCLUSIONS  
 
SNAMA is the D. melanogaster homologue of a group of proteins with interesting 
sequence features including a conserved N-terminal DWNN domain that has a 
ubiquitin-like fold, a zinc finger, a RING finger-like domain, a probable p53 binding 
region, and glutamic acid-rich and lysine-rich regions. The domains that associate 
with SNAMA indicate that this protein plays an important regulatory role in the cell 
and may function in RNA processing and in apoptosis. SNAMA may interact with 
Dmp53 probably as a suppressor of apoptosis or a negative regulator of an activator 
of apoptosis. These results are supported by abnormal patterns of apoptosis in 
l(2)rQ313 embryos, the domain configuration,  interactions with Dmp53, and 
increased levels of protein when Dmp53 is activated. The presence of the ubiquitin-
like DWNN domain and the cysteine rich RING finger-like region also suggests that 
SNAMA could be a ubiquitin domain protein with ligase activity. This would enable 
the domain to be cleaved from SNAMA and attached to a subset of cellular proteins 
posttranslationally. The exact function of the SNAMA system has got to be 
determined. The identification of possible substrates should identify its possible 
physiological roles.  
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